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ABSTRACT 
 
Many essential proteins require the assistance of molecular chaperones to 
achieve and maintain their native, folded conformations.  The E. coli GroEL-ES 
chaperonin system is capable of aiding the folding of the cellular proteome through 
several distinct mechanisms, including the blocking of intermolecular aggregation, the 
confinement of substrate proteins inside the GroEL-ES cavity, and the forced unfolding 
of substrate proteins to reinitiate the folding process.  This study describes the role of the 
C-terminal residues of the GroEL protein enhancing of the folding of substrate proteins. 
The 23 C-terminal residues of the GroEL monomer partially consist of four 
tandem repeats of a Gly-Gly-Met motif, leading to an intrinsically disordered 
conformation.  Visualized using cryo-electron microscopy, these residues extend from 
the bottom of a GroEL cavity and interact with substrate proteins both before and during 
the folding process; removal of these residues leads to deficiencies in substrate protein 
encapsulation and folding.  Interactions between the C-terminal tails of GroEL and the 
substrate protein lead to changes in both the conformation of the substrate protein and 
the binding position on the GroEL cavity surface before folding begins.  These changes 
result in the substrate protein adopting a more unfolded state and migrating deeper into 
the cavity.   
These effects were observed with two distinct substrate proteins, the carbon-
fixing enzyme RuBisCO and the metalloprotease PepQ, which have unrelated, dissimilar 
structural folds.  Changes in the subsequent intra-cavity folding relative to folding in the 
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absence of the GroEL C-termini were also observed for both proteins, indicating altered 
utilization of folding pathways or intermediates.  Significantly, these alterations of 
substrate protein conformation and folding, which lead to the enhancement of folding 
rate, are independent of any passive mechanism of preventing aggregation, as PepQ has 
no propensity for aggregation under the employed conditions.   
The results of this study show that GroEL can actively enhance the folding of 
proteins by altering the conformation of the substrate protein, thus changing the folding 
pathway and directing it towards the native-state.  
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CHAPTER I 
 INTRODUCTION 
A History of Protein Folding 
Proteins are synthesized by the ribosome as unstructured chains of amino acids 
that often need to adopt stable, three-dimensional structures.  These three-dimensional 
structures are required for the activity of many proteins, as the structure of each protein 
creates specific binding sites for ligands or positions amino acid residues correctly for 
the catalysis of chemical reactions.  For viability, cells require thousands of different 
processes to occur; therefore, the proteins that perform these processes have evolved 
many different structures.  From barrels to propeller-like structures, each protein starts 
from an unfolded form.  The process of a protein transitioning from an unstructured to a 
structured conformation is commonly referred to as protein folding. 
‘Protein’ is a common term in current times, both inside and outside of the 
scientific community.  This term originated in the early 1800s in a letter sent from the 
Swedish chemist Jöns Jacob Berzelius to the Dutch chemist Gerardus Johannes Mulder 
[1].  In his examination of proteins, Mulder determined that these molecules were 
significantly larger than the molecules that chemists at the time generally examined, with 
proteins having an average molecular weight of ~8.8 kDa [2,3].  Mulder believed that 
all proteins were nearly identical in chemical composition [ 2,3], and the determination
that several proteins had similar compositions suggested that all proteins were related 
macromolecules [4].  Although it took nearly 100 years, this 
2 
concept was partially confirmed when all of the common amino acids were finally 
discovered [5,6].  Eventually, the peptide theory was introduced by both Fischer and 
Hofmeister [7-9]; this theory stated that proteins are comprised of chains of amino acids. 
Although proteins were known to be comprised of one or more peptides, the assembly of 
these peptides into proteins remained a point of contention [9].  Methodologies were 
developed for determining the amino acid composition of proteins, as well as the 
sequence of those amino acids in the polypeptide chain [10-19].  These advances led to 
the initial characterization of many proteins [20-22], thus demonstrating the validity of 
the peptide theory and revealing the polymeric nature of proteins. 
Proteins were known to adopt stable, compact structures [23,24], but the forces 
that held proteins together were not known.  Understanding the chemical properties of 
the amino acids allowed for predictions to be made concerning the interactions that 
stabilize protein structure.  Although hydrogen bonds were presented as potentially 
ubiquitous, stabilizing interactions inside of proteins [25], there was little direct evidence 
supporting this concept.  However, having been observed in many proteins and with a 
known importance in insulin [14,26,27], disulfide bonds were considered to be an 
important, stabilizing, structural element in proteins; many early theories were explained 
or rebutted only by the observed effects on sulfhydryl groups [28].  The mechanisms 
leading to the altered accessibility of these groups upon the exposure of a protein to 
various chemicals (e.g. urea, gaunidinium, and detergents) were unknown, but it was 
known that the structure of the protein changed into a more open state under these 
conditions [29].  The inactivation of protein activity, structure, and other observable 
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properties with exposure to changed temperature, pH or the presence of the 
aforementioned chemicals was found to be reversible for many proteins [28,30-34].  
This demonstrated that proteins could adopt multiple conformations, and that proteins 
were designed to return to the functional state.  It was postulated that this could serve as 
a control mechanism for regulating protein function in vivo [28].  These observations 
involving the renaturation of proteins after exposure to chemical or thermal denaturation 
are considered the first developments in the field of protein folding.  
The advancement of protein crystallography revolutionized many aspects of 
biology and biochemistry.  Although the first crystal structures of whole proteins were 
not solved until the late 1950s [35-39], earlier structures existed of amino acids, small 
peptides, and protein fragments [40-43].  The observed bond lengths and angles in these 
structures allowed scientists to begin formulating hypotheses about protein structure 
with greater detail and accuracy.  Linus Pauling cemented his previous predictions on a 
role for hydrogen bonding in the accurate description of alpha-helices and beta-sheets 
[44,45].  The importance of hydrophobic interactions in the core of proteins was also 
gaining prominence [46-48].  With a greater understanding of the non-covalent forces 
that stabilize protein structure, protein chemists theorized that the unfolding and 
refolding of proteins caused by altered temperature or the presence of chemical 
denaturants was dominated by the loss or gain of protein tertiary structure [49]; the 
extent of secondary structure loss in protein denaturation was realized fully with the 
advancement of spectrophotometric methods [50-54].  This greater knowledge of protein 
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structure and the observed reversibility of protein denaturation are the cornerstones of 
the modern theory of protein folding. 
The process of protein folding was deduced thus: hydrogen bonding drives the 
formation of secondary structures, which then fold upon themselves and are stabilized by 
disulfide bonds and other interactions between physically adjacent side chains [49].  
Because proteins could undergo this process spontaneously and repeatedly, it was 
postulated that the primary structure of the protein encoded the instructions for the 
folding of the protein [49].  Although the reversibility of denaturation had been shown in 
many proteins, the strongest support for this hypothesis was found in the detailed studies 
on the refolding of ribonucleases led by Christian Anfinsen [54-61].  Anfinsen found 
that bovine pancreatic ribonuclease could efficiently and independently adopt its native 
conformation after being completely denatured, as long as incorrect disulfide bond 
formation could be reversed.  This demonstrated that other proteins or macromolecules 
were not required for the correct folding of ribonuclease.  Anfinsen expanded the theory 
of protein folding with his “thermodynamic hypothesis,” stating,  
“the three-dimensional structure of a native protein in its normal physiological 
milieu (solvent, pH, ionic strength, presence of other components such as metal 
ions or prosthetic groups, temperature, and other) is the one in which the Gibbs 
free energy of the whole system is lowest; that is, that the native conformation is 
determined by the totality of interatomic interactions and hence by the amino 
acid sequence, in a given environment” [62]. 
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This hypothesis eventually became known as Anfinsen’s Dogma.  Despite the 
ability of ribonuclease to fold independently, the refolding process occurred on the 
timescale of hours [56,57].  Although this result seemed too slow for Anfinsen [59], 
Cyrus Levinthal noted that if protein folding occurred through a random sampling of 
conformations, the time required for a small protein to sample every possible 
conformation would be longer than the lifetime of the universe [63].  “Levinthal’s 
Paradox” suggests that proteins must fold in a piecemeal and sequential manner [64-66], 
where small domains or individual secondary structural elements of the protein fold 
independently and then assemble together to form the final, native conformation. 
  One prediction of a stepwise folding process is the formation of intermediate 
conformations.  Earlier denaturation studies, however, suggested that proteins fold and 
unfold in a two-state process: in the presence of a denaturant, a protein is either folded or 
unfolded, and it does not adopt intermediately-folded states [28,62,67].  Although this 
two-state assumption applied to many small proteins, biophysical studies of many 
proteins revealed intermediate conformations and multi-step folding pathways [65,67-
74].  For the folding of larger proteins, the molten globule theory was suggested, where 
in the earliest stages of folding, the protein collapses into a loosely-associated globule-
like conformation [75-77].  This collapse is partially compelled by the entropic drive of 
hydrophobic residues away from water and the enthalpically favorable van der Waals 
interactions that are made among those residues [75,78].  These energetically favorable 
changes offset the reduction of conformational flexibility (and therefore, entropy) in the 
protein upon early secondary structure formation.  This compact intermediate has fewer 
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degrees of freedom in sampling the interactions between residues, which reduces the 
time required to sample and adopt the native structure [79].  With models suggesting 
globules and pathways in the folding of proteins, it became clear that most large proteins 
do not always fold through a defined set of intermediates. 
Despite the consideration of this globule conformation as the first intermediate in 
a folding pathway, the “molten” aspect of this intermediate led to the drastic expansion 
of pathway models.  The molten globule itself was not considered as one static structure, 
but rather as a collection of similar conformations [78].  Likewise, every intermediate in 
the folding pathway could represent a number of similar conformations.  Due to the 
differences in these conformations, the available interactions that could be sampled in 
the progression towards other intermediate conformations could lead to a branching of 
the folding pathway [78,80,81].  The theory of protein folding, which was originally 
thought to occur through two-state transitions, had progressed to folding funnels and 
landscapes, where a myriad of conformations exist between the unfolded and native 
states [81-85].  While multiple pathways down these funnels can yield the native 
conformation of the protein, other intermediates can proceed into non-productive 
conformations.  These non-native proteins not only lack the function of the native 
protein but can also have other effects on the cell.       
 
Troubled Folding and Protein Folding Diseases 
 While thermodynamic forces drive protein folding, many challenges can occur 
that lead a protein to a non-native structure.  Despite the prediction of Anfinsen’s dogma 
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that the primary structure of a protein is sufficient for determining the structure of the 
native conformation, Anfinsen’s hypothesis failed to account for the kinetic variables of 
protein folding.  In the course of his studies, Anfinsen observed both incorrect folding 
(also referred to as misfolding) and slow folding of RNase A [55,57,58], complications 
he attributed to incorrect disulfide bond formation [62].  These misfolded proteins have 
adopted a non-native conformation in a low-energy state that is kinetically trapped, 
preventing the return to a previous conformation through the nearly insurmountable 
energy requirements of covalent bond rearrangement [58,59,61].  Although he was able 
to observe the fast, productive folding of proteins without disulfide bonds [68,86], the 
observation of non-native states with RNase A was an early demonstration that the 
lowest-energy state may not always be the fastest-forming conformation. 
 Unproductive folding and the formation of non-native products are not issues 
limited solely to RNase A or disulfide-containing proteins.  Many proteins from many 
organisms have been shown to be unable, in whole or in part, to obtain their native 
conformations independently [30,87-90].  Included in this group are globally essential 
proteins, such as the carbon-fixing enzyme ribulose-1,5-bisphosphate 
carboxylase/oxygenase (RuBisCO) [87,91], and proteins implicated in human disease, 
such as cystic fibrosis transmembrane conductance regulator (CFTR) [92-94].  Although 
only 20-30% of wild-type (unaltered) CFTR is correctly folded and trafficked inside the 
cell (with the remaining 70-80% being degraded) [92-94], the fraction of CFTR that is 
functional is sufficient for viability.  Variations in the amino acids sequence (commonly 
referred to as mutations) in CFTR lead to a nearly complete failure of this protein to fold 
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and be further processed by the cell [94-96].  For example, in the most common disease-
associated mutant of CFTR (∆F508), the protein is trapped in an early folding 
intermediate that is subsequently degraded [94].  The loss of the CFTR protein leads to 
an imbalance in salt and water in tissues, and in the lungs, the result is a build-up of 
mucus that promotes bacterial and viral infections [97].  Such infections are commonly 
the cause of death for those bearing mutations in CFTR [97,98]. 
The inability to fold productively is at the core of not only cystic fibrosis but also 
many other diseases such as short-chain acyl-CoA dehydrogenase deficiency and 
phenylketonuria [99-101].  In many cases, however, non-native proteins interact with 
each other, forming non-native oligomers that are commonly referred to as aggregates.  
Aggregation is driven by compatible binding regions on the surfaces of non-native 
proteins; these surfaces could be comprised of entire folded domains or of exposed 
hydrophobic residues that are normally buried within the protein structure [102-107].  
Aggregation can occur from any state in the folding process, including the unfolded 
state, intermediate conformations or even after a protein has acquired the native fold 
[105,108-110].  Not only does aggregation lead to a loss of the protein, but these 
aggregates can also interfere with other cellular functions, such as membrane stability 
[111]. Both the direct and indirect effects of aggregation can cause disease states [112-
116].  Protein aggregation is the basis of many neurodegenerative diseases, including 
Alzheimer’s, Parkinson’s, and Creutzfeldt–Jakob disease [115,117-119]. 
  
 
9 
Although Alzheimer’s and cystic fibrosis are very different pathologically, both 
of these diseases, as well as many others, stem from a failure of proteins to reach and 
maintain a native state conformation. 
 
GroEL: the Essential Folding Machine 
 Although protein folding diseases predominantly affect human tissues and 
organs, these complications originate from protein misfolding and aggregation inside 
individual cells.  At the cellular level, preventing and repairing these two problems does 
not serve to prevent disease, but rather to recover proteins with the goal of restoring the 
proteins to their intended function or reducing them to individual amino acids to be used 
elsewhere.  The process of preventing and repairing protein misfolding and aggregation 
is tasked to a set of proteins in the cell known as molecular chaperones [120-122].  
These proteins have different structures, specificities, and capabilities, but all work 
together to maintain cellular proteostasis [120,123-127].  A central hub in the network of 
molecular chaperones is the Hsp60, a protein responsible for folding unfolded or 
refolding misfolded substrate proteins. 
 The first Hsp60 to be discovered and identified was the protein GroEL from 
Escherichia coli.  In the pursuit of identifying important host interactions, phage 
biologists isolated E. coli colonies that were non-permissive for bacteriophage lambda 
due to mutations in genes other than lamB, which encodes the lambda receptor [128].  
Identification of the E. coli gene responsible for this phenotype relied on a 
complementation experiment done by phage-mediated, specialized transduction.  In the 
10 
case of the Hsp60, plaque-forming isolates contained the segment of the E. coli genome 
containing the groE gene, which was named for the requirement of this gene for lambda 
growth and for its role in the proper assembly of the major capsid protein (encoded in 
the phage gene E) [128-130].  Restriction mapping and further complementation 
experiments led to the isolation of groE.  Through other phage-insensitive E. coli 
mutants and additional complementation experiments, the groE locus was found to 
contain two genes designated as groEL and groES (for large and small respectively) 
[130-132].  These proteins were subsequently identified to be essential for not only the 
propagation of other bacteriophage, including T4 and P22, but for the host E. coli as well 
[133-140]. 
Identified as host genes required for phage development, groEL and groES 
remained without a characterized function.  Electron microscopy revealed that in 
bacteria carrying mutations in groEL and groES, misshapen phage particles were 
produced [128,132], suggesting a role in capsid assembly.  However, the defect in phage 
morphogenesis was not identical across the different phage types, as some phages had 
blocked head production while others had defects in tail assembly [128,136-139]. 
Despite considerable research connecting the groE genes with bacteriophage, the role of 
GroEL and GroES was determined in other biological systems.  Several important 
breakthroughs were made in examining the influence of GroEL on β-lactamase, a 
periplasmic protein that is used by bacteria to inactivate penicillin-like antibiotics. 
Research revealed that GroEL interacts with precursor β-lactamase (pre-Bla), an 
unfolded polypeptide in the cytoplasm that must be exported before maturation [141]. 
11 
This was the first report of GroEL interacting with unfolded proteins.  Furthermore, the 
interaction between the pre-Bla and GroEL was stable for extended periods of time, 
maintaining pre-Bla in a state competent for later export and maturation [141-143]. 
Addition of adenosine triphosphate (ATP) abolished the interaction between the two 
proteins, liberating pre-Bla for transport across the cytoplasmic membrane [144]. 
Beyond establishing a role for GroEL in binding unfolded proteins, the initial study with 
pre-Bla also advanced the characterization of GroEL.  GroEL was shown by electron 
microscopy to form tetradecamers that adopt a ring-like structure [141].  This study with 
pre-Bla represented a major step forward in understanding both the structure and 
function of GroEL. 
The observed interaction between pre-Bla and GroEL lead to further studies 
exploring the interaction between GroEL and other exported proteins.  GroEL was found 
to interact with proOmpA and prePhoE, both of which are precursor forms of outer 
membrane proteins of E. coli [145].  Because GroEL could maintain exported proteins in 
a soluble form before being trafficked to the membrane, it was named a chaperone 
protein.  While GroEL was found to bind various unfolded, non-native proteins, it was 
found to be incapable of binding soluble, folded proteins [145].  The gene product of the 
second component of groE, GroES, was found to form heptamers with no affinity for 
either folded or unfolded proteins [131,145,146].  The notion that GroEL and GroES 
work in concert to support the folding of proteins was first hypothesized after a study of 
plant RuBisCO assembly, because in chloroplasts, RuBisCO requires a GroEL homolog 
known as the RuBisCO-binding protein [91].  Further research demonstrated that GroEL 
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or its homologs can enhance the folding of a number of proteins, including bacterial 
RuBisCO, chicken DHFR, and bovine liver rhodanese, providing additional evidence for 
a general role for GroEL in folding proteins [87,147-151].  The advancement of 
biochemical techniques drove the chaperonin field, with new molecular biology methods 
allowing the creation of GroEL mutants and new biophysical methods allowing the 
examination of different aspects of protein folding.  Although electron microscopy had 
previously revealed the crude structure of the chaperone, the crystal structures of GroEL, 
both apo and bound to GroES, provided key insights into the binding of ligands and the 
functioning of the chaperonin [152-154].  These structures allowed the creation of site-
directed mutants of GroEL that could be used to determine specific details about its 
function. 
With a greater understanding of the role and structure of GroEL, mechanistic 
details were becoming clearer.  One component of GroEL function is the reaction cycle: 
the binding and release of substrate protein, ATP and GroES in an ordered manner, 
timed by the hydrolysis of nucleotide (Figure 1.1).  In vivo, each GroEL tetradecamer is 
predominantly found in complex with one GroES heptamer, forming a closed cavity on 
one ring of GroEL [155-157].  This GroES-bound ring is referred to as the cis ring or cis 
cavity [154].  The entire complex is referred to as a GroEL-ES ATP bullet, named for 
the shape that the complex adopts and the fact that each GroEL monomer in the ring is 
bound to ATP.  The open, or trans, ring of this bullet contains ADP, a product of the 
ATP hydrolysis from the previous reaction cycle [158-160].  This trans ring binds to a 
substrate protein, triggering the release of the ADP from the same ring [159].  With the 
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Figure 1.1: The GroEL Reaction Cycle.  At the beginning of the reaction cycle, an 
ADP-bound cis GroEL ring (green ring, i) is unoccupied and can bind to a substrate 
protein.  The binding of a substrate protein to an open cis ring leads to the dissociation of 
ADP from that ring (ii).  At the same time, ATP in the trans ring (white ring) hydrolyses 
(ii and iii).  Once the nucleotide binding sites in the cis ring are unoccupied, ATP binds 
(iii).  ATP binding leads to the release of the substrate protein from the GroEL cavity 
wall.  Immediately after ATP binding, the cis ring then binds GroES (iii).  GroES 
binding creates a closed cavity in which the substrate protein is encapsulated (iv).  ATP 
binding in the cis ring also leads to the dissociation of GroES and any encapsulated 
protein in the trans ring (iv).  Inside the newly-formed GroEL-ES cavity, the substrate 
protein can fold (v).  This complex (v) is identical to the starting complex (i), thus 
resetting the reaction cycle. 
 
 
 
 
 
 
 
 
  
 
14 
nucleotide binding sites open, ATP binds to this open ring, leading to major 
conformational changes in both rings due to the effects of both intra- and inter-ring 
allostery [154,159,161,162].  In the cis ring, the GroES dissociates, opening the cavity 
and facilitating the release of the enclosed substrate protein [163,164].  In the trans ring, 
large structural changes in the apical domains lead to several outcomes (Figure 1.2).  
First, the size of the cavity is expanded from ~80,000 Å3 to ~175,000 Å3 (Figure 1.2A 
and 1.2B) [152,154], which provides sufficient volume for a folding protein with a 
molecular weight of ~60 kDa.  Second, the expansion of the cavity simultaneously 
expands the conformation of the bound substrate protein.  This expansion is concomittal 
due to the strong interaction between specific hydrophobic residues of GroEL and the 
exposed hydrophobic residues of a substrate protein [165,166].  The physical extension 
of the bound substrate protein disrupts residual secondary and tertiary structure, leading 
to a more unfolded state [166-169].  Third, the binding sites on GroEL for the substrate 
protein and GroES are concurrently altered [154].  The region of the apical domains that 
was previously bound to the substrate protein has a changed orientation and position, 
diminishing the hydrophobicity of the surface (Figure 1.2C and 1.2D).  Interactions 
between these GroEL residues and the substrate protein provide for the high-affinity 
binding [170], so upon the conformational change in GroEL, the chaperone’s affinity for 
substrate proteins is greatly diminished.  This transition yields the release of the bound 
substrate protein from the GroEL cavity wall [158,171,172].  At the same time, regions 
of the apical domain are reoriented to the surface of the protein, exposing the binding 
sites for GroES and allowing the cochaperone to form a closed cavity with GroEL  
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Figure 1.2: Structures of GroEL before and after ATP and GroES Binding.  (A) The 
structure of the GroEL tetradecamer without ATP bound (PDB # 1SS8).  One of the 
seven monomers of each ring is shown in orange.  (B) The GroEL-GroES7 complex 
(PDB # 1AON) after nucleotide binding.  The cis ring (yellow, with one orange 
monomer) has expanded in size relative to the apo ring (A) and can now bind GroES 
(blue).  (C)  The substrate protein binding sites (orange) account for a large surface of 
the apical domain of each monomer (different colors) in apo GroEL.  (D) After 
nucleotide binding, the same residues (orange) that comprise the substrate binding site in 
(C) have translated upwards and outwards.  These residues are now involved in binding 
GroES (GroES not shown). 
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[154,171,172].  Once this process is complete, GroEL has undergone a half cycle of the 
reaction.  Since the trans ring is now bound to GroES, it has become the cis ring, and 
vice-versa.  While a substrate protein folds in the new cis cavity, the new trans ring is 
competent to bind another substrate protein and continue the cycle.        
Despite clarifying the complicated role of substrate binding behind the 
conformational changes of the chaperonin, these details do not explain the mechanism 
by which GroEL aids in the folding of substrate proteins.  Early in the study of the 
chaperone reaction cycle, when protein folding was emerging as the likely role for 
GroEL, a debate arose concerning the release of substrate proteins into bulk solution 
during the folding process [127].  Although it would seem counterintuitive, some 
believed that unfolded proteins were released by the chaperonin into solution, where 
these proteins could then attempt to fold independently [164,173].  This theory became 
known as kinetic partitioning, because a substrate protein released from GroEL would 
fold productively with some probability and, depending on the outcome, would then 
partition into free solution or back to the chaperone.  In this model, GroEL only served 
to unfold kinetically-trapped, non-native conformations of proteins, and the folding of 
the protein was entirely spontaneous [173-175].  Others contended that GroEL 
maintained contact with substrate proteins until productive folding was accomplished 
[155,176].  This concept emphasized the role of the GroEL-ES cavity in altering the 
energy landscape of a protein during the folding process.  By reducing local energy 
minima, the chaperone could prevent or reverse substrate protein misfolding.   
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Although further work demonstrated that GroEL does release non-native proteins 
during the reaction cycle, the kinetic partitioning model was refined to account for the 
timing of the release of the substrate protein into solution [177,178].  After the 
encapsulation of a substrate protein inside the GroEL-ES cavity, a certain amount of 
time passes before the cavity is resolved and the substrate protein released 
[157,159,163].  There are two possible outcomes for the released substrate protein: it 
folded to a conformation that can only progress productively along the folding pathway, 
or it folded incorrectly or incompletely.  In the first scenario, the substrate protein has 
reached a committed state in which the protein no longer associates with GroEL and 
from which correct folding can be accomplished independently.  In the second scenario, 
the substrate protein remains in a conformation that is competent for GroEL-binding, 
allowing the substrate protein to partition back to the chaperone. 
The development of the kinetic partitioning model required an alteration in the 
proposed mechanisms of chaperonin function.  Besides acknowledging that substrate 
proteins are released into solution during the reaction cycle, the model that proposed a 
role for GroEL in altering how a protein folds remained mostly unchanged, stressing that 
interactions between the chaperone and the substrate protein prevent misfolding.  This is 
known as the cavity confinement model, as the interactions necessary for promoting 
folding occur within the GroEL-ES cavity [179,180].  The original supporters of the 
kinetic partitioning model proposed two new theories.  First, under the assumption that 
all proteins can fold independently, a model was developed asserting that the only role of 
the GroEL cavity is to block intermolecular interactions, particularly aggregation [181-
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183].  This became known as the passive- or Anfinsen-cage model, so named for 
Christian Anfinsen, who originally postulated that the primary structure of a protein 
alone was sufficient determining the native conformation [62].   
The second theory derived from kinetic partitioning maintained the significant 
role of substrate protein unfolding by the chaperonin [184-188].  In this model, the 
primary role of GroEL is to unfold kinetically-trapped conformations, resetting the 
substrate protein to a high-energy state from which the protein can fold.  Increasing the 
energy in the substrate protein is accomplished by two GroEL-mediated processes: the 
annealing of the substrate protein to the GroEL apical domain and the expansion of the 
substrate protein conformation upon the binding of ATP to GroEL 
[166,168,185,187,188].  This model became known as the iterative annealing model, 
because substrate proteins undergo multiple rounds of binding and unfolding with the 
chaperone before productive folding is achieved.  As the chaperonin field grew, the 
cavity confinement and iterative annealing models eventually fell under one umbrella, 
termed the active model.  The active model attributes the ability of GroEL to stimulate 
folding to the changing of the energy landscape of the substrate protein during the 
folding process through specific interactions between the chaperone and the substrate 
protein [189,190].                    
Each of these three mechanisms attributes the ability of GroEL to assist folding 
to some component of the chaperone structure.  The Anfinsen-cage model relies on the 
GroEL-ES cavity separating the substrate protein from the cellular environment; the 
cavity confinement model depends upon interactions between the substrate protein and 
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the GroEL cavity wall; and the iterative annealing model focuses on the expansion of the 
apical domain upon nucleotide binding.  These distinctions may be clear, but the data 
that supports each of the models is not so distinct.   
The primary argument for the Anfinsen-cage model is that many GroEL-
dependent substrate proteins have a high propensity for aggregation [90,191-194].  
Additionally, proteins are more prone to aggregation at higher temperatures, at times of 
cell stress, and when expressed at higher levels [195].  Many GroEL-dependent substrate 
proteins are highly abundant in the cell [89,90,196], so any perturbation in cellular 
homeostasis could result in a shift in the protein population towards an aggregated state.  
Although other chaperones, such as DnaK, can block aggregation, the clamp-like contact 
between those chaperones and a substrate protein can also inhibit productive folding 
during the lifetime of the interaction [197].  Because GroEL is capable of physically 
excluding a folding protein from the interactions of the cellular environment without 
maintaining a physical hold on the substrate protein [193,198], Ockham’s razor suggests 
that GroEL exists to prevent this aggregation problem during protein folding.  Besides 
this argument, biochemical data also supports the concept that GroEL functions as an 
Anfinsen cage.  The folding rate of some proteins is not enhanced by the chaperone, 
indicating that GroEL cannot accelerate folding beyond the limit imposed by the primary 
structure [199-201].  The yield of folded protein is often a function of the concentration 
of the substrate protein in solution, with higher concentrations of protein leading to an 
increased dependence on the chaperone [149,195,201,202].  This concentration 
dependence indicates that the complication in the folding of these proteins is a 
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multimolecular process.  Besides the assembly of native monomers into oligomers, any 
multimolecular process in protein folding would constitute aggregation, an unwanted, 
off-pathway product.  In this passive model, the simple isolation of substrate proteins 
inside of the GroEL-ES cavity prevents the formation of aggregates and allows folding 
to occur as dictated by the primary sequence of the substrate protein.   
Contrary to the notion that all proteins can fold independently, the active models 
define a role for GroEL in altering the folding landscape of the interacting substrate 
protein.  The first active model, the cavity confinement model, is supported by several 
observations, the most important of which is that the folding rate of proteins can be 
stimulated by intra-cavity folding in the GroEL SR1 mutant [88,199,203-205].  The SR1 
mutant is comprised of only a single, tetradecameric ring and forms complexes with 
GroES that are very long-lived [177].  In the caviy of this GroEL7:GroES7 complex, a 
substrate protein can fold in the absence of iterative annealing.  Moreover, the folding 
rate of many proteins is the same in this non-cycling, single-ring mutant and in the 
cycling, wild-type chaperone [163,206].  These observations suggest that the unfolding 
action of the chaperone is not necessary for folding.  The ability to fold in SR1, however, 
could easily be attributed to blocking intermolecular interactions that lead to aggregation 
[193].  To counter this notion, the folding of proteins that have no propensity for 
aggregation has been examined and found to be stimulated as well [88,205].  Beyond 
enhancing the ability to fold, the chaperone can induce changes in the folding pathway.  
A common observation that supports the cavity confinement model is that proteins 
undergo a compaction event inside the cavity [166,168], which is generally attributed to 
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a hydrophobic collapse that is thought to be common to the folding of most proteins 
[77,81].  The compaction of a substrate protein is taken as the result of unfavorable 
interactions between the charged residues on the surface of the GroEL cavity wall and 
the hydrophobic residues that often comprise the core of a folded substrate protein 
(Figure 1.3) [179,199,207,208].  Supporting this theory, alteration of these charged 
residues on the inner surface of the GroEL cavity reduces the stimulation of substrate 
protein folding [203,204].  The folding of some proteins may not be driven by a 
hydrophobic collapse [80,81], so if GroEL promotes the compaction of a substrate 
protein, it may affect some components of protein structure or folding more than others.  
This unequal stimulation was observed in a recent study that showed the folding of a 
core component of the protein structure to be vastly accelerated, while the folding of 
other components was not as stimulated [88].  Together, biochemical and biophysical 
data suggests a role for confining substrate proteins inside the GroEL-ES cavity as a 
means of driving protein folding.   
Many of the observations used to support the cavity confinement model can also 
be used to support the iterative annealing model.  Although folding in SR1 and wild-type 
GroEL is often reported as occurring at the same rate, these experiments were done at 
(or near) 25˚C [159,163,192,199,203,204,209].  A key prediction of the iterative 
annealing model is that any change that enhances the rate or magnitude of substrate 
protein unfolding results in an increased stimulation of folding [188].  Until structural 
stability is compromised, the activity of enzymes increases as a function of temperature 
[210].  Although the folding action of GroEL is not a chemical reaction, the ATPase  
  
 
22 
 
Figure 1.3: Charged Residues on the Surface of the GroEL-ES Cavity.  The presence of 
hydrophilic residues, and specifically charged residues, is important for the cavity 
confinement model of GroEL function.  The oxygen atoms of the sidechains of aspartic 
acids and glutamic acids are shown in red.  The nitrogen atoms of the sidechains of 
lysines and arginines are shown in blue.  These residues are only colored for one 
monomer of GroEL and one monomer of GroES. 
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activity of the chaperone qualifies.  As the cycling rate of GroEL is dependent on the 
ATPase rate, increasing the temperature would result in an increase in cavity turnover.  
This prediction was confirmed experimentally: an increase in temperature resulted in 
both an increased turnover rate and an increased folding rate [159].  An increase in 
temperature had no effect on folding in the SR1 mutant [159], however, indicating that 
the stimulation of folding by cavity confinement may be limited by some other variable.  
This variable may be the binding-driven unfolding of substrate proteins that occurs on 
the GroEL apical surface before encapsulation within the GroEL-ES cavity.  After a 
substrate protein is bound on the apical domains of a trans ring before encapsulation, it 
adopts a more unfolded conformation over time [166].  When this substrate protein is 
eventually encapsulated, the fraction that folds immediately (within the first ten seconds) 
increases as a function of the pre-encapsulation incubation time [166].  Therefore, 
increasing the extent of unfolding prior to encapsulation increases the ability of substrate 
proteins to fold on the physiologically-relevant timescale of the cycling chaperone.  
Despite the importance of iterative annealing in GroEL-mediated folding, this 
stimulation requires the presence of GroES [150,173,176,211,212].  This suggests that 
the benefits of unfolding exist only when coupled with confinement inside the cavity, 
indicating the requirement of at least two of the proposed mechanisms for the 
enhancement of folding. 
A small selection of proteins, chosen for their physiological relevance and 
availability, was utilized in the testing of these models, although few were proteins with 
which GroEL naturally interacts in the E. coli cytoplasm.  To investigate the magnitude 
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of chaperone interactions inside the cell, a proteomics survey was undertaken [89].  By 
trapping substrate proteins inside the GroEL-ES cavity and purifying these complexes, it 
was possible to identify ~250 E. coli proteins that interact with the chaperonin.  
Acquiring data on the entire proteome allowed for a comparison of proteins that interact 
with the chaperone, leading to the categorization of proteins into three classes.  Class I 
proteins bind GroEL but do not need the chaperone to fold.  Class II proteins do not have 
an absolute requirement for GroEL but greatly benefit from the interaction.  Class III 
proteins are incapable of folding without the assistance of the chaperone.  This third 
group consists of ~85 proteins, 13 of which are essential for cell viability.   
This proteomics study in the lab of Ulrich Hartl [89], and a second, independent 
proteomic survey [90], demonstrated the broad specificity of the chaperone and 
explained that the necessity of GroEL for cell viability stems from the essential roles of 
some of its substrate proteins.  It was found that although GroEL interacts with ~250 
proteins, the ~85 class III proteins populate the chaperone ~80% of the time.  The 
explanation for this discrepancy may be found in the folding of an obligate substrate 
protein, RuBisCO, which does not come from E. coli but rather from the bacterium 
Rhodospirillum rubrum.  This RuBisCO, like all RuBisCO homologs from bacteria to 
plants, requires GroEL to fold [87,91,148], but the fraction that is folded after a single 
turnover in the reaction cycle is not 100% [87,148,163,192,209].  Rather, RuBisCO 
requires multiple rounds of folding with the chaperone machinery to reach a maximal 
yield [159,163,192].  If this is true of many obligate substrate proteins, then the proteins 
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that require GroEL can only rebind to the chaperone after a failed folding attempt, 
whereas non-obligate substrate proteins are capable of folding independently. 
Despite the importance of GroEL in E. coli, in phage growth, and in the 
mitochondria and chloroplasts of eukaryotes, GroEL is not universally conserved.  In a 
small number of genera of the bacterial family Mycoplasmataceae, a GroEL homolog is 
not found in the genome [213].  Importantly, although these organisms maintain smaller 
genomes, they also maintain many of the essential proteins that are obligate GroEL 
substrate proteins in E. coli [214,215].  There are two explanations for this phenomenon. 
First, in organisms such as Ureaplasma urealyticum, the concentration of the osmolyte 
urea under normal growth conditions is comparatively very high [215,216], and this 
osmolyte has been shown to influence the thermodynamics of protein folding [217-219]. 
The second group of organisms is the bacteria in the Mycoplasma genus.  These bacteria 
are minimalist parasites that survive by importing every possible nutrient from the host 
organism [220].  A component of this minimalist nature is a reduced genome consisting 
of ~500 kbp [214].  While a decreased production of protein can reduce the stress on the 
folding proteome [221,222], other changes may have occurred in the evolution of these 
bacteria. 
The Mycoplasma homolog of DapA, which is GroEL-dependent in E. coli, can 
fold spontaneously under conditions incompatible with E. coli DapA folding [88]. 
Examination of the folding of E. coli DapA, both spontaneously and when chaperone-
mediated, revealed that the folding of specific segments of DapA was accelerated when 
folding with GroEL [88].  In the spontaneous folding of the Mycoplasma homolog, the 
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folding of these same segments was also accelerated.  This suggests that the evolution of 
this Mycoplasma protein has altered its folding pathway to adopt changes similar to 
those effected by the chaperone.  The similarities in the chaperone-mediated folding of 
E. coli DapA and the spontaneous folding of Mycoplasma demonstrate that the 
utilization of alternative intermediate conformations is an effective strategy for the 
improvement of folding, regardless of whether this change in folding pathway is the 
effect of mutation or chaperone involvement. 
The Specialization of GroEL Function 
Due to the requirement of GroEL to aid the folding of hundreds of different 
proteins, the chaperonin has maintained broad specificity over billions of years of 
evolution.  However, this specificity is not cast in stone and can be adjusted by 
mutations in either GroEL or GroES.  For example, the ability of GroEL to propagate 
phage can be abolished by single nucleotide polymorphisms without abolishing the 
chaperone’s capability to fold essential bacterial proteins [223].  Alternatively, GroEL 
can be mutated to specifically enhance the folding of one protein [224].  This 
enhancement, however, creates deficiencies in the chaperone-mediated folding of other 
proteins.  Throughout evolution, GroEL has likely mutated to strike the correct balance 
among all of its substrate proteins to assure the greatest benefit for cellular fitness. 
In some organisms, gene duplication events have led to multiple copies of the 
chaperonin gene in the genome.  The number of groEL genes in a single organism has 
been observed to be as high as eight [213].  In these cases, one copy of the gene is 
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maintained with broad specificity for the housekeeping function of folding many 
proteins, and other copies of the gene acquire mutations for a specialized function.  This 
function is often the folding of one or more specific proteins that are essential for a 
specific cellular behavior or function [213].  Despite having conserved sequences and 
maintaining the structure of the housekeeping chaperonin, these specialized variants of 
groEL are often incapable of complementing the housekeeping gene of either the 
original organism or of E. coli [213,225,226].  The benefits of specifically enhancing the 
folding of a small subset of substrate proteins must outweigh the energetic costs of 
producing multiple, similar chaperones. 
The utilization of multiple chaperone components is not limited to bacteria, as 
the genomes of a number of bacteriophage are known to include similar genes.  Perhaps 
the most studied example of this is bacteriophage T4, a phage that infects E. coli and 
carries a gene encoding a GroES homolog [227].  A major capsid protein of T4 (gp23) 
requires the assistance of the bacterial GroEL and the T4-encoded GroES homolog 
(gp31) for productive folding [134,136,227].  The bacterial GroES is not capable of 
complementing gp31 for the folding of gp23; however, gp31 can complement GroES for 
the folding of the E. coli proteome [227,228].  In this case, the alteration of the co-
chaperone gene required for altered function did not drastically alter the capability or 
specificity of the chaperone machinery.  This is likely due to the presence of the 
substrate protein binding sites on GroEL and the lack of such sites on GroES. 
While bacteriophage T4 carries a genes for a GroES homolog, several phage are 
known or predicted to carry genes for homologs of GroEL in their genomes [229-233].  
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One such virus is bacteriophage EL, which infects Pseudomonas aeruginosa, a Gram-
negative bacterium that is in the same phylogenetic class as E. coli [233].  Gene product 
146 (gp146) of bacteriophage EL is a homolog of GroEL [233,234].  Despite low 
sequence similarity with the bacterial chaperonin (Figure 1.4), gp146 forms ring-shaped 
tetradecamers.  This phage protein was demonstrated to specifically interact with another 
phage protein, gp188, which is the monomeric endolysin required for lysis of the host 
cell [234].  No other proteins were reported to interact with gp146, indicating a strong 
specificity in substrate protein binding.   
Production of gp146 begins ~15 minutes after the initial infection of the cell; 
production of gp188 begins ~60 minutes after infection [234].  This timing supports the 
concept that gp146 is required for the productive folding of gp146.  Unfortunately, the 
folding of this endolysin, either spontaneously or in the presence of a chaperone system, 
has not been examined.  However, at elevated temperatures, gp188 has been shown to 
aggregate, and this aggregation is mitigated by the presence of the bacteriophage GroEL 
homolog [234,235].  In the absence of chaperonin, a decrease in endolysin activity is 
also observed over time at 37˚C, the optimal temperature for P. aeruginosa growth and 
replication [236].   
The maintenance of endolysin by the chaperonin required the presence of ATP, 
but not of any co-chaperone.  This suggests several possible roles for gp146 in regards to 
gp188.  First, the native conformation of endolysin may be susceptible to converting to a 
misfolded conformation that is aggregation prone, and gp146 serves to unfold this 
substrate protein to allow for spontaneous refolding.  Another possibility is that the  
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Figure 1.4: Sequence Alignment of E. coli GroEL and Pseudomonas Phage EL gp146.  
Alignment of GroEL (accession number P0A6F5) and gp146 (Q2Z0T5) was performed 
using CLUSTALW [237] and graphically organized with ESPript [238].  Completely 
conserved residues are highlighted in red and highly conserved residues or regions are 
boxed and shown in red text.  Numbering shown is for E. coli GroEL.   
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chaperonin functions as a reservoir, holding the protein in a pro-functional state.  This 
may allow the effective concentration of endolysin to surpass its critical concentration 
for aggregation, which would increase the subsequent rate of peptidoglycan degradation 
during host cell lysis.  ATP would be required for this function to partition the substrate 
protein off of the chaperonin ring.  Differentiating these models or defining other models 
will require more biochemical and biophysical data.  Many of the traditional experiments 
used in the examination of GroEL substrate proteins have not yet been done, leaving 
open questions concerning the role of the GroEL-GroES cavity in the folding or 
prevention of aggregation of gp188. 
Although much remains unknown about how gp146 can aid in the folding or 
maintenance of gp188, or about the interactions that lead to the altered specificity of 
gp146, mutations in the chaperonin have changed the array of interactions that gp146 
can make with substrate proteins, allowing for a new, highly specialized function.  
Although the host chaperonin could facilitate both roles in unfolding and in increasing 
the allowable concentration of endolysin in the cell, the availability of a specific 
chaperonin would provides a key advantage.  During the phage infection, the host 
GroEL would still be functioning in the folding of host proteins.  Competing against the 
host proteome would lead to reduced accessibility to the host chaperonin for gp188.  
Depending on the mechanism behind the aggregation of gp188, either the bulk 
concentration or the concentration of a potentially misfolded sate would be increased in 
this scenario, leading to the loss of functional protein through aggregation.   
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Another challenge posed by utilizing the host machinery is that gp188 would 
displace the proteins that would otherwise be interacting with the host GroEL.  These 
proteins would partition onto other chaperones, leading many proteins to degradation 
pathways [123,239,240].  The stress response induced to cope with widespread 
misfolding and aggregation would likely temper the production of phage proteins.  The 
production of a specific chaperonin for the maintenance of the endolysin monomers 
would alleviate both challenges associated with utilizing the host machinery.  The 
enhanced specificity for gp188 would also reduce interactions with bacterial proteins, 
which would reduce the amount of gp146 required to associate with gp188, decreasing 
the amount of resources needed for this process. 
Specific interactions between the chaperone and substrate proteins have been 
shown to be required for the productive folding and assembly of certain proteins in 
organisms with multiple chaperonins [213,225,241-243].  This same strategy is being 
utilized by pseudomonas phage EL for the production of a lysis protein.  Although 
gp146 has a role in preventing gp188 aggregation, it is also possible that the phage 
chaperone also has a role in the folding of the endolysin.  Much is still unknown about 
gp146; however, the examination of its sequence and preliminary biochemical finding 
suggest that this chaperonin evolved for a specific function, and this function was 
important enough to be retained through billions of years of phage evolution. 
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The Importance of the GroEL C-terminus 
Considerable work has been done in the study of the various domains of GroEL, 
but the last 23 amino acids of the chaperonin escaped much of this scrutiny devoted to 
other aspects of GroEL function [244].  These residues, K-N-D-A-A-D-L-G-A-A-G-G-
M-G-G-M-G-G-M-G-G-M-M, follow proline-525, which is the last visualized residue of 
GroEL in every crystal structure of the chaperone [152-154,227,245].  Lacking a 
resolvable structure and containing nine glycines, these residues were believed to adopt a 
disordered conformation.  Removal of the C-terminus in vivo by mutation of the E. coli 
genome was not lethal for the bacteria under various common growth conditions, 
showing that these residues are not essential for chaperone function [246-248].  
Although the studies using genomic mutations of GroEL did not investigate the bacterial 
genome for second-site suppressors, the conclusion has been widely accepted 
[198,244,249].  Without a structure or any observed interactions, the role of the C-
terminal tail was examined in the context of non-specific functions, including the 
occupation of space inside the cavity and altering the timing of the GroEL reaction 
cycle. 
 One potential impact of the GroEL C-terminus that was investigated was a role in 
establishing the available volume of the GroEL-ES cavity.  The charged residues in the 
first six of the 23 C-terminal amino acids creates a repulsion that prevents these 
appendages from coalescing [250], causing these residues to extend upwards from the 
bottom of the cavity.  Because each GroEL ring contains seven monomers, a total of 161 
residues with a combined molecular weight of 14.4 kDa occupy the bottom of the cavity.  
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Increasing or decreasing the length of this C-terminus would alter the available volume 
in the cavity for a substrate protein to fold.  If the evolution of the chaperonin selected 
for this length for the C-terminus, then one would predict that an increase or decrease in 
the number of residues after proline-525 should be detrimental to folding.  This theory 
was tested through the use of various C-terminal truncation and extension mutants 
[203,204].  These studies showed that none of the alterations in the length of the C-
terminal tail were beneficial for the folding of several substrate proteins.  Although this 
result suggests that the length of the GroEL C-terminus was under selective pressure 
during the evolution of the chaperonin, it could not exclude roles for the C-terminal tail 
other than cavity volume adjustment. 
A second role for the GroEL C-terminus was examined concurrently with the 
cavity volume role.  Altering the length of the C-terminus impacted the rate of ATP 
hydrolysis by the chaperone, which drives the turnover of this molecular machine 
[157,163].  Increasing the length of the C-terminal tail increases the ATP hydrolysis rate, 
while a truncation decreases this rate [209,244].  The focus of these studies was the 
effect of these changes on the lifetime of the GroEL-ES cavity.  As in the other studies, 
detrimental effects were observed with both extensions and truncations of the C-terminal 
residues [209].  In the context of complex turnover, the conclusion was that decreasing 
the lifetime of the cavity provided less opportunity for the substrate proteins to fold, 
therefore decreasing the folding rate.  However, these authors provided no explanation 
for why the folding rate was decreased in the absence of the C-terminal tail. 
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The results of these studies were fundamentally the same, though each was 
interpreted in the context of a different model for GroEL function.  The results of both 
studies were complicated by other impacts of the C-termini, including the roles 
described by the competing studies [203,204,209], the decrease in substrate protein 
encapsulation [209], the possible aggregation of the C-terminal residues [250], and other 
aspects of GroEL function that were not considered.  An important result of both studies 
was that alterations of the GroEL C-terminus did not impact every substrate protein 
equally.  The GroEL cavity evolved under the selective pressure of aiding multiple 
essential proteins [89,90,196], and changes in the cavity that benefit some proteins are 
generally detrimental to other proteins [224,251].  The same is likely true of the C-
terminal tail, such that the role of these residues strikes a balance for the optimal effect 
on the entire proteome. 
Although research has primarily focused on the E. coli chaperonin, the 
composition and length of the C-terminal tail of the mitochondrial chaperonins has 
remained mostly unchanged from the C-terminus of E. coli GroEL (Figure 1.5) [252-
260].  For example, the E. coli C-terminal tail contains four copies of a Gly-Gly-Met 
motif, while the human mitochondrial Hsp60 ends with three repeats of a Gly-Gly-Gly-
Met motif [253,255,256].  The conservation is striking, given that the proteomes of an E. 
coli cell and human mitochondria are of significantly different size and composition 
[255,256,261,262].  The conservation from prokaryotes to eukaryotes implies an 
importance for the mild hydrophobicity and flexibility of these residues.  These 
attributes would not be necessary if the role of these residues was simply to occupy 
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Figure 1.5: Sequence Alignment of Conserved C-Terminal Sequences in GroEL 
Homologs.  Alignment of the E. coli GroEL (top, accession number P0A6F5) C-terminal 
residues (starting with proline-525) and the C-terminal sequences of GroEL homologs 
was performed using CLUSTALW [237] and graphically organized with ESPript [238].  
Completely conserved residues are highlighted in red and highly conserved residues or 
regions are boxed and shown in red text.  From the top, sequences shown are from: E. 
coli GroEL (accession number P0A6F5), Bacillus subtilis GroEL (P28598), 
Saccharomyces cerevisiae mitochondrial Hsp60 (P19882), Arabidopsis thaliana 
mitochondrial Cpn60 (P29197), and Homo sapiens mitochondrial Hsp60 (P10809). 
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space or to modulate the rate of ATP hydrolysis by the chaperone.  This conservation 
suggests that there are other roles for these residues.  
One possible role for the C-terminal tail of GroEL is suggested by the similarity 
of the C-terminal sequence with sequences found in other chaperones.  Hsp40s are 
chaperone proteins that bind to non-native proteins and function in concert with Hsp70s 
to perform a number of roles inside the cell, such as protein disaggregation, complex 
disassembly, and protein folding [124,197,263,264].  In Sis1, an Hsp40 found in S. 
cerevisiae, the linker region between the two domains of the protein has been implicated 
in having some role in responding to substrate protein binding [265].  This region of the 
protein contains multiple repeats of the Gly-Gly-Met motif [266,267], and has been 
identified in other Hsp40s [264,265,268-270].  Although not identical to the Gly-Gly-
Met motif, the same region in another S. cerevisiae Hsp40, Ydj1, contains Gly-Gly-X 
repeats, with X being alanine or phenylalanine [267,271].  The E. coli Hsp40, DnaJ, also 
contains multiple Gly-Gly-X repeats, with X being methionine or phenylalanine 
[255,272].  Not only do many Hsp40s contain this motif, but it is also found in many 
Hsp70s [246].  The presence of this motif in chaperone proteins that are responsible for 
binding to non-native proteins suggests a similar role in substrate protein binding for the 
C-terminal tail of GroEL. 
 
The Specialization of the GroEL C-terminus 
 The C-terminal tail of E. coli GroEL may have evolved for broad specificity, but 
the same is not true of the C-terminus of the chaperonin in every bacteria.  Duplication 
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events in the genomes of some bacteria have created second copies of groEL in those 
organisms [213,273,274].  With the original GroEL providing the essential function of 
broad-spectrum protein folding, the additional genes have not faced strict selective 
pressure for viability [275].  This has led to mutations arising in the additional 
chaperonin genes, specifically in the region encoding the C-terminal tail, in organisms 
such as actinobacteria, cyanobacteria, and α-proteobacteria (Figure 1.6) [213,226,276-
278].  These specialized chaperonins have developed altered specificities in support of 
particular functions in these bacteria. 
 Although many actinobacteria have been identified with mutations in the C-
terminal region of the chaperonin, the most well-known genus of actinobacteria is 
Mycobacterium.  Mycobacterium includes several pathogenic organisms [276,279], the 
most well-known of which is Mycobacterium tuberculosis.  Mycobacteria, including M. 
tuberculosis, contain at least one additional copy of groEL [213].  This gene, cpn60.2, is 
located distant from the cpn60.1 operon in the genome and does not have an adjacent 
copy of groES [280].  Interestingly, cpn60.2 is the essential gene and is capable of 
complementing ∆groEL in E. coli, while cpn60.1 is not essential and cannot complement 
E. coli ∆groEL [225,275,281].  Although both Cpn60.1 and Cpn60.2 form 
tetradecamers, bind nucleotide, bind GroES and are capable of folding proteins 
[213,225,273,278,281,282], two significant differences exist in the sequences of these 
paralogs.  First, the sequence of the Cpn60.1 N-terminus, a region of the chaperonin that 
is involved in oligomerization, is highly altered [280,283].  This difference causes the 
chaperone to be less stable, requiring the presence of nucleotide or high concentrations  
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Figure 1.6: Sequence Alignment of Divergent C-Terminal Sequences in GroEL 
Homologs.  Alignment of the E. coli GroEL (top, accession number P0A6F5) C-terminal 
residues (starting with proline-525) and the C-terminal sequences of GroEL homologs 
was performed using CLUSTALW [237] and graphically organized with ESPript [238].  
Completely conserved residues are highlighted in red and highly conserved residues or 
regions are boxed and shown in red text.  From the top, sequences shown are from: E. 
coli GroEL (accession number P0A6F5), Mycobacterium tuberculosis Cpn60.2 
(P9WPE7), M. tuberculosis Cpn60.1 (P9WPE9), Myxococcus Xanthus Cpn60.2 
(Q1D2S1), M. Xanthus Cpn60.1 (Q1D3Y5), Synechococcus sp. (PCC 6301) GroEL2 
(Q5N3T6), Synechococcus sp. (PCC 6301) GroEL1 (P12834), Rhizobium 
leguminosarum GroEL1 (Q1MKX4), R. leguminosarum GroEL2 (Q1MJF2), and R. 
leguminosarum GroEL3 (Q1M3H2). 
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of salt to remain oligomerized [278,283,284].  Although this factor may influence the 
initial formation of the tetradecamer, most models of the GroEL reaction cycle show the 
chaperone as constantly bound to nucleotide [157,163,206], which may solve this 
stability problem.  Importantly, while the reaction cycle has been studied extensively 
using E. coli GroEL, it has not yet been demonstrated that the mycobacterial protein 
utilizes the same cycle.   
The second region of the mycobacterial Cpn60.1 that differs from Cpn60.2 or E. 
coli GroEL is the C-terminal tail [225,280,283].  After the conserved proline residue in 
M. tuberculosis, the sequence of the Cpn60.1 is only 14 amino acids long (A-K-A-E-D-
H-D-H-H-H-G-H-A-H).  Although this sequence retains the presence of charged 
residues distal to the proline residue, the subsequent Gly-Gly-Met repeats have been 
replaced with a shorter, less flexible, more polar sequence.  The presence of multiple 
histidines in the C-terminal tail of GroEL paralogs is unique to actinobacteria [225].  The 
role of this region of Cpn60.1 was revealed by its role in phage development. 
Mycobacterium smegmatis can be infected by the mycobacteriophage Bxb1, which 
integrates into the bacterial genome at the 3’-end of cpn60.1 [285].  This in-frame 
insertion of phage DNA changes the sequence and shortens the C-terminal tail of 
Cpn60.1 [285].  This mutation in cpn60.1, or the deletion of the entire gene, has no 
effect on normal growth of the bacteria, but it does render the bacteria incapable of 
forming biofilms [225,285].  This effect is due to the role of Cpn60.1 in the maturation 
of two proteins, KasA and KasB [225].  These two proteins function in the synthesis of 
mycolic acid, a critical component of the mycobacterial cell wall during biofilm 
  
 
40 
maturation [286].  Although Cpn60.1 physically interacts with KasA utilizing the same 
binding surface as classical chaperonins [225,282], no evidence yet exists to support a 
role for Cpn60.1 in folding KasA.  Whether Cpn60.1 stimulates the folding of KasA or 
performs some other function, such as trafficking KasA inside the cell, the unique C-
terminal sequence of this paralog is necessary for both the maturation of this protein and 
the maturation of the bacterial biofilm.  
 In Gram-negative bacteria, one example of an organism containing multiple, 
differentiated chaperonin genes is Myxococcus xanthus.  The genome of M. xanthus is 
~9.1 Mbp and contains many duplicated genes, including two copies of groEL 
[287,288].  As in the M. tuberculosis Cpn60s, the C-terminal tails of the GroEL paralogs 
of M. xanthus are starkly different.  While GroEL2 retains multiple repeats of the Gly-
Gly-Met motif, the glycine-rich C-terminus of GroEL1 includes four aspartic acid 
residues in the final nine positions of the protein [287].  Unlike the mycobacterial gene 
duplication, the differentiation of GroEL1 and GroEL2 in M. xanthus did not lead to a 
loss of the house-keeping capability for either chaperone, since either chaperone is 
independently sufficient for cell viability [241].  While maintaining this house-keeping 
role, both chaperonins also gained specialized functions.  It was reported that these 
chaperonins are differentially expressed under normal growth conditions and 
differentially induced by heat-shock [288].  Although the basal abundance of GroEL1 is 
roughly 5-10 fold lower than GroEL2, GroEL1 expression was observed to quickly 
surpasses GroEL2 upon heat-shock and achieves a higher maximal expression level.  
Although GroEL2 was up-regulated approximately fivefold under heat-shock [288], only 
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GroEL1 was capable of maintaining cell viability at higher temperatures [241,242].  
Maintaining the cellular proteome under stress conditions is a role for GroEL in most 
organisms [121,289,290], but this differential regulation suggested that these proteins 
may serve different functions.   
Myxobacteria are characterized by a number of features that are uncommon in 
other bacteria, such as colonial predation, intercellular spore formation processes, and 
the presence of eukaryotic-like gene regulation [291-293].  In these functions a 
differentiated role for M. xanthus GroEL1 and GroEL2 can be found.  Although M. 
xanthus can survive on normal laboratory growth medium, these bacteria can also utilize 
other bacteria (such as E. coli) as a food source [291].  The ability of these myxobacteria 
to swarm and prey upon other microbes is strongly dependent on the presence of 
GroEL2 [241].  Conversely, in times of starvation, these bacteria form multicellular 
fruiting-bodies that develop into spores [291]; these processes in development are 
severely deficient in the absence of GroEL1 [241].  As chaperone proteins, neither 
GroEL1 nor GroEL2 would have a direct function in either predation or development, 
but substrate proteins that require the assistance of these chaperonins could have roles in 
these processes.  An investigation of the interaction proteomes of GroEL1 and GroEL2 
identified several dozen substrate proteins that interact specifically with one chaperonin 
or the other [242].   
Although many proteins in the M. xanthus proteome remain uncharacterized, 
several putative substrate proteins, annotated with functions in polyketide or non-
ribosomal peptide synthesis, were identified as specifically using either GroEL1 or 
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GroEL2 [242].  Bacteria use polyketide and other non-ribosomal mechanisms for the 
biosynthesis of small molecules involved in the development and the defense of the 
manufacturing organism [294-296].  In M. xanthus predation, the secondary metabolite 
myxovirescin serves as an antibiotic to kill potential food sources [297]; the production 
of this compound requires the GroEL2 gene [243].  In examining the role of the GroEL 
paralogs, not only for the production of myxovirescin, but also for other aspects of 
predation and for the development of fruiting-bodies and spores, the C-termini of the 
chaperonins were interrogated by site-directed mutagenesis [242,243].  For both GroEL1 
and GroEL2, removal of the C-terminal sequence or exchanging the sequences of the 
two paralogs results in a loss of the observed phenotypes associated with each 
chaperonin [242,243].  The deletion of the C-teminus from either chaperonin could not 
be complemented by a variant of the other chaperonin featuring a mutated C-terminus 
that matched the deleted sequence.  This suggests that these C-terminal tails function 
along with other components of the GroEL structure in the folding of these specific 
substrate proteins.  However, the details of this mechanism and the details about the 
interactions between the C-termini and the substrate proteins that promote their folding 
remain unresolved.      
 The development of functional specialization for additional chaperonins has also 
been identified in the chloroplasts of some plants [298-302].  Two different types of 
subunits (alpha (α) and beta (β)) comprise the chloroplastic chaperonin of Arabidopsis 
thaliana, and each subunit is encoded in multiple genes [303,304].  Each of these genes 
is expressed at different levels, but not all genes are required for viability [305,306].  
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These subunits form mixed tetradecamers that are generally composed of seven alpha 
and seven beta subunits [303].   Three of the four beta subunits expressed in A. thaliana 
are ~90% identical with each other; however, Cpn60β4 is only ~60% identical to the 
other three subunits [304].  Deletion of the Cpn60β4 subunit does not lead to a loss of 
plant viability; the only observed effect was a loss of NADH dehydrogenase-like 
complex (NDH) activity [307].  Although the NDH protein was found to bind to Cpn60 
tetradecamers that lacked the β4 subunit, tetradecamers lacking this subunit could not 
compensate for the loss of the Cpn60β4 subunit [307].  The Cpn60β4 subunit shares 
only ~60% identity with the other beta subunits; the C-termini of these subunits are 
notably different.  The C-terminal tail of the Cpn60β4 subunit is more positively charged 
and at least 26 amino acids longer than the C-termini of the other Cpn60β subunits in A. 
thaliana [307].  Extension or deletion of this β4 C-terminal tail drastically reduces NDH 
activity, although not to the same extent as a deletion of the entire subunit [307].  This 
suggests that the C-terminus has a critical, but not essential, role in the folding of NDH 
by Cpn60β4.  Despite the importance of this subunit, no research has been conducted 
into the actual mechanism used by Cpn60β4 to support the folding of NDH.   
Even after multiple studies investigating the role of the C-terminus, its role in 
chaperonin function has not been definitely established.  In general, the GroEL C-
terminus is highly conserved in many organisms.  However, when this sequence has 
changed, the new GroEL paralog supports a secondary cellular function.  Sequence 
similarity of the GroEL C-terminus to regions of the Hsp40 and Hsp70 proteins suggests 
a role in substrate protein binding; this concept is supported by the observed specificities 
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of the diverged C-terminal sequences of the myxobacterial chaperonin paralogs.  
Whether this potential binding activity is required for the initial capture of the substrate 
protein on the apical domain of GroEL, for the subsequent encapsulation of the substrate 
protein, or for intracavity folding remains unknown.  Only through extensive, focused 
biochemical and biophysical characterization will an understanding of the mechanistic 
role of the GroEL C-terminal tails be gained.   
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CHAPTER II 
VISUALIZING GROEL/ES IN THE ACT OF ENCAPSULATING  
A FOLDING PROTEIN*  
 
 Many essential proteins fold only when assisted by ATP-powered machines 
known as molecular chaperones [239]. The GroEL/ES system of E. coli is a well- 
studied example of the chaperonin class of molecular chaperones [190,198]. GroEL is a 
tetradecamer of 57 kDa subunits, arranged as two stacked, seven-membered rings, each 
containing a large, solvent-filled cavity [152]. The cavity-facing surface of the apical 
domain of each subunit is lined with hydrophobic amino acids that tightly bind 
substrates that are neither random coil, nor natively folded proteins (so-called non-native 
proteins; [165]). Efficient folding of proteins that strictly depend on GroEL (so-called 
stringent substrate proteins) requires encapsulation of the non-native substrate protein 
within a cavity formed by GroEL plus the smaller, ring-shaped co-chaperonin GroES 
[163,177,206,308]. Encapsulation seals the GroEL cavity and results in the release of the 
substrate protein into an enlarged GroEL-GroES chamber (a cis complex). Upon release, 
folding is initiated and continues for a brief period, until the cavity is disassembled and 
the protein, folded or not, is ejected back into free solution [164,173,177,206,308]. 
 Encapsulation and initiation of folding ultimately depend upon ATP-driven 
structural rearrangements [157,161,162].  ATP binding to GroEL equatorial domains  
                                                             
*Reproduced, with modifications, with permission from Chen, et al. (2013) Cell 153: 
1354-1365.  Copyright 2013 Elsevier Inc.  For the original publication: JW designed and 
performed biochemical experiments, and analyzed the corresponding data.  JW did not 
perform or analyze any of the microscopy experiments, which were done by DHC.  
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results in large, cooperative rearrangements, which elevate and rotate the apical domains 
[154,309,310].  Exposed sites bind GroES, which results in a switch of the apical-
domain surfaces from hydrophobic to polar [154], a switch believed to be essential for 
releasing substrate and triggering folding.  While protein folding is initiated inside the 
GroEL-GroES cavity, the relatively short lifetime of this complex limits the amount of 
time a protein has to fold [157,164,173,309]. The timer for complex disassembly is set 
by the rate of ATP hydrolysis within the cis cavity, ranging from 4-20 sec, depending on 
temperature and the concentration of non-native substrate protein [157,160,309].   
Recent structural work provides insight into how a non-native substrate protein is 
bound to an open GroEL ring and a view of a fully folded protein inside the GroEL 
cavity [311-314], but structural information about non-native proteins during and 
immediately following encapsulation, the point at which folding is initiated, remains 
limited.  In fact, the cooperative structural transitions of the GroEL ring that occur in 
response to ATP binding appear to create a paradox.  Given that non-native substrate 
proteins and GroES are thought to bind to overlapping sites on the GroEL apical 
domains, how is it possible for ATP binding to drive a GroEL ring into a state with high 
affinity for GroES without causing premature release of the folding intermediate outside 
the chaperonin? 
 Binding competition between GroES and a substrate protein to the apical 
domains could be avoided if the ATP-bound GroEL ring populates an intermediate 
conformation that transiently binds both substrate protein and GroES [171]. Entry into 
and exit from such a state would require an orderly allosteric cascade designed to 
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enforce a specific ligand binding sequence [158,171,172,315].  The sequence begins 
with the non-native substrate protein binding to the open trans ring of an asymmetric 
GroEL-GroES complex with high affinity for the substrate protein, but without 
significant affinity for GroES (Figure 2.1A; [166]).  Cooperative binding of ATP to the 
same GroEL ring is then thought to initiate encapsulation through a series of 
conformational states, which sequentially weaken the interaction between GroEL and the 
substrate protein, while simultaneously strengthening the interaction with GroES (Figure 
2.1B-1F).  While functional and kinetic studies strongly suggested the existence of such 
an allosteric cascade, because they are only transiently populated, the structural nature of 
these key intermediate states has remained poorly understood.  A recent electron cryo-
microscopy (cryo-EM) study of GroEL in the presence of ATP has begun to fill in some 
of these missing details, by successfully classifying several intermediate conformations 
of the GroEL apical domains [315].  This study provides structural evidence for a 
sequential allosteric cascade, as well as insight into the intermediates populated by an 
ATP-bound GroEL ring prior to encapsulation. However, the absence of GroES and 
non-native substrate protein in these studies leaves unresolved the key structural 
transitions that lead to substrate protein encapsulation, release and folding. 
 Here we show a non-native substrate protein trapped inside the GroEL-GroES 
cavity during encapsulation. We used cryo-EM and single-particle three-dimensional 
(3D) reconstruction to determine the structure of a chemically modified GroEL mutant, 
which stalls in an allosteric state just prior to substrate protein release (the R2 state; 
[158]).  
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Figure 2.1: The GroEL Protein Folding Cycle Involves a Series of Allosteric Transitions 
within the Chaperonin Complex.  Non-native substrate proteins enter the GroEL reaction 
cycle by binding to the open trans ring of an asymmetric GroEL-GroES complex, 
pulling the trans ring into the high-affinity “T” state (A; for cycle details, see 
[171,190,198]).  Protein encapsulation is initiated by highly cooperative binding of ATP 
to the trans ring, populating the R1 state (B), a conformational state of the GroEL 
ring with high affinity for the non-native protein but not yet for GroES.  The R2 state (C) 
retains substantial, though weakened, affinity for the non-native protein, binds GroES 
and encapsulates the substrate protein (D).  Transitions into or between the R1 and R2 
states are also linked to disassembly of the GroEL-GroES complex on the opposite ring.  
The ATP-bound GroEL-GroES complex has a high affinity for GroES in the R3 state 
(E), which releases the non-native substrate protein into the enclosed cis cavity, to 
initiate folding. Hydrolysis of ATP within the cis ring triggers a transition of the 
complex to at least one additional conformational state (F).
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Experimental Procedures  
Proteins.  Wild-type GroEL, EL398A, EL43C and EL43C398A, were expressed 
and purified as previously described [166].  EL∆526 was purified in the same manner as 
wild-type GroEL.  GroES, RuBisCO and GFP were also expressed and purified as 
previously described [157,163,166,190].  Bovine rhodanese was purchased from Sigma 
and purified as previously described [158,173].  
 Labeling of proteins with fluorescent dyes.  EL43C and EL43C398A were 
specifically labeled at Cys43 with the thiol-reactive dye N-1-pyrene maleimide (PM) to 
generate EL43Py and EL43Py398A, as previously described [158].  Wild-type RuBisCO 
was fluorescently labeled at Cys58 with the thiol-reactive dye 5-
iodoacetamidofluorescein (5IAF) to create 58F-RuBisCO as previously described 
[157,166,190].  Both PM and 5IAF were obtained from Invitrogen (Molecular Probes; 
Eugene, OR) and were prepared fresh from dry powder in anhydrous DMF immediately 
prior to use.  The extent and specificity of dye conjugation was confirmed as previously 
described [166,168,316].  For 58F-RuBisCO, EL43Py and EL43Py398A, the labeling 
efficiency was confirmed to be 98-100% by at least two different methods of analysis 
[158,316]. 
 Refolding, enzymatic and encapsulation assays.  Rhodanese folding was assayed 
essentially as previously described [206]. Native rhodanese was first denatured in acid 
urea buffer (25 mM glycine-phosphate, pH 2.0, 8 M urea), and then diluted 50 fold into 
refolding buffer containing a given GroEL variant. Folding was then initiated by 
addition of GroES and ATP. For single turnover experiments, GroEL cycling was 
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prevented by the addition of hexokinase and glucose within 5 s of the initial ATP 
addition, as previously described [158,166].  
All encapsulation experiments were conducted in sample buffer: 50mM HEPES, 
pH 7.6, 15 mM Mg(OAc)2, 100 mM KOAc and 2 mM DTT. In all cases, the substrate 
protein (58F-RuBisCO, GFP or rhodanese) was denatured in acid urea buffer for 30-60 
min at room temperature (in the dark) to yield working stocks of dRub, dGFP, dRho. 
ADP bullets complexes were created essentially as previously described, by adding 
GroEL (WT or ∆526), GroES and ATP to final concentrations of 7 µM, 14 µM and 150 
µM respectively, followed by a 10 min incubation at room temperature [166]. ADP 
bullet complexes with either non-native GFP or rhodanese bound to the trans ring were 
formed by adding dGFP or dRho (250 nM final) to cold buffer containing 250 nM ADP 
bullets. After a five min incubation at room temperature, ATP was added to 1mM to 
permit GroES binding and protein encapsulation. Following a 10 s incubation, the 
ambient ATP was quenched by the addition of hexokinase (50 U/ml) and glucose (10 
mM). In the case of GFP, the sample was then incubated for an additional 10 min at 
room temperature to allow GFP folding, followed by injection of the sample onto a 
Superose 6 gel filtration column, equilibrated in sample buffer and supplemented with 
50 µM ADP, connected to an in-line fluorescence detector. For experiments with 
rhodanese, unencapsulated protein was removed by treatment with 0.25 mg/ml 
Proteinase K for 10 min. The protease was inactivated at room temperature by addition 
of 1 mM PMSF prior to injection of the sample onto the gel filtration column. The 
GroEL-GroES peak was collected and total protein was precipitated with cold TCA. The 
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concentrated protein sample was then loaded onto a 10% SDS-PAGE gel to separate 
rhodanese from GroEL and GroES. Following Coomassie staining, the intensity of the 
rhodanese band was quantified by densitometry. Encapsulation experiments with 58F-
RuBisCO were conducted in a similar manner, except that ATP was added 3 s after the 
non-native RuBisCO was bound to the ADP bullet trans ring. Unencapsulated RuBisCO 
was removed prior to injection on the column by treatment of the sample with Proteinase 
K, as described above. As with GFP, the extent of 58F-RuBisCO encapsulation was 
determined by direct fluorescence measurement of the GroEL-GroES peak.  
 TCA Precipitation of GroEL-GroES Samples.  1.3 ml of each sample was added 
to 200 ml of 100% TCA in a 1.5 ml microcentrifuge tube. These were incubated 
overnight at 4 C. Sa mples were centrifuged at 13,000 rpm at 4 C for 15 min. The 
supernatant was removed and the pellets were washed with acid acetone. Samples were 
centrifuged at 13,000 rpm at 4 C for 15 min. The supernatant was removed and the 
pellets were allowed to air-dry. Pellets were then resuspended for gel electrophoresis 
(2:1 solution of 50mM NaHCO3, pH 10.5 and gel loading buffer).  
 Preparation of Chaperonin Complexes for Cryo-EM.  Preparation of the 
EL43Py398A-GroES-ATP complex was performed by mixing EL43Py398A (8 µM), 
GroES (7.2 µM) and ATP (100 µM) in 50 mM HEPES (pH 7.6), 5 mM KOAc, 10 mM 
Mg(OAc)2, 2 mM DTT. The reaction products were immediately deposited to the grids 
for freezing. The EL43Py398A-RuBisCO-GroES-ATP and EL398A-RuBisCO-GroES-
ATP complexes were prepared in a similar manner, as follows: 0.1 µM denatured 
RuBisCO was quickly diluted into 1 ml of cold, high K+ refolding buffer (same 
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composition as above, but with the KOAc concentration increased to 50 mM) containing 
0.1 µM EL43Py398A or EL398A. The solution was warmed to room temperature for 5 
min to allow RuBisCO binding to the chaperonin, before 0.1 µM GroES and 1 mM ATP 
were added. Within 10 s, 600 ml of solution was transferred to a Vivaspin 500 
ultrafiltration unit (100K MWCO) and centrifuged at 12,000 x g in a swinging bucket 
rotor for 6 min in an Eppendorf Microcentrifuge 5417 R at 4 C. Approximately 20 ml 
of this concentrated solution was recovered, from which a sample was immediately 
applied to the holey grids, blotted and plunged into liquid ethane.  
 Cryo-EM.  Sample preparation and freezing for all experiments was complete 
within 10 min. Using freshly glow-discharged Quantifoil grids (R1.2/1.3, Quantifoil 
Micro Tools GmbH, Jena, Germany), 3 ml of the sample solution was applied onto the 
holey film side of each grid and then blotted at room temperature for 1.0 s at 95%–100% 
humidity prior to plunging into liquid ethane cooled by liquid nitrogen using an 
automated vitrification device, Vitrobot (FEI Company, http://www.fei.com/Vitrobot). 
Frozen grids were stored in liquid nitrogen until examined in an electron cryo-
microscope. Images for the EL43Py398A-GroES-ATP complex were collected on 
Kodak SO-163 photographic film at an effective magnification of 61,060x with the 
specimen temperature at 4 K, a 2 s exposure time, and a dose of 25-36 e/Å 2 per image 
from a 300-kV JEOL JEM-3000SFF liquid-helium-cooled electron microscope. Images 
for the EL43Py398A-RuBisCO-GroES-ATP complex were collected on a Gatan 
Ultrascan 4k x 4k CCD at a detector magnification of 73,530x with a specimen 
temperature of 50 K, a 2 s exposure time, and a dose of 30 e/Å 2 per image on a JEM-
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3000SFF. Images for the EL398A-RuBisCO-GroES-ATP complex were collected using 
a Gatan Ultrascan 4k 3 4k CCD at a detector magnification of 70,760x using a 300-kV 
JEOL JEM-3200FSC with a specimen temperature of 101 K, a 1 s exposure time, a dose 
of 20 e/Å 2 per image and an energy slit of 20 eV in the in-column energy filter. The 
pixel size for the CCD images of the EL43Py398A-RuBisCOGroES-ATP and the 
EL398A-RuBisCO-GroES-ATP complexes were 2.04 Å and 2.12 Å at the specimen 
level, respectively. The films for recorded images of the EL43Py398A-GroES-ATP 
complex were developed for 12 min in Kodak D19 developer, fixed for 10 min in Kodak 
fixer at 20 C and then scanned using a Nikon Super Coolscan 9000 scanner at a 6.35 
mm step size, yielding a pixel size of 1.04 Å at the specimen level. The scanned 
EL43Py398A-GroES-ATP images were then averaged twice to produce data at 2.08 Å 
/pixel.  The digital images were pre-processed by boxing particle images and 
determining contrast transfer function parameters for each micrograph using EMAN1 
program [317]. 
 Image Processing.  Particle selection for each complex was performed semi-
automatically using the EMAN1 [317] program, boxer, followed by manual screening-
out of large contaminants and aggregates. The contrast transfer function fitting for each 
photographic film or CCD frame was performed automatically using the program, 
fitctf.py [318], and then fine-tuned manually using the EMAN1 program, ctfit. The 
methodology of EMAN1 multiple-model refinement (EMAN1 program multirefine) for 
compositionally and conformationally heterogeneous complex analysis, which has been 
previously described [319], was used to sort different particle sub-populations from all 
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the data sets (Figure 2.2A). Briefly, several consecutive multiple-model refinements 
were applied to ‘‘computationally purify’’ a sub-population of the relatively 
homogeneous bullet-shaped particle images of greatest interest for each of three 
complexes described in this study. Each sub-population with ‘‘purified’’ particle images 
was then subjected to a single-model refinement (EMAN1 program refine) to obtain a 
final converged bullet-shaped 3D reconstruction. In the case of the EL43Py398A + 
GroES + ATP sample (71,200 particle images in total), an initial model was generated 
from the crystal structure of the GroEL-GroES-ADP complex (PDB ID code 1AON) 
with C7 symmetry by first low-pass filtering this structure to 40 Å resolution. Flatband 
Gaussian noise was then added to this 40-Å map, yielding three structurally identical 
initial models that possessed distinct Gaussian noise. These three initial models were 
used for the first-round multiple-model refinement. Tens of cycles for this first multiple-
model refinement were performed until a reasonable convergence was achieved for each 
sub-population. The number of refinement cycles was determined when the number of 
particle images was stabilized in successive iterations for each sub-population data. This 
initial multiple-model refinement divided the data set into three sub-populations: free 
GroEL tetradecamer (no GroES bound, 12,490 particle images), bullet-shaped GroEL-
GroES complexes (with GroES bound to only one end of GroEL tetradecamer, 35,170 
particle images) and football-shaped GroEL-GroES2 complexes (with GroES bound to 
both ends of the GroEL tetradecamer, 23,540 particle images).  
Because of substantial heterogeneity in the EL43Py398A + GroES + ATP 
sample, single-round multiple-model refinement based on three initial models, which  
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Figure 2.2: Data Processing Flow Chart and Euler Angle Distributions of Bullet-Shaped 
Complexes. (A) A general flow chart for our data processing strategy using the 
consecutive multiple-model refinement is shown. The first-round multiple-model 
refinement was seeded with three initial models. These initial models were derived from 
the GroEL-GroES-ADP (PDB ID code 1AON) X-ray structure after it was low-pass 
filtered to 40 Å and different Flatband Gaussian noises were added to each of the three 
initial models. Tens of cycles for this first-round multiple-model refinement were 
performed until a reasonable convergence was obtained for each sub-population. The 
bullet-shaped particle images were extracted for a few more multiplemodel refinements 
until a relatively homogeneous data set for this bullet-shaped particle images was sorted 
out. This final highly computationally selected bullet shaped particle images were 
subjected to the single-model refinement to generate a converged 3D reconstruction. (B) 
The Euler angle distribution for the C7 structure of EL43Py398A-GroES-ATP shown in 
Figure 2.3A. (C) The Euler angle distribution for the symmetry-free structure of 
EL43Py398A-RuBisCO-GroES-ATP shown in Figure 2.4A. (D) The Euler angle 
distribution for the symmetry-free structure of EL398A-RuBisCO-GroES-ATP shown in 
Figure 2.5A. The top of each triangle represents top views and the two bottom corners of 
each triangle represent side views. 
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sorted all the particle images into only three sub-populations, could not reliably sort the 
entire population. In order to further differentiate the sub-population of bullet-shaped 
GroEL-GroES complexes from the EL43Py398A + GroES + ATP sample, several 
additional rounds of consecutive multiple-model refinement were applied to the sub-
population of bullet-shaped GroEL-GroES complexes obtained from the first-round 
multiple-model refinement. The second-round multiplemodel refinement sorted the 
bullet-shaped GroEL-GroES complexes (35,170 particle images) into three sub-
populations: 5,370 particle images without GroES bound, 17,950 particle images with 
bullet shape and 11,850 particle images with football shape. The third-round multiple-
model refinement further purified the bullet-shaped GroEL-GroES complexes (17,950 
particle images) into a relatively homogeneous sub-population of bullet-shaped particle 
images (8,372 particle images). This final bullet-shaped sub-population was further 
processed using a single-model refinement with imposed C7 symmetry for a map at 8.9 
Å resolution.  
The strategies employed for heterogeneity sorting for EL43Py398A + RuBisCO 
+ GroES + ATP sample and EL398A + RuBisCO + GroES + ATP sample were similar. 
In the case of the EL43Py398A + RuBisCO + GroES + ATP sample (235,000 particle 
images), the three initial models was also generated from the crystal structure of the 
GroEL-GroES-ADP complex (PDB ID code 1AON) with C7 symmetry by first low-pass 
filtering this structure to 40 Å resolution and adding flatband Gaussian noise. The first 
several consecutive multiple-model refinements reduced the EL43Py398A + RuBisCO + 
GroES + ATP sample to 62,350 particle images with the bullet-shape. The final 
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multiple-model refinement sorted this bullet-shaped data set to two major sub-
populations: one without substrate RuBisCO (24,580 particle images) and one with 
substrate RuBisCO (17,610 particle images). The final sub-population with RuBisCO 
inside the cis cavity for the EL43Py398A + RuBisCO + GroES + ATP sample was 
processed using a single-model refinement for a converged bullet-shaped structure 
without imposing symmetry at 9.2 Å resolution.  
In the case of the EL398A + RuBisCO + GroES + ATP sample (284,070 particle 
images), the first multiple-model refinement sorted the heterogeneous sample for the 
bullet-shaped complex with 108,870 particle images. After several consecutive multiple-
model refinements, the final refinement round sorted this bullet-shaped data set into the 
sub-population of 8,189 particle images containing RuBisCO inside the cavity. The final 
sub-population with RuBisCO inside the cis cavity for the EL398A-RuBisCO-
GroESATP sample was processed using a single-model refinement for a converged 
bullet-shaped map without imposed symmetry at 15.9 Å resolution.   
In the initial round of multiple-model refinement for heterogeneity sorting, C7 
symmetry was applied. However, subsequent rounds of multiple-model refinement and 
each final single-model refinement did not impose any symmetry on the data from the 
EL43Py398A + RuBisCO + GroES + ATP sample or the EL398A + RuBisCO + GroES 
+ ATP sample. However, a C7 symmetry restraint was imposed on all multiple-model 
and single-model refinements for the EL43Py398A + GroES + ATP sample.  
The Euler angular distributions of particle images corresponding to each of the 
reconstructions (Figure 2.3A, 2.4A and 2.5A) are shown in Figures 2.2B-D, respectively.   
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Figure 2.3: The Structure of the EL43Py398A-GroES-ATP Complex Determined at 8.9 
Å Resolution by Cryo-EM with C7 Symmetry Imposed.  (A) Side view of the 
EL43Py398A-GroES-ATP density map displayed at a contour level of 1.3 σ.  Individual 
GroEL subunits are shown in different colors; GroES is magenta.  All other density 
maps shown in this study are displayed at a contour level of 1.0 σ (unless otherwise 
noted).  (B) Close-up view of a single EL43Py398A cis-ring subunit (contour level of 
1.5 σ) overlapped with a rigid-body, flexibly refined fit of the GroEL-GroES-ADP 
crystal structure (PDB ID: 1AON; magenta) using the program DireX [320].  The stem 
loop containing Cys 43 and the GroEL C-terminus are labeled with arrows.  (C) A 
medial slice of the density map shown in (A), with the density rendered transparent and 
superimposed on a rigid-body, flexibly refined fit of the GroEL-GroES-ADP crystal 
structure.  In (C), extra density is visible at the tips of the equatorial stem loops of each 
GroEL subunit (amino acids 34-52; black dashed circles).  The observed densities 
beyond amino acid 525 in the C-terminal tails are indicated by red arrows.  (D) The 
additional stem-loop density for each subunit is shown (inside of black dashed circle), 
viewed from above, at a slice level indicated by the dashed blue line in (A). The seven 
stem loops are labeled 1-7, respectively.  A single N-1-pyrene maleimide dye molecule 
(green) was rigid-body fit into the density at the tip of one stem loop in the 
EL43Py398A-GroES-ATP complex using Chimera.  (E) View of the cis-ring equatorial 
domain near the subunit C-termini, viewed from above, at the slice level indicated by the 
black dashed line in (A).  Substantial density (large red arrow) is visible in the region of 
the subunit C-termini, well beyond the last crystallographically resolved residue (small 
red arrow).  The position of the GroEL subunit N-terminus is indicated by the blue 
arrow. 
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Figure 2.4: The Structure of the EL43Py398A-GroES-ATP Complex Containing Non-
Native RuBisCO within the Cis Cavity Determined at 9.2 Å by Cryo-EM without 
Imposed Symmetry.  (A) A side view of the density map of EL43Py398A-RuBisCO-
GroES-ATP complex (contour level 1.23 σ) shown colored as in Figure 2.3, with density 
from the encapsulated, non-native RuBisCO monomer shown in gold.  (B)  A medial 
slice of the EL43Py398A-RuBisCO-GroES-ATP complex with the density rendered 
transparent and overlapped with a rigid-body, flexibly refined fit of the GroEL-ADP-
GroES crystal structure (PDB ID: 1AON) to the cryo-EM map.  Additional density 
around the GroEL equatorial domain stem loops makes direct contact with the non-
native RuBisCO monomer (dashed black circles).  The RuBisCO is also in contact with 
the lower region of the apical domain of one cis-ring GroEL subunit in the region of 
F281 (black arrow).  (C) A close-up view of one cis-ring GroEL subunit in direct contact 
(long black arrow) with the non-native RuBisCO monomer (gold; contour level of 1.05 
σ).  The GroEL subunit stem loop (short black arrow) and C-terminus (red arrow) are 
indicated.  (D) A medial slice of the variance map derived for the EL43Py398A-
RuBisCO-GroES-ATP complex (red; see Experimental Procedures) is shown overlapped 
with the average map of the complex (gray; orientation as in panel B), calculated from 
100 3D reconstructions of the complex computed during the variance calculations.  The 
largest variations in the density map are from the non-native RuBisCO monomer and 
cavity-facing regions of the GroEL equatorial domains, most likely the C-termini of the 
cis and trans rings.    
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Figure 2.5: The Structure of the EL398A-GroES-ATP Complex Containing RuBisCO 
within the Cis Cavity Determined at 15.9 Å by Cryo-EM Reconstruction without 
Imposed Symmetry.  (A) A side view of the EL398A-RuBisCO-GroES-ATP density 
map. (B) Medial slice of the EL398A-RuBisCO-GroES-ATP complex indicates direct 
contact between the folding RuBisCO monomer and the C-terminal and stem-loop 
region of one cis-ring GroEL subunit (black arrow). 
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The final resolutions for the refined structures were assessed using the gold-standard 
criterion of Fourier Shell Correlation (FSC) cut-off at 0.143 from two independent half-
sets of data [321] after the particle images were highly purified from our consecutive 
multiple-model refinement procedures.  Chimera [322] was used for the surface 
representations of all the cryo-EM density maps.  The 3D variance map of the 
EL43Py398A-RuBisCO-GroES-ATP complex was calculated using the EMAN1 
program calculateMapVariance.py with the bootstrap technique implemented [323,324]. 
 Resolution Assessment of Reconstruction from Computationally Purified Particle 
Images.  To further confirm our resolution for each finally sorted subpopulation, we 
performed the new gold standard resolution test [321,325], which was recently adopted 
by the cryo-EM community as the most rigorous criterion. First, the data set was 
separated into two half sets of the finally sorted particle images for completely 
independent reconstructions. Second, initial model for each of the two half data sets was 
built from scratch based on the reference-free class-averages from EMAN1’s program 
refine2d.py. Third, each data set was refined to a converged map. Fourth, two final maps 
were aligned using EMAN20 s program e2align3d.py. Lastly, the FSC between the two 
independently reconstructed maps was computed. According to the gold standard FSC = 
0.143 criterion, the resolutions are: 8.9Å, 9.2Å and 15.9Å, for EL43Py398A-GroES-
ATP (in C7), EL43Py398A-RuBisCO-GroES-ATP (in C1) and EL398A-RuBisCO-
GroES-ATP (in C1) respectively (Figures 2.6C, 2.7A, and 2.8B).  
 Variance Map Calculations.  Briefly, 100 3D reconstructions were obtained from 
randomly sampled subsets of particle images with determined orientations from which  
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Figure 2.6: The EL43Py398A-GroES-ATP Complex.  (A) A hydrolysis deficient 
variant of EL43Py (EL43Py398A) stalls at the same point in the GroEL-GroES folding 
cycle as EL43Py. Assisted folding by EL43Py and EL43Py398A was examined using a 
single turnover folding assay. So that the extent of folding could be assessed inside the 
GroEL-GroES cavity, without the need to disrupt the complex and release the protein for 
assembly, the monomeric enzyme Rhodanese (rho) was employed. Native rho was 
denatured using acid-urea and was then mixed with either of four different tetradecamer 
GroEL variants to form binary complexes: (1) wild-type GroEL (wt EL), (2) 
EL43C/D398A, the same variant of GroEL from which EL43Py398A is derived, but 
with no dye attached to position 43 (EL43C398A), (3) EL43Py and (4) EL43Py398A. In 
each case, 100 nM denatured rho was mixed with 250 nM GroEL tetradecamer and the 
samples were then incubated at room temperature for 10-15 min. Each complex was then 
rapidly mixed with 500 nM GroES and 0.1 mM ATP, incubated for 5 s, followed by 
rapid depletion of excess ATP with hexokinase and glucose to prevent cycling. Because 
the added GroES can bind to either the substrate-occupied or empty rings of each 
tetradecamer (but not, under these conditions, both rings), the maximum theoretical 
folding yield for wild-type GroEL should be 50%. Both wt GroEL and the hydrolysis 
deficient, but dye free, EL43C398A variant display essentially identical rho refolding 
curves, with a plateau at 55%–60%. The EL43Py398A variant, despite being unable to 
hydrolyze its bound ATP, displays folding behavior comparable to EL43Py. Error bars 
are one SD. (B) A typical cryo-EM image for the EL43Py398A- GroES-ATP complex at 
a defocus of 2.88 mm is shown. (C) Resolution assessment EL43Py398A-GroES-ATP 
complex map using the gold standard 0.143 FSC cut-off criterion yielded a resolution of 
8.9 Å. The subpopulation of the asymmetric, bullet- shaped EL43Py398A-GroES-ATP 
complex was sorted from the heterogeneous mixture of several other complexes (e.g., 
uncomplexed and symmetric EL43Py398A-GroES2- ATP; see Experimental Procedures) 
and reconstructed with C7 symmetry imposed. (D) The crystal structure of the 
GroEL-GroES-ADP complex does not display extra density around the equatorial stem 
loops and C-termini. The X-ray structure of the GroEL- GroES-ADP complex (PDB ID 
code 1AON; green) is superimposed on its transparent density map, low-pass filtered to 8 
Å (gray). A medial slice of the structure along the 7- fold symmetry axis is shown. Note 
that no extra density exists beyond the stem loops 
(dashed circles) and C-termini, compared to Figure 2.3C. (E) Association of the GroEL 
C-terminal tails with the engineered pyrene dyes in the EL43Py398A-GroES-ATP 
complex. A slice of the EL43Py398A-GroES-ATP complex along the 7-fold symmetry 
axis is shown at a slightly lower contour level (0.9 s) than in Figure 2.3C and is overlaid 
with a model obtained from flexibly refined, rigid-body fitting (magenta). The density 
for the EL43Py398A-GroES-ATP is rendered transparent. The C-termini from the cis 
(upward pointing red arrows) and trans (downward pointing red arrows) rings curve 
toward, and appear to make intimate contact with, the engineered pyrene dyes on the 
equatorial stem loops. 
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Figure 2.7: The EL43Py398A-RuBisCO-GroES-ATP Complex. (Related to Figure 2.4) 
(A) The FSC curve for the EL43Py398A-RuBisCO-GroES-ATP structure is shown. The 
resolution of the structure is 9.2 Å by the gold standard 0.143 FSC cut-off criterion. (B) 
The C7 symmetry of the GroEL trans ring is slightly broken in the EL43Py398A-
RuBisCO-GroES-ATP. A plot of the cross correlation coefficient between the trans ring 
apical domains of the EL43Py398A-RuBisCO-GroES-ATP complex (shown in Figure 
2.4A) and one subunit from the C7-symmetrized map of the same trans-ring apical 
domains, rotated along the applied C7 symmetry axis, is shown. The peaks in each curve 
have different heights and spacing, indicating the C7 symmetry of the canonical GroEL 
rings is broken on the trans ring, as well as the cis ring (Figure 2.6B). (C) A slice across 
the cis ring equatorial domain is shown at a contour level of 1.35 s, illustrating the well 
resolved equatorial helices and highlighting the subnanometer resolution of the 
reconstruction. (D) Interaction of the non-native RuBisCO monomer with density near 
the pyrene dye attachment points on the cis-ring equatorial stem loops. A transverse slice 
across the cis ring equatorial domain of the EL43Py398A-RuBisCO-GroES-ATP 
structure, overlapped with the model obtained from strongly restrained flexible fitting 
(blue) with the density rendered transparent. This slice is slightly above the stem loops 
and is viewed from the cis ring toward the trans ring. The nonnative RuBisCO monomer 
is rendered in gold and each of the seven GroEL subunits are shown in a different color 
and labeled (1-7). At this contour level (1.0 s) the stem loop can be seen to make direct 
connect with the RuBisCO monomer, though with different apparent strengths; the 
stem-loop region from subunit 4 shows no apparent connection to the RuBisCO 
monomer. 
65 
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Figure 2.8: The EL398A-RuBisCO-GroES-ATP Complex. (A) A typical cryo-EM 
image for the complex at a defocus of 2.98 mm. (B) FSC curve for the structure, 
indicating a resolution of 15.9 Å by the gold standard 0.143 FSC cut-off criterion. (C) A 
medial slice of the refined structure is shown, using a different initial model low-pass 
filtered to 40 Å from the GroEL-GroES-ADP crystal structure (PDB ID code 1AON). 
Note that this starting model contains no density inside the cavity of GroEL/ES. Even 
though refined from a different starting model, the final structure still shows the 
association (black arrow) between the RuBisCO and one of C-terminal/stem-loop 
regions. In our gold standard resolution test, in which the initial models were built from 
scratch, the connection density between the substrate protein and the region of the 
GroEL C-termini and stem loops still exists in both independent maps from two separate 
half data sets (data not shown). 
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the 9.2 Å density map in Figure 2.4A was reconstructed. A 3D variance map and a 3D 
average map were calculated using these 100 reconstructions. The final variance map 
was low-pass filtered to 15 Å and the average map was low-pass filtered to 9.0 Å.  
 Flexible Model Fitting to Cryo-EM Maps.  The GroEL-GroES complexes 
examined here all contain the hydrolysis deficient D398A mutation and, therefore, have 
ATP bound within the cis complex. In order to determine whether the results of the 
fitting analysis were affected by the starting X-ray structure, the EL43Py398A-
RuBisCO-GroES-ATP complex was re-analyzed using the X-ray structure of an ATP-
bound GroEL-GroES complex (PDB ID code 1PCQ). The differences between the fitted 
models derived from a starting ADP-bound X-ray structure (PDB ID code 1AON) and a 
starting ATP-bound X-ray structure were negligible, with a per subunit RMSD for the 
Ca atoms of 0.6-0.7 Å. This is less than the per-subunit Ca RMSD between the X-ray 
structures themselves (0.7-1.0 Å), and less than the difference between the starting 
1PCQ model and the fitted model derived from this X-ray structure (0.9 - 1.3 Å). These 
results demonstrate that the final models obtained from the fitting analysis outlined 
above are not biased by the use of the ADP-bound GroEL-GroES-ADP structure (PDB 
ID code 1AON) as the starting model.  
A network of elastic restraints was used, with in total 117,388 (two times the 
number of atoms) harmonic distance restraints which were randomly chosen from the 
list of atom pairs that are initially within a distance of 3 to 12 Å. This choice of restraints 
was used for all model refinements expected for the lower resolution EL398A-
RuBisCO-GroES-ATP map, for which 176,610 distance restraints (three times the 
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number of atoms) were chosen from a distance interval of 3-15 Å , leading to overall 
stronger restraints (almost equivalent to rigid-body fitting). With these strong restraints, 
the structure of each subunit remained very close to the starting crystal structure, with an 
RMSD value of only 0.3 Å for the cis-ring subunits. In general, no restraints between the 
different monomers were used. It should be noted that the elastic network was chosen 
not to be deformable, i.e., the gamma value was set to zero. In total, 100 steps of 
refinement with DireX were performed. A cross-validation approach was used to 
identify the optimally fitted model and to prevent overfitting. In brief, only Fourier 
components of the cryo-EM density map lower than 9 Å were used for fitting, while 
Fourier components from the so called ‘free’ interval 7–9 Å were used for validation 
only. For this, the cross-correlation coefficient, Cfree, is calculated between the model 
density map and the cryo-EM density map, both of which were band-pass filtered using 
the free interval, thus containing information that has not been used for fitting. Both the 
choice of the restraints and the choice of which of the 100 models generated during 
fitting were picked for final analysis were based on maximizing the Cfree value. For the 
EL398A-RuBisCOGroES-ATP case a free interval of 9–12 Å was used, i.e., only 
Fourier components with a resolution lower than 12 Å were employed for fitting. Elastic 
restraints within secondary structure elements were weighted twice as strong as in loop 
regions. 
Fitting of X-ray structure into cryo-EM density maps.  To standardize the pixel 
size of the substrate occupied and empty density maps of the GroEL-GroES complexes, 
a number of density maps were generated with different pixel sizes between 2.0 and 2.2 
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Å because different electron microscopes and recording media were used.  The X-ray 
structure of the GroEL-GroES-ADP complex (PDB ID: 1AON) was then refined against 
each of these density maps using DireX [320].  As the orientation of the equatorial 
domains in the density maps was very similar to the X-ray structure, we used those 
domains as reference regions for magnification calibration for each map.  The RMSD 
between all equatorial domains of the fitted models and the X-ray structure of the 
GroEL-GroES-ADP complex was calculated and the optimal pixel size was chosen as 
the one that leads to the smallest RMSD value.  The optimized pixel sizes for the three 
density maps of the EL43Py398A-GroES-ATP, EL43Py398A-RuBisCO-GroES-ATP 
and EL398A-RuBisCO-GroES-ATP complexes were 2.08, 2.04 and 2.12 Å, 
respectively.  
The GroEL-GroES-ADP crystal structure (PDB ID: 1AON) was fitted as a rigid 
body into the density maps of the EL43Py398A-GroES-ATP, EL43Py398A-RuBisCO-
GroES-ATP, EL398A-RuBisCO-GroES-ATP and EL398A-GroES-ATP complexes.  
This rigidly docked structure served as the starting point for our strongly restrained 
flexible fitting using the program DireX [320].   
 Accession Numbers.  The cryo-EM density maps for EL43Py398A-GroES-ATP 
complex, EL43Py398A-RuBisCO-GroES-ATP complex and EL398A-RuBisCO-GroES-
ATP complex are deposited to the EMDB with accession numbers EMD-2325, EMD-
2326 and EMD-2327, respectively. The fitted models are deposited in the PDB with 
accession numbers 3zpz, 3zq0 and 3zq1, respectively. 
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Results 
Cryo-EM of a functionally trapped GroEL (EL43Py)-GroES complex.  Previous 
work showed that the GroEL variant EL43Py is a potent tool for examining the linkage 
between substrate protein encapsulation, release and folding [158].  EL43Py was created 
through homogeneous N-1-pyrene maleimide alkylation of a surface-exposed Cys 
residue engineered into a stem-loop at the bottom of the GroEL cavity.  EL43Py 
encapsulates non-native substrate proteins beneath GroES, but only very slowly releases 
them into the GroEL-GroES cavity to initiate folding.  The EL43Py variant thus 
provides an excellent opportunity to trap and structurally characterize a key 
conformation of the GroEL-GroES complex that is essential for substrate protein 
encapsulation, but which is normally highly transient (the GroES-bound R2 state of the 
GroEL ring; Figure 2.1D).  In order to facilitate this study, we incorporated one 
additional modification into the EL43Py background, introducing a well-established 
mutation (D398A) that prevents ATP hydrolysis by GroEL, without affecting ATP or 
GroES binding [163].  EL43Py398A stalls at the same point in the allosteric cycle as 
EL43Py (Figure 2.6A), but cannot hydrolyze ATP (data not shown).  Using 
EL43Py398A and limiting amounts of ATP and GroES, we were thus able to create a 
chaperonin sample enriched in asymmetric EL43Py398A-GroES-ATP complexes (a so-
called ATP bullet complex) with the cis cavity trapped in the R2 configuration.  Cryo-
EM was used to image this sample (Figure 2.6B), which contains multiple molecular 
species even when using an optimized mixing protocol, because the assembly reaction 
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can never be driven to completion to yield a single, unique EL43Py398A-GroES-ATP 
bullet complex.   
We applied a consecutive multiple-model refinement strategy, which was used to 
successfully analyze images of chaperonins with mixed conformations and compositions 
[319,323,326].  The first round of processing of 71,200 particle images yielded three 
sub-populations of images that resulted in free GroEL tetradecamer (no GroES bound), 
bullet-shaped GroEL-GroES complexes (with GroES bound to only one end of the 
GroEL tetradecamer) and football-shaped GroEL-GroES2 complexes (with GroES 
bound to both ends of the GroEL tetradecamer).  Because we were only interested in the 
structure of the bullet-shaped complex in the present study, we did not pursue a 
structural determination of the other sub-populations.  
The subset of images corresponding to the bullet-shaped complex was subjected 
to several additional rounds of multiple-model refinement to yield a final homogeneous 
dataset of 8,372 bullet-shaped particle images.  This final data set was split into two 
halves for two completely independent reconstructions for a gold standard resolution 
assessment [321].  A 3D structure of the bullet complex at ~ 8.9 Å was reconstructed 
using C7 symmetry (Figure 2.3A and Figure 2.6C) from all 8,372 highly selected 
particle images.  A symmetry-free reconstruction from the same set of 8,372 highly 
selected particle images was also obtained at 13.9 Å resolution.  Without a symmetry 
imposition, the subunits are not perfectly symmetrically arranged, but do not deviate far 
from 7-fold symmetry (data not shown).  Because the symmetry-free map is close to C7 
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symmetry, and the symmetry imposition generated a higher resolution map, we 
employed the symmetry-imposed map for subsequent structural analysis.  
The structures of the wild type GroEL-GroES-ADP complex and the 
EL43Py398A-GroES-ATP complex bear substantial similarities at ~ 9 Å resolution, 
except in three locations.  First, the position of the GroEL apical domains and the 
orientation of GroES, are slightly shifted in the EL43Py398A-GroES-ATP complex (an 
R2-ES complex; see below).  Secondly, substantial additional density protrudes into the 
chaperonin cavity from the end of a stem loop (amino acids 34 - 52) at the base of the 
EL43Py398A-GroES cis cavity (Figure 2.3B-2D and 2.6D).  This density emanates in 
part from the expected attachment point of the pyrene dyes at position 43, which resides 
at the tip of the stem loop (Figure 2.3B).  However, the density near this position is 
larger than can be accounted for by the dye molecule alone (Figure 2.3D).  Thirdly, 
significant density rises up from the bottom of each GroEL subunit (large red arrow in 
Figures 2.3C, 2.3E and 2.6E), beyond the last crystallographically resolved residue at 
position 525, toward the dye attachment position.  The location of this additional density 
is consistent with the normally flexible C-terminal tails of the GroEL subunits, which 
extend from residue 526 to the C-terminus (a total of 23 amino acids), rising from the 
bottom of the GroEL subunits and interacting with the pyrene dyes attached to the 
protruding stem loop (Figure 2.3C and 2.3D, Figure 2.6E).  Additional density is also 
apparent in the trans ring of the complex (Figure 2.6E), though the density in this ring is 
somewhat more complex than that observed in the cis ring, and may suggest that the 
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GroEL C-terminal tails in the trans ring make contact with both the pyrene dyes and the 
apical domains.  
 Visualizing an encapsulated non-native protein.  We next examined the 
conformation of the EL43Py398A-GroES-ATP complex in the presence of a non-native 
substrate protein.  To accomplish this goal, we modified our original preparation 
protocol to add the well-characterized GroEL-dependent substrate protein RuBisCO.  In 
brief, EL43Py398A was first mixed with non-native RuBisCO to form a binary complex.  
The EL43Py398A-RuBisCO binary complex was then mixed with limiting ATP and 
GroES, which results in the formation of multiple species, including the bullet-shaped 
EL43Py398A-RuBisCO-GroES-ATP complex, both with and without non-native 
RuBisCO inside the cis chamber.  After cryo-EM imaging (Figure 2.9A) and 
heterogeneity sorting of the particle images, we examined the first of two major sub-
populations of bullet-shaped particle images, which were used to produce both 
symmetry-imposed and symmetry-free maps.  The symmetry-imposed map for this 
RuBisCO-free sub-population, which is devoid of density within either cis or trans 
cavities (Figures 2.9B-2.9C), is very similar to that of the empty EL43Py398A-GroES-
ATP complex (Figure 2.3A).  Additionally, the unwrapped density in the symmetry-free 
reconstruction from the same set of RuBisCO-free particle images shows that the 
complex retains 7-fold symmetry (Figure 2.9D).   
We examined the second major sub-population of bullet-shaped particle images 
to generate a 9.2 Å symmetry-free reconstruction of the bullet-shaped complex (Figure 
2.4A and Figure 2.7A).  Remarkably, this map displays strong density within the cis  
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Figure 2.9: Reconstructions of a RuBisCO-Free, Bullet-Shaped Subpopulation from the 
EL43Py398A+RuBisCO+GroES+ATP Sample. (A) A typical cryo-EM image of the 
complex at a defocus of 3.1 mm. (B and C) C7 symmetry was imposed for these 
reconstructions to achieve subnanometer resolution. The isosurface thresholds for the 
whole map (B) and the cutaway map (C) were 1.2 s and 0.9 s, respectively. Note that (B) 
is very similar to Figure 2.3A and no substrate protein density was observed from (C). 
(D) Side view of the unwrapped map for a separate, symmetry-free reconstruction of the 
same RuBisCO-free, bullet-shaped sub-population at 10 Å resolution. The isosurface 
threshold was 1.1 s. Note that there is no apparent symmetry break-down among the 
subunits within the cis ring. 
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cavity, most likely from the non-native RuBisCO monomer trapped within the stalled R2 
complex (gold in Figure 2.4A).  The estimated mass of the visible RuBisCO monomer at 
a contour level of 1.0 σ is ~ 35 kDa, representing roughly 70% of the native RuBisCO 
monomer mass, assuming the central density comes from the RuBisCO alone.  However, 
no regular secondary structural elements could be defined in the putative RuBisCO 
density either visually or quantitatively (based on SSEHunter; [327]), and no fragment of 
the RuBisCO crystal structure could be docked convincingly into the density.   
The presence of the non-native RuBisCO within the R2 cavity also alters the 
structure of the GroEL-GroES complex itself.  The rotational symmetry of the 
EL43Py398A apical domains, on both the cis and trans rings, is broken in the presence 
of non-native RuBisCO (Figure 2.10A-2.10C and Figure 2.7B), with a gap appearing 
between the apical domains of two cis-ring neighboring subunits (Figure 2.10A and 
2.10C).  Interestingly, the point at which the cis ring appears to break 7-fold rotational 
symmetry coincides with direct physical interaction between the non-native RuBisCO 
monomer and the lower segment of the apical domains of two cis ring subunits (Figure 
2.4B-2.4D; Figure 2.10C and 2.10D).  The reliability of this connecting density is 
substantiated by its low variance in the 3D variance analysis from 100 reconstructed 
maps with different subsets of particle images (red in Figure 2.4D).  The cis-ring 
equatorial domains also deviate slightly from C7 symmetry, which can be observed as 
differences in the separation of the equatorial domain helices between different subunits 
(Figure 2.7C).   
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Figure 2.10:  The C7 Symmetry of the GroEL Cis-Ring is Broken in the EL43Py398A- 
RuBisCO-GroES-ATP Complex near Points of Contact between the Non-Native 
RuBisCO and the GroEL Cavity Wall.  (A) Cis-ring apical domains of the 
EL43Py398A-RuBisCO-GroES-ATP structure are shown as in Figure 2.4A, viewed 
from the top of the cis ring.  A gap (black arrow) in the ring density is observed between 
subunit 2 (purple) and subunit 3 (dark cyan). (B) The cross correlation coefficient 
between the map of the cis-ring apical domains and a symmetric reference indicates 
subunit 4 is closer to subunit 3, which is approximately 9 degrees off its C7 symmetrical 
 position, leaving a gap between subunits 3 and 2 (black arrow).  (C) The gap (black 
arrow) between two neighboring GroEL subunits is shown in an unwrapped, planar 
display from the outside of the 9.2-Å density map of
EL43Py398A-RuBisCO-GroES-ATP, as viewed from the side. (D) Top-view slice of the 
planar map, through the lower region of the cis ring apical domains (panel C, blue dashed 
line) shows interactions between the non-native RuBisCO monomer and the lower aspect 
of the GroEL apical domains of subunits 2 and 4 (blue circles).  (E) Top- view slice of 
the planar map through the upper section of the equatorial domains (panel C, dashed 
black line) indicates contacts with the GroEL subunits near the stem-loop region of the 
equatorial domain. The isosurface threshold for (D and E) is 0.9 σ. 
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A role for the GroEL C-terminal tails in protein encapsulation.  A second 
striking feature of the R2 state revealed by the EL43Py398A-RuBisCO-GroES-ATP 
complex is a direct, physical contact between the non-native RuBisCO monomer and 
density from the base of the GroEL cavity wall (Figure 2.4B-2.4C; Figure 2.10E; Figure 
2.7D).  This interaction site is principally in the region of the dye-modified stem loops 
near amino acid 43, and some of this interaction is probably due to contact between the 
pyrene dyes and the non-native substrate protein (Figure 2.7D).  However, in the 
absence of RuBisCO substantial density from the GroEL C-termini is also present in this 
region (Figure 2.3C and 2E; Figure 2.6E).  Several studies have suggested that the C-
terminal tails of the GroEL subunits play important, though poorly defined, roles in 
protein folding and regulation of the GroEL ATPase cycle [203,209,246,250]. 
Additionally, 3D variance analysis of the EL43Py398A-RuBisCO-GroES-ATP structure 
suggests a direct and heterogeneous interaction between the non-native RuBisCO and 
the C-terminal region of the GroEL subunits (Figure 2.4D).  By far some of the largest 
3D variance in the GroEL subunits in the EL43Py398A-RuBisCO-GroES-ATP complex 
appears around the equatorial domains, in regions near or containing the C-terminal tails 
of the GroEL subunits.  While high variance regions (red in Figure 2.4D) are observed 
on both the cis and trans rings, in the cis ring these regions appear to be in intimate 
contact with the non-native substrate protein (Figure 2.4D).  The putative RuBisCO 
density also displays high variance, suggesting that the non-native protein remains 
conformationally heterogeneous at this stage of the GroEL reaction cycle. 
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We next considered whether the observed contacts between the C-terminal tails 
and non-native RuBisCO require the presence of the pyrene dyes.  Using a mixing 
protocol similar to that described above, we created a population of asymmetric 
complexes using the GroEL variant D398A (EL398A) that does not contain the pyrene 
dye.  Following imaging (Figure 2.8A) and heterogeneity sorting, the bullet-shaped 
structure of the EL398A-RuBisCO-GroES-ATP complex with RuBisCO within the cis 
cavity was solved to 15.9 Å without imposing a symmetry constraint (Figure 2.5 and 
Figure 2.8B).  Because the EL398A-GroES complex does not stall in the R2 state, but 
productively releases the substrate into the cis cavity and initiates folding, though it 
cannot hydrolyze its bound ATP [163], the EL398A-RuBisCO-GroES-ATP complex 
constitutes a substrate-occupied R3 state of the cis ring (Figure 2.1E).   
Once again, a substantial amount of density from the RuBisCO monomer is 
visible within the cis cavity (Figure 2.5B).  The apparent mass of the RuBisCO 
monomer in this complex appears to be less than that in the EL43Py398A-RuBisCO-
GroES-ATP structure (Figure 2.4B and Figure 2.7D).  This is likely due to the fact that 
the R3 cavity of the EL398A-GroES complex is fully folding active (Figure 2.1E), 
unlike the R2 cavity of the EL43Py398A-GroES complex (Figure 2.1D).  Even though 
the EL398A complex was rapidly processed for cryo-EM freezing to prevent complete 
folding of the encapsulated RuBisCO, the initiation of folding in this complex could not 
be blocked at a specific step, as it is with EL43Py398A.  The enclosed RuBisCO 
monomer will thus be a highly heterogeneous mix of both folded and non-native states, 
resulting in a lower resolution reconstruction.  The C-terminal tails of the GroEL 
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subunits are also not resolved, because the map represents a heterogeneous ensemble of 
interactions between the RuBisCO monomer and the C-terminal tails.  Nonetheless, a 
significant contact between the base of the GroEL cavity wall, in the region of the C-
terminal tails and stem loop and the RuBisCO monomer is apparent (Figure 2.5B).  To 
further validate this structure, a completely independent reconstruction of this structure 
with a different initial model in which the cis cavity was empty (a low-pass filtered X-
ray structure of GroEL-GroES-ADP complex; PDB ID: 1AON) still converged well and 
displayed a very similar contact between the encapsulated RuBisCO and the GroEL C-
terminal region and stem loops (Figure 2.8C).  As expected for a released and folding 
competent RuBisCO monomer, this contact is less substantial than observed in the 
EL43Py398A complex (Figure 2.10E, Figure 2.7D and Figure 2.5B) and, more 
importantly, does not depend upon the presence of the pyrene dyes.  
The contact between the GroEL C-terminal tails and non-native RuBisCO 
suggests that the C-termini play a direct and important role in ensuring efficient substrate 
protein encapsulation beneath GroES.  In order to test this hypothesis, we generated a 
GroEL variant with a C-terminal truncation at the last crystallographically resolved 
residue (EL∆526).  A similar truncation has been previously observed to display both 
perturbed ATPase activity and a reduced ability to support folding of several model 
substrate proteins [203,209,250].  We employed this GroEL variant in a gel filtration 
assay designed to score the efficiency of protein encapsulation (Figure 2.11A).  When 
non-native GFP is bound to the trans ring of a wild-type GroEL-GroES-ADP bullet, 
approximately half of the initially bound protein is encapsulated inside a new cis cavity  
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Figure 2.11:  Removal of the GroEL C-Terminal Tails Results in Premature Substrate 
Protein Release and Reduced Encapsulation Efficiency.  (A) Experimental schematic:  
non-native substrate protein (blue) is bound to the open trans ring of a GroEL ADP 
bullet complex in the presence of excess GroES.  Encapsulation is initiated by the 
addition of ATP.  ATP binding and turnover is limited to a single round by addition of 
hexokinase and glucose within 10 sec of ATP addition.  Complexed and free substrate 
proteins are separated by gel filtration chromatography with an in-line fluorescence 
detector.  (B) Example of an encapsulation experiment using GFP as the substrate 
protein.  The positions of encapsulated GFP (GroEL-GroES complex) and released GFP 
(free GFP) are indicated with arrows, for both wild-type GroEL (wtGroEL) and the 
∆526 truncation mutant (∆526).  Encapsulation is quantitated for three independent 
substrates: (C) GFP (normalized fluorescence peak area; n = 6), (D) rhodanese 
(normalized SDS-PAGE band intensity by densitometry; n = 4) and (E) RuBisCO 
(fluorescently labeled; n = 6).  The reduction in encapsulation of non-native substrate 
protein by ∆526 GroEL relative to wtGroEL is robust: P = 6.5 x 10-9 for GFP, P = 
0.0007 for rhodanese, and P = 0.0007 for RuBisCO (paired t-test; error bars are one 
standard deviation). 
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upon the addition of limiting ATP (Figure 2.11B).  However, when the GroEL C-
terminal tails are removed in the EL∆526 variant, the efficiency of GFP encapsulation 
beneath GroES drops dramatically (Figure 2.11C).  Similar results are obtained when the 
same experiment is conducted with both non-native rhodanese (Figure 2.11D) and 
RuBisCO (Figure 2.11E), though the drop in encapsulation efficiency is not as 
substantial.   
Structural changes in the GroEL-GroES complex between the R2 and R3 states 
Following GroES binding and substrate protein encapsulation, the R2 state of the 
GroEL-GroES complex must then execute a shift to the R3 state, whereupon the 
substrate protein is released into the GroEL-GroES cavity and folding is triggered 
(Figure 2.1).  In order to gain additional insight into this transition, we re-examined our 
cryo-EM data using strongly restrained flexible fitting of the atomic model of the 
GroEL-GroES-ADP complex (PDB ID: 1AON) into our cryo-EM maps (Figures 2.3A, 
2.4A and 2.5A) with the program DireX [320].  The models generated from each flexible 
fitting analysis were then compared with each other in an attempt to isolate the 
conformational changes that lead from the R2 to the R3 state of the GroEL-GroES 
complex.     
We first sought to identify structural differences between the R2 and R3 
complexes that do not depend on the presence of the non-native substrate protein.  This 
was accomplished by comparing the EL43Py398A-GroES-ATP complex, representing 
an empty R2 complex, to a previously described EL398A-GroES-ATP complex [328], 
representing, in principle, an empty R3 complex (Figure 2.1E).  Surprisingly, the 
  
 
83 
conformational differences between these two complexes are relatively small.  The cis 
ring apical domains appear to display slight counter-clockwise rotations (1-2 degrees) 
within the plane of the ring, but the overall position and elevation of the apical domains 
do not appear to change substantially (Figure 2.12A and 2.12B).  Likewise, the 
equatorial domains show almost no movement at the current resolution (Figure 2.12A).  
The position and conformation of the GroES heptamer also appear mostly unchanged 
(Figure 2.13A).  The lack of substantial conformational differences between these two 
complexes suggests that either (1) the conformation we observe for the EL43Py398A-
GroES-ATP complex is further along the R2-to-R3 transition than expected or (2) that 
the detailed conformational properties of either the R2 or R3 state are not observable or 
stable in the absence of the non-native substrate protein.   
To address these questions, we compared the empty R2 complex (EL43Py398A-
GroES-ATP from Figure 2.3A) with the substrate protein occupied R2 complex 
(EL43Py398A-RuBisCO-GroES-ATP from Figure 2.4A).  As shown in Figure 2.14, 
only slight differences between the two complexes are apparent, with the notable 
exception of the disruption of rotational symmetry and local structural shifts in the apical 
domains that make direct contact with the non-native substrate protein.  These 
observations suggest that the global conformation of the R2 state of the EL43Py398A cis 
ring is stable in the presence of the substrate protein. 
We next examined whether conformational differences between an R2 and R3 
complex can be detected when the cis cavity is occupied by a substrate protein.  
Strikingly, the substrate-occupied R3 complex (EL398A-RuBisCO-GroES-ATP from  
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Figure 2.12: The Transition from the R2 to the R3 State in the Presence of RuBisCO 
Involves Large Structural Rearrangements of Both the Cis and Trans Rings.    
(A-C) Atomic models of the GroEL-GroES complex (PDB ID: 1AON) were refined 
against density maps of the empty EL43Py398A-GroES-ATP (R2ATP; Figure 2.3A) and 
EL398A-GroES-ATP (R3ATP; [328]) complexes.  (D-F) Atomic models of the GroEL-
GroES complex (PDB ID: 1AON) were refined against density maps of the 
EL43Py398A-RuBisCO-GroES-ATP complex (R2ATP + sub; Figure 2.4A) and the 
EL398A-RuBisCO-GroES-ATP (R3ATP + sub; Figure 2.5A).  (A) Side view of the 
EL43Py398A-GroES-ATP density map: structural shifts associated with movement from 
an empty R2 complex to an empty R3 complex are illustrated with a field of difference 
vectors (blue lines and dots) to indicate the change in Cα-positions from R2 (start) to R3 
(end; square). Vector lengths are scaled by a factor of 2 to improve visibility.  (B) View 
of structural changes in the cis apical domains and (C) trans ring apical domains.  (D) 
Side view of the EL43Py398A-RuBisCO-GroES-ATP density map: structural shifts 
indicating the differences between the substrate-occupied R2 and R3 complexes.  (E) 
View of structural changes in the cis apical domains, and (F) the trans ring apical 
domains.  For (B), (C), (E) and (F) the viewing direction and selected slice density are 
indicated by the black arrow and horizontal lines on the GroEL-GroES density map 
shown in the inset, to the lower right.  In all cases, strongly restrained flexible model 
refinement was carried out with DireX.  The designations R2 and R3 reference the 
functional allosteric states of the GroEL ring, illustrated in Figure 
2.1. 
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Figure 2.13: The Orientation of GroES Shifts as the Cis Ring Switches between 
Allosteric States. (A) The conformational differences of the GroES heptamer between an 
empty R2 and an empty R3 state are shown. The viewing direction and selected density 
region for each comparison are shown by the black arrow and horizontal lines on the 
GroEL-GroES density map in the lower middle panel. (B) The change in conformation 
of the GroES heptamer as the RuBisCO-occupied cis cavity transitions from the R2 to 
the R3 state. As in Figure 2.12, the conformational shift for each comparison is 
illustrated with a set of difference vectors (blue lines) illustrating the change in Ca-
positions from the starting point to the ending point (square). The models used to 
generate each difference vector field, as well as the superimposed density maps shown, 
are the same as in Figure 2.12. 
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Figure 2.14: Nonnative RuBisCO Induces Modest, Asymmetric Changes in the Apical 
Domains of the R2 State of the GroEL-GroES Complex. (Related to Figure 2.12) (A–C) 
Atomic models of the GroEL-GroES complex (PDB ID code 1AON) were refined 
against density maps of the EL43Py398A-GroES-ATP (R2ATP) and EL43Py398A-
RuBisCO-GroES-ATP (R2ATP + sub) complexes. Flexible model refinement was 
carried out with DireX. (A) A side view of the EL43Py398A-RuBisCO-GroES-ATP 
density map is displayed, superimposed on a vector field showing the difference between 
the empty (R2ATP) and substrate protein-occupied (R2ATP + sub) complexes. The 
conformational differences between the empty and occupied complexes are illustrated 
with a set of difference vectors (blue lines and dots) showing the change in Ca-positions 
from the starting point to the ending point (square). The vector lengths are scaled by a 
factor of 2 for improved visibility. (B) A view of structural changes in the cis apical 
domains is shown, with the viewing direction and selected slice density indicated by the 
black arrow and horizontal lines on the GroEL-GroES density map shown to the lower 
right. (C) A view of the structural changes in the trans-ring apical domains is shown, 
with the viewing direction and selected slice density indicated by the black arrow and 
horizontal lines on the GroEL-GroES density map shown to the lower right. 
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Figure 2.5) shows substantial rearrangements compared to the substrate-occupied R2 
complex (EL43Py398A-RuBisCO-GroES-ATP from Figure 2.4; see Figure 2.12D-
2.12F).  The cis apical domains of the substrate-occupied R3 ring display sizable 
outward tilts and elevations (Figure 2.12D-2.12E), increasing the cavity volume 
compared to the R2 ring, as well as shifting the position of the bound GroES heptamer 
upward (Figure 2.12D).  This tilt and elevation are also associated with a small 
clockwise rotation of the apical domains within the plane of the ring (Figure 2.12E).  
The conformation of the bound GroES heptamer also changes, with the average position 
of the GroES subunits shifting outward in concert with the apical domains, resulting in a 
somewhat larger opening in the GroES dome orifice (Figure 2.13B).  The equatorial 
domains display only small movements, which are most notable as an outward shift in 
the region near the C-termini (Figure 2.12D).  The collective movements of the R3 cis 
ring thus appear poised to peel away the remaining contacts between the non-native 
substrate protein and the apical domains and C-terminal tails.  Notably, both release 
events occur once GroES is already bound.  The final elevation and rotation of the apical 
domains in the R3 state are likely responsible for locking GroES into its highest affinity 
state for the ATP-bound GroEL ring [163,171]. 
 
Discussion 
Conformational properties of an encapsulated folding intermediate.  The 
structure of the EL43Py398A-RuBisCO-GroES-ATP complex provides the first view of 
a protein folding intermediate inside the GroEL-GroES cavity (Figure 2.4).  While 
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earlier studies have visualized non-native proteins bound to an open GroEL ring 
[312,313,315], as well as fully folded proteins inside the GroEL-GroES cavity 
[311,314], the RuBisCO folding intermediate we describe here exists in transition 
between the two.  Earlier work demonstrated that the RuBisCO monomer upon which 
GroEL operates is likely a middle- to late-stage protein folding intermediate 
[166,168,329], where the polypeptide chain has collapsed but is not as compact as the 
native state, and which possesses significant secondary structure, but poorly organized 
and highly heterogeneous tertiary structure.  We examined the RuBisCO density in the 
EL43Py398A-RuBisCO-GroES-ATP complex for recognizable structural elements of 
native RuBisCO.  Secondary structural elements should theoretically be identifiable in 
this structure, given the sub-nanometer resolution of the entire reconstruction.  For 
example, helices in the equatorial domain of the GroEL subunits can be readily assigned 
(Figure 2.7C).  However, our analysis failed to objectively identify any native state 
secondary structural elements.  The lack of identifiable secondary structural elements in 
the putative RuBisCO region is consistent with the RuBisCO monomer populating a 
heterogeneous ensemble of collapsed and partially organized states (Figure 2.4A). 
  Coordinated action of the GroEL apical domains and C-termini.  Our results 
suggest that direct contact between non-native substrate proteins and the C-terminal tails 
of the GroEL subunits helps prevent premature substrate protein escape during 
encapsulation beneath GroES.  However, this interaction alone cannot fully explain 
efficient encapsulation on an R2 ring.  Indeed, most of the non-native RuBisCO and 
rhodanese are still correctly captured in the absence of the C-termini (Figure 2.11D-
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2.11E), suggesting that contacts between the GroEL apical domains and non-native 
RuBisCO must also play an important role.  The structure of the R2 cavity in the 
EL43Py398A-RuBisCO-GroES-ATP complex provides strong evidence for this 
mechanism.  As shown in Figure 2.4 and Figure 2.10, the non-native RuBisCO makes 
direct, physical contact with the lower section of two cis apical domains in the region of 
Phe 281, a segment of the inner apical domain previously identified as important for 
substrate protein encapsulation and folding [165].  Simultaneous binding of the non-
native substrate protein by both the C-terminal tails and the lower segment of the cis 
apical domains could thus provide a mechanism for retaining the non-native substrate 
protein while the GroEL ring shifts into the R2 state to permit loading of GroES. 
How GroES makes initial contact with a GroEL ring already occupied by a large 
and bulky non-native substrate protein remains unclear.  The earliest stages of the 
encapsulation reaction undoubtedly follow an ATP-driven elevation and movement of 
the GroEL apical domains, structural shifts that are capable of mechanically unfolding 
the bound substrate protein [166,315].  However, only a subset of the apical domains 
must maintain contact with the non-native protein during the encapsulation reaction 
[330].  This observation suggests that, in the earliest stages of contact between GroES 
and a substrate-occupied GroEL ring, apical domains not in direct contact with the 
substrate protein are the ones employed to initially capture GroES.  Such a loading 
mechanism would likely require that the cooperative interactions between the apical 
domains in the R2 cis ring be relaxed or partially uncoupled, in order for different apical 
domains to bind to two distinct ligands in different positions.  In support of this idea, we 
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find that the substrate-occupied EL43Py398A-GroES complex breaks C7 rotational 
symmetry (Figure 2.10A-2.10C). 
 Effects of non-native substrate protein on inter ring allostery.  While changes in 
the cis ring complex are essential for the progression of the GroEL folding cycle, the 
trans ring also plays a central role.  Substrate proteins first enter the GroEL reaction 
cycle on the open trans ring of the asymmetric GroEL-GroES complex, and the 
nucleotide state of each ring directly influences the functional state of the other ring 
[163,166,331,332].  For example, the presence of ATP on one ring inhibits ATP binding 
to the other ring (negative cooperativity) and the presence of ADP on one ring, while 
permitting ATP to bind to the second ring, nonetheless non-competitively inhibits ATP 
hydrolysis on the other ring [156,309,310].  These trans ring effects are thought to be 
essential for imposing the ring-ring asymmetry needed for the GroEL-GroES machine to 
function as a two-stroke motor [156,157,309,333,334].  While the structural nature of 
this ring-ring allostery remains incompletely understood, our flexible fitting analysis of 
different GroEL-GroES complexes provides insight into structural changes imposed on 
the trans ring by the ligand status of the cis ring.  
The occupancy of a cis ring R2 cavity by non-native RuBisCO appears to be 
communicated to the trans ring through substantial and asymmetric displacements of the 
trans ring apical domains (Figure 2.12C, 2.12F and Figure 2.7B).  The apical domains of 
the R2 complex trans ring appear to be drawn inward, resulting in a smaller ring opening 
(Figure 2.12C and 2.12F).  This change involves both counter-clockwise rotations and 
outward tilting of the trans ring apical domains (Figure 2.12C and 2.12F), resulting in a 
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reordering the cavity-facing apical surface.  Interestingly, the conformational shift of the 
trans ring is different in detail when RuBisCO is present in the cis cavity, with the 
magnitude of the apical domain movement in the trans ring being considerably larger, 
and the extent of domain rotation being much smaller (Figure 2.12C and 2.12F).  The 
observed closing down of the trans ring opening in the R2 complex, both with and 
without non-native protein in the cis cavity, could provide a mechanism to prevent non-
native substrate proteins from binding to the trans ring until the substrate protein inside 
the cis complex is committed to release and folding. 
 A model for substrate protein encapsulation, release and folding.  The 
observations described here thus suggest a multi-step model for substrate protein 
encapsulation, release and folding.  Initial capture of a non-native substrate protein on 
the apical face of a GroEL ring is accompanied by additional binding contacts between 
the substrate protein and the C-terminal tails of the GroEL subunits.  Subsequent binding 
of ATP to the GroEL ring initiates the movement of the GroEL apical domains, 
weakening the interaction between the non-native substrate protein and the apical 
domains [151,176,335].  Binding contacts between the non-native substrate protein and 
the C-terminal tails at the base of the cavity serve to reduce the probability of premature 
substrate protein escape as the apical domains move to accommodate GroES.  Our 
structural analysis of the EL43Py398A complexes further suggests that population of the 
GroES acceptor state (the R2 state) requires an intermediate arrangement of the GroEL 
apical domains (Figure 2.12).  The consequence of this altered apical position involves a 
shift in the binding position of the GroES heptamer and the simultaneous exposure of a 
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partial binding surface for the non-native substrate protein at the bottom of the apical 
domains (Figure 2.12).  A subsequent allosteric transition of the GroEL-GroES cavity to 
the R3 state of the ring then results in a shift of the apical domains to their high-affinity 
state for GroES, fully occluding the apical binding surface and ejecting the non-native 
substrate protein from the apical face [158,171,172].  Coordinated movements in the C-
terminal regions of the equatorial domains serve to draw the C-terminal tails away from 
the substrate protein, resulting in full release of the non-native substrate protein and the 
initiation of folding.  However, this release from the C-termini does not appear to be 
total, as the C-terminal tails continue to make ongoing, though reduced, physical 
contacts with the substrate protein following release and the initiation of folding (Figure 
2.5).  Whether these ongoing contacts directly influence the folding of a substrate protein 
remains to be determined. 
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CHAPTER III 
THE C-TERMINAL TAILS OF THE BACTERIAL CHAPERONIN GROEL 
STIMULATE PROTEIN FOLDING BY DIRECTLY ALTERING THE 
CONFORMATION OF A SUBSTRATE PROTEIN* 
 
To function, most proteins must fold into specific three-dimensional structures. 
Although the native conformation of a protein is ultimately governed by the 
thermodynamics of its amino acid sequence in aqueous solution, protein folding is often 
prone to errors [62,82]. Side reactions, like misfolding and aggregation, frequently occur 
and can be especially serious for large and topologically complex proteins inside the 
concentrated interior of a living cell [191,336]. Fundamentally, the twin problems of 
misfolding and aggregation are kinetic in nature and biologically solved by the early 
evolution of several families of specialized machines known as molecular chaperones 
[337]. In general, molecular chaperones prevent or correct folding and assembly errors 
and thereby permit proteins to attain the native states thermodynamically encoded in 
their sequences [239]. Molecular chaperones are thus kinetic editors of protein folding 
reactions. 
Within the network of molecular chaperones that maintain cellular protein 
homeostasis, the Hsp60s or chaperonins occupy a central and essential hub  
                                                            
*Reproduced, with modifications, with permission from Weaver J, Rye HS (2014) J Biol 
Chem 289: 23219-23232.  Copyright 2014 American Society for Biochemistry and 
Molecular Biology, Inc.  For the original publication: JW conceived and designed 
experiments, performed experiments, analyzed data, and contributed to the writing of the 
manuscript. 
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[123,198,239]. The Hsp60s are ancient and widespread and are present in virtually every 
organism currently known. The chaperonin system of Escherichia coli, GroEL-GroES, is 
perhaps the best studied example of this molecular chaperone family 
[190,198,338]. GroEL is a homotetradecamer composed of 57-kDa monomers arranged 
in two stacked, heptameric rings [152]. Each GroEL ring contains a large solvent-filled 
cavity and the upper cavity-facing surface of each ring is lined with hydrophobic amino 
acids that capture incompletely folded substrate proteins (non-native proteins) [152,165]. 
Proteomic surveys suggest that ~80–100 E. coli proteins possess an obligate dependence 
on GroEL for folding, with an additional larger number of proteins gaining an 
intermediate level of assistance from the GroEL-GroES system [89,90]. 
Following capture, most substrate proteins are encapsulated within a sealed 
cavity formed between the GroEL ring and the smaller lid-like GroES co-chaperonin, a 
heptamer of 10-kDa subunits [154,163,177,206,308]. The assembly of the GroEL-
GroES folding cavity results in the initiation of protein folding by release and 
confinement of the substrate protein inside the privileged volume of the GroEL-GroES 
chamber [163]. The formation of the GroEL-GroES folding cavity is a highly ordered 
process, in which binding of the non-native protein on the open trans ring of a GroEL-
GroES complex is followed by the obligate binding of ATP and then GroES to the same 
ring [157-159,163,166]. The encapsulated protein can persist and fold within the GroEL-
GroES cavity for a brief period of ~5–25 s, depending on conditions [157,159,309]. 
Hydrolysis of the ATP inside the GroEL-GroES cavity (the cis cavity) prepares the 
complex for disassembly upon binding of substrate protein and ATP to the 
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second trans ring [157]. Disassembly of the GroEL-GroES cavity results in the release of 
the full population of enclosed substrate protein, folded or not [164,173,339]. Folding 
intermediates that do not commit to their native states within the lifetime of the GroEL-
GroES cis cavity and that cannot complete folding in free solution must be recaptured 
for another round of processing. Thus, under the biologically relevant conditions of 
steady-state ATP turnover, the GroEL-GroES machine proceeds through a highly 
dynamic reaction cycle, the timing of which is ultimately set by the rate of ATP 
hydrolysis [157,159,309,340]. 
Despite over 2 decades of effort, the precise manner in which GroEL facilitates 
protein folding remains controversial. Several mechanisms have been proposed, which 
cluster into two classes based upon whether GroEL is postulated to act passively or 
actively [190,198,239,338]. The prevailing passive mechanism, referred to as the 
Anfinsen cage model, assumes that the folding of GroEL-dependent proteins is, in 
general, only limited by the tendency of on-pathway folding intermediates to aggregate. 
In this view, GroEL facilitates folding by simply binding and sequestering aggregation-
prone intermediates, blocking aggregation, and thereby allowing the inherent 
thermodynamic drive programmed into the protein sequence to express itself 
unencumbered [192,198,338]. Active mechanisms, by contrast, accept the possibility 
that GroEL-dependent substrate proteins populate off-pathway states that have no direct 
access to the native state. Such misfolded conformations are also likely to be highly 
aggregation-prone but, because they cannot be rescued by simple sequestration, require 
an additional corrective action by the chaperonin [190,239]. The nature of this corrective 
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mechanism remains poorly understood but has been suggested to come from either (i) 
repetitive unfolding and iterative annealing [187,341] or (ii) smoothing of a substrate 
protein's free energy landscape as a result of confinement inside the GroEL-GroES 
cavity, where either spatial constraints or interactions between the substrate protein and 
the chaperonin cavity alter the ensemble of folding intermediates, eliminating inhibitory 
states or favoring productive ones [190,239,338]. 
One reason a coherent picture of GroEL-mediated protein folding has yet to 
emerge stems from the broad range of proteins upon which GroEL operates. Several 
proteins have been shown to satisfy the conditions required for a purely passive folding 
mechanism [200,342-344]. However, other proteins appear to require more active 
participation of the GroEL-GroES system to fold [168,199,205]. In examining active 
mechanisms of GroEL-mediated protein folding, we have focused on the CO2-fixing 
enzyme from Rhodospirillum rubrum, RuBisCO, one of the most highly GroEL-
dependent substrate proteins known. We previously demonstrated that RuBisCO 
populates a kinetically trapped, misfolded monomer that is efficiently rescued 
by GroEL in the absence of aggregation [168]. We also showed that GroEL assists 
RuBisCO folding, at least in part, through two phases of multiple axis unfolding of the 
misfolded RuBisCO monomer [159,166,173]. In addition, we observed an 
encapsulation-dependent compaction of the RuBisCO folding intermediate, hinting at 
the possibility of an active role for confinement inside the GroEL-GroES chamber 
[159,166,173]. Work on RuBisCO by others [199,203] also suggested that confinement 
of the RuBisCO monomer alters the folding landscape of the protein. In this case, 
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confinement was suggested to be the dominant mechanism of folding assistance, and the 
nature of the effect was assigned to either the restricted volume or charge character of 
the GroEL-GroES cavity [199,203,204,345]. More recent observations have challenged 
some of these conclusions, however, calling into question confinement-based active 
mechanisms [192,209,346]. 
To probe the relative contribution of unfolding versus confinement, we have re-
examined the folding of RuBisCO using a variant of GroEL in which the character and 
volume of the GroEL cavity have been altered by removal of the unstructured C-terminal 
23 amino acids of the GroEL subunits. Deletion of these C-terminal tails, which project 
upward from the equatorial plane of the GroEL ring into the bottom of the cavity, has no 
effect on the stability of the GroEL tetradecamer but has a notable impact of the folding 
of several proteins, as well as a modest in vivo phenotype [203,204,209,246,250]. 
Additionally, although the C-terminal tails are not resolved in the x-ray crystal structures 
of the chaperonin, using high resolution cryo-EM we recently demonstrated that the C-
terminal tails interact directly with the non-native RuBisCO folding intermediate during 
and immediately after encapsulation by GroES [347]. At the same time, other studies 
have suggested that the amphipathic character of the C-terminal tails is essential for 
efficient folding of several proteins [250]. Still other work has suggested that the 
combined mass of the seven C-termini at the base of the GroEL-GroES cavity is 
important for restricting the volume of the cavity [203,204]. 
Consistent with previous observations, we find that removal of the C-terminal 
tails results in a several fold drop in RuBisCO folding with actively cycling 
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tetradecamer GroEL. However, when RuBisCO folding is confined to the GroEL-GroES 
cavity by using a noncycling, single ring version of GroEL, removal of the C-terminal 
tails displays a much smaller impact on RuBisCO folding. We show that, in part, the 
larger impact of tail removal on the cycling tetradecamer is due to a slowing of 
the GroEL reaction cycle and a large shift in a key allosteric transition of 
the GroEL machine. Removal of the tails also results in a modest slowing of several 
kinetically distinct RuBisCO folding transitions inside the GroEL-GroES chamber. 
Surprisingly, however, the more substantial consequence of C-terminal tail removal is a 
large reduction in unfolding of the RuBisCO monomer at the early stages of 
the GroEL reaction cycle. Reduced unfolding results in a decrease in the fraction of the 
RuBisCO monomers that rapidly commits to the native state. The GroEL C-terminal 
tails thus not only assist in substrate protein encapsulation, but directly participate in 
protein unfolding, a process that is required for maximally efficient folding of the highly 
stringent substrate protein RuBisCO. 
 
Experimental Procedures 
Proteins.  Wild-type and variants of GroEL (SR1, single-cysteine mutants and C-
terminal truncation mutants), wild-type and E98C GroES, and wild-type and cysteine 
mutants of R. rubrum RuBisCO were all expressed and purified as described previously 
[158,159,166,168]. 
 Labeling of Proteins for FRET.  RuBisCO variants were labeled as described 
previously [158,159,166,168], using either 5-iodoacetamidofluorescein (fluorescein, F) 
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and/or 5-(2-acetamidoethyl) aminonaphthalene 1-sulfonate (EDANS, 
ED). GroEL variants were labeled with fluorescein, and GroES-98C was labeled with 
EDANS as described [157,316]. All dyes were purchased from Molecular 
Probes (Eugene, OR) and prepared fresh in anhydrous N, N-dimethylformamide 
immediately before use. The extent of labeling was determined by protein quantification 
by the Bradford assay (Bio-Rad) and dye quantification under denaturing conditions 
using known molar extinction coefficients [157,316]. For RuBisCO variants, site-
specific labeling was verified through denaturing anion-exchange chromatography and 
analysis of proteolytic fragments [316]. GroES-98ED was re-purified via anion 
exchange, and only protein labeled with 2 dyes/heptamer was used. All GroEL variants 
were labeled with 2–3 dyes/ring. 
 Stopped-flow Fluorescence.  Stopped-flow experiments were conducted as 
described previously [166,168,316], using an SFM-400 rapid mixing unit (BioLogic) 
equipped with a custom-designed two-channel fluorescence detection system. Mixing 
was done using two syringes, one containing GroEL-RuBisCO complexes and one 
containing GroES and ATP. The donor-side FRET efficiency was calculated from 
matched sets of donor-only and donor-acceptor experiments as described previously 
[157,316]. 
 Enzymatic Refolding.  The refolding of wild-type RuBisCO was assayed by 
enzymatic activity as described previously [157,163]. Acid-urea-denatured RuBisCO 
was bound to an excess of full-length or truncated SR1. After a 10-min incubation at 
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25°C, GroES and ATP were added. Intra-cavity folding was quenched by addition of 
EDTA and incubation at 4°C, as described [159]. 
 Steady-state and Time-resolved FRET.  Steady-state fluorescence measurements 
were conducted with a PTI fluorometer, with temperature regulation through a jacketed 
cuvette holder (Neslab). Fluorescence lifetimes were measured in the time domain using 
a TimeMaster Fluorescence Lifetime Spectrometer (PTI), with sample excitation from a 
pulsed nitrogen laser coupled to an optical boxcar detector [348]. The average distance 
between donor and acceptor probes was calculated from donor-side FRET efficiencies, 
extracted from both steady-state and time-resolved data, as described previously [166]. 
The Förster distance, R0, was calculated independently for each donor-acceptor pair in 
each complex examined. The value of κ2 was assumed to be ⅔ for all distance 
measurements. In all cases, the average anisotropy of the donor and acceptor probes, at 
each labeling position, was the same when non-native RuBisCO was bound to either 
full-length or truncated GroEL (data not shown). All protein complexes were 
equilibrated with a 10-min incubation at 25°C prior to measurement. Note that in the 
absence of the C-terminal tails, and under active cycling conditions, 10-20% of the 
RuBisCO initially bound to a GroEL ring can escape prior to GroES binding [347]. 
However, under the experimental conditions employed here, in which RuBisCO-
GroEL binary complexes are incubated for several minutes prior to the addition of 
GroES and ATP, the amount of RuBisCO that escapes from a ∆526 ring prior to 
encapsulation by GroES, compared with a wild-type GroEL ring, is negligible (<2%, 
data not shown). 
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Protease Protection.  The protease sensitivity of non-native RuBisCO bound to 
a GroEL ring was conducted as described previously [158,166]. Briefly, 58F-RuBisCO 
was bound to asymmetric GroEL-GroES ADP bullets. Trypsin was added, and time 
points were taken, with the reaction stopped with PMSF. Samples were run on 10% 
SDS-PAGE and imaged using a Typhoon Trio (GE Healthcare). 
 
Results 
Deletion of GroEL C-Termini Slows RuBisCO Folding and Perturbs the GroEL 
Reaction Cycle.  To examine how a change in cavity character impacts the folding of a 
stringent substrate protein, we created a GroEL variant in which the C-terminal 23 
amino acids of the GroEL subunits have been removed. This variant, GroEL∆526–548 
(hereafter ∆526), displays no detectable alteration in tetradecamer assembly or stability 
at room temperature. The behavior of the ∆526 variant during expression, purification, 
and on gel filtration chromatography is identical to wild-type GroEL (data not shown). 
The ∆526 variant also supports a functional chaperonin cycle, in which GroES is bound 
and released in an ATP hydrolysis-dependent manner. However, key properties of 
the GroEL hydrolytic cycle change upon removal of the C-termini. When folding of the 
stringent substrate protein ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO) 
from Rhodospirillum rubrum is examined by tryptophan fluorescence, we observe a 
greater than 2-fold decrease in the apparent folding rate constant with the ∆526 variant, 
compared with full-length GroEL (Figure 3.1A). Notably, the yield of folded RuBisCO 
is not significantly different between full-length GroEL and ∆526 (Figure 3.1A, inset),  
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Figure 3.1: Presence of the GroEL C-Terminal Tails Enhances Protein Folding.  (A) 
folding of RuBisCO by cycling GroEL-GroES was monitored by an increase in 
tryptophan fluorescence. Chemically denatured, wild-type RuBisCO (100 nM) was 
bound to GroEL (200 nM), wild-type (EL; blue), or C-terminal deletion (∆526; green) 
and rapidly mixed with an equal volume of excess GroES (400 nM) and ATP (2 mM) in 
a stopped-flow apparatus. Curves were fit to a single-exponential rate law (black line), 
resulting in observed rate constants of 0.225 + 0.002 min-1 for GroEL and 0.104 + 0.003 
min-1 for ∆526. In each case, the overall folding yield was examined by allowing each 
folding reaction to run to completion (~30 min), followed by a measurement of the total 
tryptophan fluorescence (inset). (B) folding of RuBisCO inside stable single ring-GroES 
complexes monitored by an increase in tryptophan fluorescence. Chemically denatured 
wild-type RuBisCO (100 nM) was bound to full length SR1 (SR, blue) or ∆526 
(SR∆526, green) single-ring variants of GroEL (300 nM) and rapidly mixed with an 
equal volume of excess GroES (600 nM) and ATP (2 mM) in a stopped-flow apparatus. 
Curves were fit to single-exponential rate laws, yielding observed rate constants of 0.225 
+ 0.002 min-1 for SR1 and 0.155 + 0.002 min-1 for SR∆526. n = 10 replicates, with a 
100-ms sampling time. AU, arbitrary units. 
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indicating that the observed decrease in apparent folding rate is not due to an increase in 
aggregation in the presence of cycling ∆526. This result is consistent with observations  
made using other C-terminally perturbed tetradecameric GroELs, using different assay 
methods [203,204,209,250]. 
We next considered whether slower RuBisCO folding is due to a change in intra-
cavity folding in the absence of the GroEL C-termini. To prevent cycling and confine 
RuBisCO folding to the interior of the GroEL-GroES cavity, we employed a previously 
described single-ring variant of GroEL, SR1 [177]. For comparison, we constructed a 
∆526 variant of SR1 (hereafter SR∆526) that is the single ring analog of tetradecameric 
∆526 [203,209,250]. Binding of RuBisCO and GroES to SR∆526 was unchanged from 
SR1 (data not shown). However, RuBisCO folding within the SR∆526-ES cavity is 50–
70% slower than folding inside the SR1-ES cavity (Figure 3.1B). Thus, although we do 
observe a drop in intra-cavity folding rate, the magnitude of this decrease cannot fully 
explain the greater than 2-fold drop in folding rate observed with tetradecameric ∆526. 
Because progression of the GroEL ATPase cycle is essential for facilitated 
folding, we next examined the hydrolytic cycle of ∆526 in greater detail. Previous 
studies demonstrated that C-terminal GroEL truncations like ∆526 can result in a 
reduction of the steady-state ATP hydrolysis rate [204,209,244,250]. However, the 
source of this reduced turnover, as well as the impact on the overall GroEL reaction 
cycle, has not been assessed. The decrease in ATPase rate caused by C-terminal 
truncations, as well as our previous observation of accelerated ATP turnover caused by 
dye-induced perturbations of the C-termini [158], suggested that the C-terminal tails are 
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coupled to the allosteric transitions of the GroEL machine. To test this, we examined the 
rate of ATP hydrolysis by both GroEL and ∆526 at different ATP concentrations. With 
full-length GroEL, we observe the well described, positively cooperative binding of ATP 
to the first GroEL ring (Figure 3.2A) [174,310,349]. Fitting of this transition to the Hill 
equation results in values for the turnover (kcat = 0.12 s
−1 per active subunit), half-
saturation point (K½ = 12.4 µM), and Hill coefficient (nH = 3.3) that are consistent with 
previous measurements. By contrast, ATP hydrolysis by ∆526 displays a substantially 
different response. Although ∆526 shows an initial, positively cooperative transition 
similar to full-length GroEL, the maximal ATPase rate attained is ~40% lower than full-
length (Figure 3.2A). 
Strikingly, ∆526 has a marked roll-off in ATP turnover as the ATP concentration 
exceeds ~20 µM. This decrease in ATP turnover is highly reminiscent of the negative 
cooperativity roll-off displayed by full-length GroEL, except in the case of ∆526, it 
occurs at a far lower ATP concentration. Positive cooperativity in ATP binding to the 
first GroEL ring, followed by negative cooperativity between the rings as the second 
ring fills with ATP is a defining feature of the nested cooperativity model 
of GroEL allostery [310]. The ATPase response curve of ∆526 is well described by the 
nested cooperativity model, with parameters for the initial, positively cooperative event 
(nH = 3.8; L1 = 2.5 × 10
−3, where L1 is the apparent allosteric constant for the first 
transition) shifted to a lower turnover rate (kcat = 0.09 per active subunit) and lower half-
saturation concentration (K½ = 1.5 µM). Additionally, ∆526 displays a dramatic shift in  
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Figure 3.2: Stimulated Folding of RuBisCO is Not the Product of Extended GroEL-ES 
Cavity Lifetime. (A) full-length (EL; blue) or C-terminal deletion (∆526; green) GroEL 
(200 nM) was mixed with various concentrations of ATP, and the steady-state rate of 
hydrolysis was measured. For GroEL, the observed change in initial rate was well fit by 
the Hill equation, yielding kcat = 0.12 + <0.01 s
-1 per active subunit, K1⁄2 = 12.4 + 0.1 
µM, nH = 3.3 + 0.1. The data for ∆526 at low ATP concentrations was also well fit to a 
two-state Hill model (green dashed line), yielding kcat = 0.08 +  <0.01 s 1 per active 
subunit, K1/2 = 6.9 + 0.1 µM, nH = 3.2 + 0.1. The full ∆526 data set was also fit to the 
nested cooperativity model [310], yielding kcat,1 = 0.09 + <0.01 s
 1 per active subunit; 
kcat,2 = 0.05+ <0.01 s
 1 per active subunit, K1⁄2 = 1.5+0.1 µM, nH = 3.8 + 0.1, L1 = 2.5 x 
10 3 + 0.1x10 3, L2 = 9.3 x 10
 5 + 2.7 x 10 5. (B) steady-state ATP hydrolysis by 
GroEL (125 nM) and ∆526 (125 nM) was measured in the presence of excess GroES 
(250 nM), with and without non-native denatured RuBisCO (dRub, 100 nM; SP).  
Addition of dRub to the GroEL-GroES system results in a hydrolysis rate enhancement 
of 1.8-fold (2.1 µM/min to 3.8 µM/min), consistent with previous observations using 
saturating levels of the substrate protein malate dehydrogenase [157]. Addition of dRub 
to the ∆526-GroES system results in a rate enhancement of 2.4-fold (1.2 µM/min to 2.9 
µM/min). (C) lifetime of the GroEL-GroES complex in the absence of substrate protein 
was examined using a previously described FRET assay [157]. ATP (2mM) was added 
to GroES-98ED (100 nM) and either 315F- labeled full-length (EL; blue), or C-terminal 
deletion (∆526; green) GroEL (125 nM). After a one min incubation, unlabeled GroES 
(2 µM) was introduced as a competitor. The change in FRET was calculated from 
matched donor-only and donor-acceptor traces. The curves were fit to a 
single-exponential rate law, yielding rates of 1.32 + 0.02 min-1 (EL) and 0.45 + 0.01 
min-1 (∆526). The average of three experiments is shown. (D) lifetime of the 
GroEL-GroES complex upon addition of a  stoichiometric amount of non-native 
RuBisCO was examined using the same FRET assay as in (C) [157]. Experiential 
conditions are similar; except that a stopped-flow apparatus was employed, and 100 nM 
denatured RuBisCO was mixed with the cycling GroEL-GroES system simultaneously 
with excess, unlabeled GroES. The average of 10 experiments is shown. As reported 
previously, the observed change in FRET efficiency in the presence of non- native 
substrate protein requires a triple-exponential rate law for a good fit [157]. The rate of 
the dominant decay component (k2), previously shown to reflect the substrate 
protein-induced acceleration of GroES release [157], is ~1 s-1 for GroEL and ~0.6 s-1 for 
∆526. 
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the value of the second allosteric coupling parameter, which describes ATP binding to  
the second ring (L2= 9.3 × 10
−5), compared with full-length GroEL (L2 = 6.0 × 10
−9, 
where L2 is the apparent allosteric constant for the second transition). These observations 
strongly suggest that both intra- and inter-ring allostery are altered by removal of the C-
termini in ∆526. 
Because non-native substrate protein can accelerate the GroEL reaction cycle 
[157] and may also induce a shift from a cycle dominated by asymmetric bullet-shaped 
complexes to one dominated by symmetric football-shaped complexes [340,350-352], 
we examined the effect of non-native substrate protein on both ATP turnover and GroES 
release. As with GroEL, non-native substrate protein accelerates the rate of ATP 
hydrolysis by ∆526 in the presence of GroES (Figure 3.2B). However, although the 
magnitude of substrate-stimulated turnover is larger for ∆526 (1.8-fold 
for GroEL versus 2.6-fold for ∆526), the maximal turnover rate for ∆526 is still ~60% 
slower than GroEL. These observations are consistent with steady-state ATPase 
stimulation seen with GroEL and a C-terminal truncation variant using other substrate 
proteins [244]. 
The changes in ATP turnover and allostery exhibited by ∆526 suggested that this 
C-terminal truncation variant progresses through the canonical GroEL reaction cycle 
more slowly than wild-type GroEL. If true, the lifetime of the ∆526-GroES complex 
should lengthen compared with full-length GroEL. To test this possibility, we exploited 
a previously described fluorescence resonance energy transfer assay (FRET) capable of 
tracking the dynamics of the GroEL-GroES complex [157]. In this assay, an acceptor 
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fluorescent probe was covalently attached to a nonperturbative cysteine substitution on 
the backside of the apical domain of either full-length GroEL or ∆526. A donor probe 
was attached to GroES, and the extent of complex formation between the GroEL and 
GroES was then observed by FRET. As shown in Figure 3.2C, the lifetime of the ∆526-
GroES complex in the absence of substrate protein is substantially longer than the 
GroEL-GroES complex (~2.5 times) under conditions of steady-state ATP turnover. The 
rate of GroES release from a ∆526-GroES complex is also slower in the presence of 
non-native substrate protein, although the difference is not as dramatic (Figure 3.2D). 
Interestingly, the differences between GroEL and ∆526 in substrate protein-stimulated 
GroES release and ATP turnover were essentially identical (∆526 is 60% slower). This 
observation suggests that the ∆526 reaction cycle is limited by the same substrate-driven 
release of ADP from the trans ring as is GroEL [158,160,340], but in the absence of the 
C-terminal tails, the system responds more slowly. In combination, these results show 
that the progression of the GroEL reaction cycle is coupled to the dynamics of 
the GroEL C-terminal tails, such that removing the tails slows down the 
functional GroEL cycle. 
It is important to note that the stimulated ATPase rate observed with near 
saturating levels of non-native substrate proteins (Figure 3.2B) is unlikely to apply to the 
RuBisCO folding experiments described here. To minimize aggregation, the GroEL-
GroES or ∆526-GroES systems are typically present in a several fold molar excess over 
the non-native RuBisCO in refolding experiments. Consequently, the overall rate of ATP 
turnover will only be slightly affected by this amount of substrate protein, and the 
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limiting cycling rate for both GroEL and ∆526 will approach the rate observed in the 
absence of substrate protein (Figure 3.2, B and C). 
GroEL C-Termini Alter the Conformation of a RuBisCO Folding Intermediate.  
We next considered whether, at different points in the GroEL reaction cycle, the 
conformation of the RuBisCO monomer is altered by the presence of the C-terminal 
tails. We first examined whether the RuBisCO monomer is bound in the same average 
position on a GroEL ring in the presence and absence of the C-termini. For these FRET 
experiments, the donor was attached to the RuBisCO monomer (Figure 3.3A), and the 
acceptor was positioned either near the outer and upper edge of the ring (EL315-F) or 
near the bottom of the cavity (EL43-F). In all cases, the RuBisCO labeling positions 
were homogeneously derivatized with the donor dye, although the GroEL variants were 
lightly modified at ~2–3 dyes per ring. Acceptor-labeled, ADP-bullet complexes of both 
full-length GroEL and ∆526 were prepared and then mixed with one of four different, 
denatured, and donor-labeled RuBisCO variants. Matched donor-only experiments were 
also performed with unlabeled full-length GroEL and ∆526. Following RuBisCO 
binding, the extent of FRET between four different locations on the folding intermediate, 
relative to two positions on the GroEL tetradecamer, was determined. For all donor 
positions and both acceptor locations, a strong FRET signal is observed, ranging in 
efficiency from 0.42 to 0.75 (Figure 3.3, B and C). Robust differences between the 
different donor-labeled positions suggest that the RuBisCO monomer is asymmetrically 
bound to both the full-length GroEL and ∆526 trans rings. More striking, however, is the 
distinct pattern of differences that emerge when full-length GroEL and ∆526 are  
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Figure 3.3: Contact with the C-Termini Promotes Deeper Initial RuBisCO Binding 
within the GroEL Cavity.  (A) structure of one monomer of the native RuBisCO dimer 
(PDB ID: 9RUB) is shown. Positions of five amino acid locations employed for the 
attachment of exogenous fluorescent probes are indicated. Except for position 58, which 
is a naturally occurring surface-exposed Cys residue, these positions were mutated to 
encode Cys and labeled with thiol-alkylating fluorescent dyes as described previously 
[157,316]. Sites successfully paired for intramolecular FRET assays, in which donor and 
acceptor dyes are attached to the same RuBisCO monomer, are indicated by dotted lines. 
(B) steady-state FRET measurements between chemically denatured, donor-labeled 
RuBisCO (100 nM) bound to the trans ring of acceptor-labeled, full length (EL; blue) or 
C-terminal deletion (∆526; green) GroEL-GroES ADP bullets (120 nM). For these 
measurements, RuBisCO was labeled with EDANS at each of four sites (amino acids 34, 
209, 356, and 454), and GroEL was labeled with fluorescein near the bottom of the 
cavity through a unique, introduced Cys at position 43 [353]. Error bars represent the 
standard deviation for n = 3 experiments. (C) steady-state FRET measurements as in (B), 
but using GroEL labeled with fluorescein near the top of the cavity, through a unique 
introduced Cys at position 315 [157]. 
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compared.  
For all RuBisCO donor positions, full-length GroEL shows a consistently higher 
FRET efficiency than ∆526 when the acceptor dye is located at the base of the GroEL 
ring (Figure 3.3B). By contrast, this pattern reverses when the acceptor dye is moved to 
the upper edge of the GroEL cavity, with ∆526 showing a consistently higher FRET 
efficiency (Figure 3.3C). These observations suggest that the RuBisCO monomer is, on 
average, shifted higher up the GroEL cavity when the C-termini were removed. 
To investigate the effect of the C-terminal tails on RuBisCO folding in greater 
detail, we next employed an intramolecular FRET assay. The assay is designed to follow 
the conformation of a RuBisCO monomer as it transits the GroEL reaction cycle 
[159,166,168]. A series of RuBisCO variants were used, in which a donor probe was 
attached to one position and an acceptor probe attached to another (Figure 3.3A). We 
used four distinct FRET pairs to measure the intramolecular FRET efficiency of the 
RuBisCO monomer bound to the trans ring of full-length GroEL and ∆526 ADP bullets. 
In all cases, the donor-side FRET efficiency was determined by both steady-state and 
time-domain lifetime measurements. An example of experimental data from one FRET 
pair (209ED-58F) is shown in Figure 3.4A and 3.4B, and the FRET efficiencies and 
calculated distances for all four pairs are shown in Table 3.1. For each pair of sites, the 
measured intramolecular distance was shorter when the RuBisCO monomer is bound to 
a ∆526 ring, compared with a full-length GroEL ring. These measurements suggest that 
the non-native RuBisCO monomer is more compact and less unfolded when it is bound 
to a ∆526 ring. If true, this predicts that RuBisCO bound to a ∆526 ring should be more  
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Figure 3.4: RuBisCO Adopts a More Unfolded Conformation on a GroEL Ring in the 
Presence of the C-Termini. (A) steady-state fluorescence of chemically denatured, 
donor-only (209ED) or donor-acceptor (209ED-58F) labeled RuBisCO (100 nM) bound 
to the trans ring of full-length (EL, blue) or C-terminal deletion (∆526; green) GroEL-
GroES ADP bullets (120 nM). The spectra shown are the average of n = 3 experiments. 
(B) time-resolved fluorescence decay measurements of the same complexes in (A). The 
instrument response function is also shown (IRF). (C) fluorescently labeled RuBisCO 
(58-F; 100 nM) was chemically denatured and bound to the trans ring of either GroEL or 
∆526 ADP bullets (120 nM) and then treated with trypsin for the indicated times before 
quenching with PMSF (1mM). The samples were analyzed by SDS-PAGE and laser-
excited fluorescence gel scanning. An arrow shows the migration position of full-length 
RuBisCO, and brackets indicate the position of three dominant groups of proteolytic 
fragments. (D) amount of full-length RuBisCO remaining at each time point in (C) was 
quantified and plotted as a function of time. The average half-time for the digestion of 
RuBisCO bound to full-length ADP bullets was ~1.5 min (EL, blue) and ~4 min for C-
terminal deletion ADP bullets (∆526, green). AU, arbitrary units. Error bars represent 
the standard deviation of n = 3 experiments. 
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Table 3.1: Intramolecular FRET Measurements of RuBisCO Bound to Wild-Type 
and ∆526 GroEL 
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resistant to protease digestion than a monomer bound to a full-length GroEL ring. As 
shown in Figure 3.4C and 3.4D, RuBisCO bound to a full-length GroEL ring is digested 
by trypsin more rapidly (~3 times) than RuBisCO bound to a ∆526 ring. 
We previously demonstrated that the C-terminal tails help prevent premature 
substrate-protein escape during GroES binding [347]. This finding suggests that the C-
termini maintain contact with the folding intermediate even as the apical domains, which 
bind different parts of the substrate protein, re-arrange in response to ATP binding [347]. 
As the C-terminal tails appear to contribute to binding-induced unfolding, we reasoned 
they may also impact a later step, ATP-driven forced unfolding [159,166]. To test this 
possibility, we examined the conformation of the GroEL-bound RuBisCO monomer 
during ATP and GroES binding. Using the same set of intramolecular FRET pairs 
described above, in combination with stopped-flow rapid mixing, we examined the time-
resolved changes in conformation of a trans ring-bound RuBisCO monomer as ATP and 
GroES bind. An example of the changes for two FRET pairs (34ED-454F and 209ED-
58F) is shown in Figure 3.5A and 3.5B. All four pairs displayed similar overall behavior. 
The kinetic behavior observed with full-length GroEL is consistent with our 
previous observations of forced unfolding upon ATP binding, followed by compaction 
of the RuBisCO monomer as GroES binds [159,166,168]. We observe a very rapid drop 
in FRET efficiency over the first 200–500 ms, which is followed by a slower increase in 
FRET efficiency (Figure 3.5A and 3.5B). With ∆526, we also observe the early and 
rapid drop in the FRET efficiency with all four site pairs, although the amplitude of the 
rapid FRET decrease is smaller with ∆526 compared with full-length GroEL (Figure  
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Figure 3.5: Removal of the GroEL C-Termini Diminishes Both Forced Unfolding and 
Compaction of RuBisCO. (A) and (B), change in FRET efficiency of labeled RuBisCO 
(100 nM), bound to the trans ring of either a full-length GroEL-GroES (blue) or 
EL∆526-GroES (green) complex (120 nM), during encapsulation by GroES. The change 
in FRET efficiency for 34ED-454F is shown in (A) and for 209ED-58F is shown in (B). 
(C) and (D), change in FRET efficiency of labeled RuBisCO (100 nM) bound to the 
single ring GroEL variants SR1 (blue) or SR∆526 (green) (500 nM), during 
encapsulation by GroES (1 µM). The change in FRET efficiency for 34ED-454F labeled 
RuBisCO is shown in (C) and 209ED-58F is shown in (D). In each case, the starting 
FRET efficiency of non-native RuBisCO bound to each GroEL variant is shown, 
beginning at t = 0. At t = 2.25 s (arrow), the complex was rapidly mixed with ATP and 
GroES; n = 21 replicates, with sampling times of 20 ms. The small gap in each plot is a 
consequence of the removal of data points collected during the mixing dead time. 
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3.5A and 3.5B). More striking is the change in the GroES-dependent compaction phase, 
which is absent when the RuBisCO intermediate is encapsulated on a ∆526 trans ring. 
The change in compaction of the RuBisCO monomer was also observed using 
SR1 and SR∆526. With SR1, we readily observed forced expansion of the RuBisCO 
monomer, followed by compaction of the folding intermediate. Because each FRET pair 
again displayed similar overall behavior, we only show the data for the 34ED-454F and 
209ED-58F pairs in Figure 3.5C and 3.5D. Interestingly, we observe a larger amplitude 
compaction phase upon GroES binding to SR1 than is observed with the trans ring of 
the GroEL-GroES complex [159]. The reason for this difference is not known, but is 
likely due, as least in part, to the fact that the SR1 sample does not cycle. By contrast, 
for tetradecamer GroEL, cycling was initiated within the first several seconds of the 
experiment, resulting in asynchronous reaction phases for the RuBisCO monomers and 
an apparent difference in average FRET efficiency. When RuBisCO is bound to 
SR∆526, we observed a reduced forced expansion phase, as well as the complete 
disappearance of the GroES-dependent compaction phase. The extent of GroES binding 
and RuBisCO encapsulation was similar for all of the GroEL variants employed in these 
experiments (both ∆526 and full-length) under the conditions used, ruling out trivial 
explanations for this change. Taken together, these observations indicate that the C-
termini directly contribute to unfolding by binding and holding segments of a folding 
intermediate near the bottom of the GroEL cavity. 
GroEL C-Termini Enhance Productive RuBisCO Folding.  In addition to their 
involvement in protein unfolding, the C-terminal tails appear to affect protein folding 
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within the GroEL-GroES cavity. We and others observe a modest but clear difference in 
intra-cavity folding rate in the presence and absence of the C-termini (Figure 3.1) 
[204,209]. To gain greater insight into the impact of the C-termini on intra-cavity 
folding, we examined the changes in intramolecular FRET efficiency of labeled 
RuBisCO monomers during folding inside the SR-GroES and SR∆526-GroES cavities. 
Because the four FRET vectors span several different regions and length scales of the 
RuBisCO monomer, we anticipated that this assay would provide a higher resolution 
examination of intra-cavity folding and potentially illuminate how the C-termini enhance 
the process. 
All four RuBisCO FRET pairs demonstrate substantial decreases in FRET 
efficiency upon the initiation of folding inside both SR1-GroES and SR∆526-GroES 
cavities (Figure 3.6). The observed decrease in FRET efficiency shows that as the 
monomer folds, the labeled sites move apart, indicating that, on average, the kinetically 
trapped RuBisCO folding intermediate is more structurally collapsed than the committed 
monomer. In most cases, the observed FRET transients were not well fit by single 
exponential rate laws and required double exponentials for good fits (Table 3.2). The 
precise reason for this kinetic complexity is unknown. However, one plausible 
explanation is the appearance of two kinetically resolvable RuBisCO subpopulations in 
the GroEL-GroES cavity that possess distinct conformational transition rates in the 
regions probed by the different FRET pair. Despite this kinetic complexity, the four 
FRET pairs detect three average temporal regimes in the folding process (Table 3.2). 
Although the 356ED-58F pair appears to track the same committed step in folding that is  
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Figure 3.6: Intra-Cavity Folding of RuBisCO with and without the GroEL C-Termini 
Monitored by Intramolecular FRET. RuBisCO folding inside full-length and truncated 
single ring GroEL-GroES complexes monitored by intramolecular FRET with four 
different site pairs as follows: (A) 356ED-58F; (B) 209ED-58F; (C) 34ED-454F; and 
(D) 454ED-58F. Chemically denatured, fluorescently labeled RuBisCO (100 nM) was 
bound to full-length SR1 or SR∆526 (500 nM). This complex was rapidly mixed with an 
equal volume of excess GroES (1 µM) and ATP (2 mM) in a stopped-flow apparatus. 
Shown is the average of n = 12 replicates of matched experimental pairs, calculated from 
donor-only and donor-acceptor samples. Sampling time was 150 ms. In all cases, the 
change in FRET efficiency was well fit by a bi-exponential rate law (black line), and the 
average folding rate constant is shown for each case. Table 3.2 contains the rate 
constants for each fit. 
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Table 3.2: Intra-Cavity Folding Rates of RuBisCO with and without the GroEL C-Termini 
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observed by enzymatic activity, the other pairs report on steps both slower (454ED-58F) 
and faster (209ED-58F and 34ED-454F). Interestingly, each of the three kinetic phases  
identified during folding within the SR1-GroES cavity are also present when RuBisCO 
folds in the absence of the C-termini inside the SR∆526-GroES cavity. However, the 
average rate of each kinetic phase is slower by 20–50% when folding proceeds in the 
SR∆526-GroES cavity (Table 3.2). 
As a complement to the stopped-flow FRET measurements, we employed 
changes in tryptophan fluorescence to report on the folding of the RuBisCO monomer at 
early times inside the SR1-GroES and SR∆526-GroES cavities. The tryptophan emission 
spectra of non-native RuBisCO bound to SR1 and SR∆526 are very similar (Figure 
3.7A, inset), suggesting that the average exposure and environment of the RuBisCO 
tryptophan residues are also similar in both starting complexes. Consistent with our 
earlier measurements, a rapid decrease in fluorescence intensity was followed by a much 
slower rise in fluorescence that matches the rate of the committed folding step (Figure 
3.7B), when ATP and GroES are added to the SR1 complex [163]. The early drop in 
tryptophan fluorescence intensity likely reports on the process of conformational 
expansion, GroES binding, and release of the RuBisCO monomer into the SR1-GroES 
cavity. However, the early folding behavior with SR∆526 is quite different. Although we 
observe a rapid decrease in fluorescence intensity upon the addition of ATP and GroES 
to the SR∆526 complex, the decrease is slower, biphasic, and shows a greater amplitude 
compared with SR1 (Figure 3.7A and 3.7B). In addition, the rising phase that reports on 
formation of the committed RuBisCO monomer is dramatically delayed, relative to SR1. 
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Figure 3.7: GroEL C-Termini Enhance the Fraction of RuBisCO that Folds Rapidly 
upon Encapsulation beneath GroES. (A) intra-cavity folding of RuBisCO at early times 
monitored by changes in tryptophan fluorescence following addition of GroES and ATP 
to complexes of wild-type RuBisCO bound to SR1 (blue) or SR∆526 (green). 
Conditions are as in Fig. 3.1B, except with sampling time of 20 ms. The steady-state, 
tryptophan fluorescence emission spectra of wild-type RuBisCO bound to SR1 (blue) or 
SR∆526 (green) are shown (inset). (B) same as in (A) but with the time scale expanded 
to show the full 50 s of folding monitored in this experiment. (C) RuBisCO folding at 
early times with SR1 and SR∆526 monitored by regain of enzymatic activity.  
Chemically denatured, wild-type RuBisCO (100 nM) was bound to either 500 nM SR1 
(blue) or SR∆526 (green), to which excess GroES (1 µM) and ATP (2mM) were added. 
Folding was quenched by adding EDTA and simultaneously lowering the temperature to 
nonpermissive folding conditions. AU, arbitrary units. Error bars represent the standard 
deviation from n = 3 experiments. 
  
 
124 
Given the more extensive unfolding and compaction of the RuBisCO monomer 
seen with SR1  (Figure 3.4 and 3.5), the reduced perturbation in tryptophan fluorescence  
over the same time period is surprising. A simple explanation is suggested by the 
increase in tryptophan fluorescence that accompanies the committed folding step, which 
follows release of the less fluorescent, non-native monomer into the cavity (Figures 
3.1, 3.7A and 3.7B) [163]. In SR1, the committed step is completed much sooner than in 
SR∆526 (Figure 3.7A and 3.7B). If a subpopulation of the RuBisCO monomers achieves 
the committed monomer conformation very rapidly, then formation of small amounts of 
this more fluorescent, committed conformation would partially compensate for the drop 
in fluorescence of the more slowly progressing subpopulation, thereby accounting for 
the smaller amplitude of the tryptophan fluorescence drop within SR1. The larger 
apparent drop in tryptophan fluorescence within SR∆526 would then be the result of less 
extensive unfolding and a correspondingly smaller subpopulation of a rapidly folding 
monomer. This explanation predicts that folding within SR∆526 should result in a 
substantially reduced fraction of RuBisCO monomers that commit rapidly upon addition 
of ATP and GroES. Rapid commitment is detected as a dead-time burst in native enzyme 
activity in single turnover folding experiments [166]. As shown in Figure 3.7C, we 
observe a greater than 2-fold drop in the early fraction of rapidly committed RuBisCO 
monomers in comparison with SR1. The fact that this prediction is met suggests strongly 
that the C-terminal tails help stimulate RuBisCO folding through structural disruption of 
kinetically trapped RuBisCO monomers. 
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Discussion 
The results we present here strongly support an active role for GroEL in assisted 
protein folding (Figure 3.8). We have shown that the unstructured C-terminal tails of 
GroEL bind and pull a partially structured RuBisCO folding intermediate toward the 
bottom of the GroEL cavity. In the absence of the C-termini, several distinct folding 
transitions of the RuBisCO monomer slow inside the GroEL-GroES cavity, suggesting 
that the conformational search executed by the RuBisCO folding intermediate is more 
efficient in the presence of the C-terminal tails. In addition, the C-termini participate in 
protein unfolding, both during the initial capture of a folding intermediate on an 
open GroEL ring, as well as during the forced expansion of the intermediate upon ATP 
binding. When unfolding is diminished by removal of the C-termini, the fraction of the 
RuBisCO monomers that populate the most rapid folding pathways is substantially 
reduced. 
Our observations are consistent with a key role for substrate protein unfolding in 
GroEL-stimulated folding but inconsistent with an exclusive role for substrate protein 
confinement. Removal of the C-terminal tails in the ∆526 GroEL variant not only slows 
the rate of RuBisCO folding but also simultaneously increases the lifetime of the GroEL-
GroES complex. If the stimulation of folding occurs mainly through substrate protein 
confinement within the GroEL-GroES cavity, then the longer lifetime of the ∆526-
GroES complex presents a paradox; even taking into account the modest reduction in 
intra-cavity folding observed with SR∆526 (Figures 3.1 and 3.6), the considerably  
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Figure 3.8: Model for the Role of the GroEL C-Termini in Substrate Protein Unfolding.  
A schematic is shown for the steps involved in substrate protein loading and the 
initiation of folding by GroEL. Step i, a non-native substrate protein (irregular blue 
shape) enters the GroEL reaction cycle on the open trans ring (green) of the ATP bullet 
complex [159]. Step ii, substrate protein binding accelerates both the release of ADP 
from the trans ring and ATP hydrolysis in the opposite, cis ring (gray) 
[156,158,160,340]. Step iii, binding of the non-native substrate protein by the C-terminal 
tails (black), helps pull the substrate protein into the GroEL cavity and, in combination 
with additional binding by multiple apical domains, results in substrate protein 
unfolding. Step iv, ongoing association of the C-termini with the substrate protein during 
ATP-driven encapsulation by GroES both retards pre-mature protein release [347] and 
provides an anchor point for forced expansion of the substrate protein as the apical 
domains shift to accommodate GroES binding. Assembly of the new folding cavity on 
the trans ring is directly coupled to the disassembly of the folding cavity on the opposite 
ring, potentially through a transient, symmetric intermediate [340,350-352]. Step v, a 
subsequent allosteric shift of the GroEL-GroES complex results in full ejection of the 
substrate protein in the enclosed GroEL-GroES cavity and the initiation of folding [347]. 
The C-terminal tails may continue to interact with the folding intermediate, influencing 
the spectrum of states populated during folding. 
 
 
 
 
 
 
  
 
127 
longer ∆526-GroES cavity lifetime (Figure 3.2) should result in better RuBisCO folding 
compared with full-length GroEL, not worse. This points to some other property of  
the GroEL machine that must contribute to the stimulation of RuBisCO folding. We 
previously demonstrated that a RuBisCO monomer is subjected to two phases of 
multiple axis unfolding prior to the initiation of productive folding inside the GroEL-
GroES cis cavity as follows: 1) binding-driven unfolding upon capture of a folding 
intermediate by the GroEL ring, and 2) forced unfolding upon ATP binding to a 
RuBisCO-occupied GroEL ring [159,166,168]. The fraction of the RuBisCO population 
that populates efficient folding pathways is proportional to the magnitude of this 
unfolding [166]. Furthermore, the rapidly cycling GroEL-GroES system can achieve 
assisted folding rates that are substantially faster than what confined folding in the 
GroEL-GroES cavity can achieve alone [159]. These observations are consistent with 
predictions of the iterative annealing model of stimulated protein folding by 
GroEL [187,341]. 
Importantly, the behavior of the ∆526 GroEL variant also satisfies predictions of 
the iterative annealing model. If GroEL acts, at least in part, as an iterative annealing 
machine, disrupting inhibitory and kinetically trapped states through partial unfolding, 
then any modification to the machine that reduces the extent of unfolding and slows the 
rate of turnover should result in a reduced rate of stimulated folding [341]. As we have 
shown with observations of the ∆526 GroEL variant, these predictions are met. Not only 
does removal of the C-terminal tails reduce both binding-induced and forced unfolding, 
resulting in a substantial decrease in the fraction of RuBisCO that rapidly commits to the 
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native state, but removal of the tails also slows the rate at which the GroEL-GroES 
system cycles, reducing the frequency with which a given population of RuBisCO 
folding intermediates can be subjected to unfolding. 
Although our observations with ∆526 GroEL are consistent with key elements of 
the iterative annealing model, they do not exclude a role for protein confinement. 
Indeed, we previously demonstrated that encapsulation of the RuBisCO monomer 
beneath GroES is associated with compaction of the folding intermediate, a 
conformational restriction that is, in principle, consistent with confinement-based models 
[159,168]. Notably, the magnitude and kinetics of this compaction event are 
compromised by removal of the GroEL C-termini (Figure 3.5). At the same time, intra-
cavity folding of RuBisCO is measurably slower in the absence of the C-termini (Figures 
3.1 and 3.6). It is possible that the reduced rate of RuBisCO folding inside the SR∆526-
GroES cavity is simply the result of reduced initial unfolding, so that the rate of all 
subsequent steps are impacted by the starting conformation of the protein at the moment 
of encapsulation. Indeed, it is remarkable that each of the kinetically distinct steps 
identified with the intramolecular FRET assay all slow to a similar extent in the absence 
of the C-termini (Figure 3.6 and Table 2). However, both cavity volume and character 
have also been suggested to impact intra-cavity folding, and both properties should be 
altered by deletion of the C-terminal tails [199,203,204,345]. Yet, the shift in the 
RuBisCO binding position upon removal of the C-terminal tails is inconsistent with a 
volume effect alone. If the C-termini primarily act via spatial constriction of the cavity, 
their removal would be expected to either have no effect on the RuBisCO binding 
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position or would allow it to occupy more of the cavity volume and thus bind more 
deeply into the cavity. However, we observe the opposite effect, i.e. removal of the C-
terminal tails results in a more elevated average binding position (Figure 3.3). This 
observation, in combination with our earlier cryo-EM observations [347], suggests a 
direct binding interaction with the RuBisCO folding intermediate, whereby the C-termini 
help pull and stretch the monomer toward the bottom of the GroEL cavity. 
In confinement-based mechanisms, the spectrum of partially folded intermediates 
in the GroEL-GroES cavity should differ from the ensemble of states populated in free 
solution. Precisely how interactions between the C-terminal tails and a protein folding 
intermediate could impact this distribution is not understood. Transient interactions 
between the weakly hydrophobic interior of the GroEL cavity and a folding intermediate 
have been proposed to assist productive folding through an annealing process that 
prevents or destabilizes kinetically trapped states [190,338]. Consistent with a role for 
the C-termini in such a process, we observe ongoing, although weakened, interactions 
between the RuBisCO folding intermediate and the C-terminal tails during early stages 
of intra-cavity folding [347]. Additionally, the amphipathic character of the C-terminal 
tails appears to be a key property of these unstructured segments as follows: 
modifications that make them either too polar or too hydrophobic inhibit folding 
[203,250]. Notably, RuBisCO displays a striking ability to fold inside the GroEL-GroES 
cavity under conditions where the monomer in free solution folds slowly or not at all 
[163,168,199]. More recently, a double mutant of the maltose-binding protein has been 
shown to display similar behavior [205]. For stringent substrate proteins like RuBisCO, 
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it is tempting to speculate that a combination of unfolding and confinement might 
provide the most efficient method of stimulating productive folding. In a combined 
mechanism, unfolding and disruption of kinetically trapped, misfolded states would 
increase the chance of opening a productive folding pathway. Subsequent confinement 
of the partially unfolded intermediate within the GroEL-GroES cavity could then 
provide a maximally conducive environment, in which the probability of populating 
inhibitory conformational states is minimized, at least for the short duration of 
the GroEL-GroES complex. 
Given the clear impact of the GroEL C-termini on both protein encapsulation and 
folding, it is striking that these segments are not essential in vivo [246,247]. At the same 
time, the C-terminal tails are well conserved in the majority of chaperonins [354]. These 
observations, combined with the near universal essentiality of chaperonins across phyla, 
suggest that the efficiency of protein folding by chaperonins is a tight evolutionary 
constraint, a conclusion supported by recent studies on the linkage between both fitness 
and protein evolutionary rates and chaperonin activity [355-359]. In this view, even a 
modest loss of folding capacity, like that caused by the absence of the C-terminal tails, 
would result in a steep reduction in overall fitness. Indeed, one of the first studies to 
examine the role of the GroEL C-termini observed just such an effect [246]. In 
competition experiments between otherwise identical E. coli strains expressing either a 
full-length or a C-terminally truncated GroEL, cells forced to rely on a truncated 
GroEL rapidly lost out. Modifications of the C-termini may also be linked to shifts in 
substrate specificity or activity of different chaperonin subtypes. Many microbial species 
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maintain multiple, distinct chaperonin variants in the same cytoplasm, with the 
actinobacteria of particular note [213]. In most cases, the essential housekeeping 
chaperonin (Cpn60.2) has a C-terminal tail that retains the sequence character and Gly-
Gly-Met motifs common to eubacterial chaperonins like GroEL. Strikingly, a secondary 
chaperonin (Cpn60.1), thought to be a specialized variant important for biofilm 
formation and pathogenesis, possesses a modified tail in which the sequence character 
has been dramatically altered, and the typically conserved Gly-Gly-Met motifs have 
been replaced with sequences enriched in His [213]. Thus, although the results we report 
here shed additional light on the role of the GroEL C-termini, our understanding of the 
role of these important and characteristic chaperonin domains remains incomplete. 
 
 
  
 
132 
CHAPTER IV 
STRUCTURAL BASIS OF SUBSTRATE SELECTIVITY OF THE E. COLI 
PROLIDASE* 
 
Prolidases, also known as Xaa-Pro dipeptidases, are metalloproteases that 
catalyze the hydrolysis of dipeptides containing a C-terminal proline residue.  These 
enzymes are conserved in prokaryotes and eukaryotes, including not only single-celled 
organisms, such as yeast, but also humans and higher plants [360-367].  In higher 
organisms, prolidase serves a critical role in the recycling of collagen, as the penultimate 
products of collagen catabolism include the dipeptides Ala-Pro and Gly-Pro [368-370].  
In humans, specific mutant alleles of prolidase have been linked to a wide array of 
physiological problems, which are known collectively as prolidase deficiency [369-372].  
Despite the importance of human prolidase and the disease states associated with various 
mutations of the gene, knockout and knockdown studies in several eukaryotic model 
organisms have yet to reveal an essential role for prolidase [373-376].  Therefore, further 
studies are required for insight into the role of prolidase in collagen metabolism and 
human health. 
In contrast to the human enzyme, there are no observable phenotypes for 
Escherichia coli prolidase mutants [377].  While a physiological role for prolidase in  
                                                            
*Reproduced with permission from Weaver J, Watts T, Li P, Rye HS (2014) PLoS One 
9: e111531.  Copyright 2014 Weaver, et al.  For the original publication: JW conceived 
and designed experiments, performed experiments, analyzed data, and contributed to the 
writing of the manuscript. 
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bacteria remains to be established, the enzyme is known to possess protective activity 
against toxic organophosphates [365,378-380].  The E. coli enzyme may also play a role 
similar to that of human prolidase – the breakdown of dipeptides stemming from protein 
catabolism – or an additional, regulatory role [381].  In support of this theory, 
Mycoplasma species possess Xaa-Pro peptidases [214,382,383].  These bacteria, which 
evolved to retain only those cellular functions essential to their parasitic lifestyle, import 
most amino acids and lipids from the host cell [220].  The fact that Mycoplasma retain 
an enzyme for cleaving Xaa-Pro bonds suggests that prolyl peptide catabolism plays a 
broad and generally important physiological role. 
Prolidases share a number of conserved sequence and structural features.  These 
enzymes possess an N-terminal domain and a C-terminal catalytic domain, and form 
dimers through contact between both domains in a head-to-tail arrangement [364].  The 
catalytic site features a binuclear metal cluster in the center of a pita-bread fold that is a 
canonical feature of this family of enzymes [381,384].  While the identity and 
configuration of the coordinating ligands are conserved, the types of metals found in the 
active site vary widely, though manganese, cobalt and zinc appear to be the most 
common metals used [385].  Such metal variability has been observed in other pita-bread 
fold proteins [386,387].  Interestingly, the human prolidase can utilize magnesium, 
though to significantly lower extent than manganese – a feature not commonly seen in 
other prolidases [361,363,385,388].  Crystal structures of various prolidases, particularly 
those with bound substrates or inhibitors, have provided important structural insights 
  
 
134 
into how these enzymes bind substrate peptides and metals, though few members of this 
enzyme family have been thoroughly examined biochemically. 
Members of the pita-bread fold family of proteins, which also includes other 
metalloproteases, share a number of sequence-specific features that permit robust 
structure/function prediction, despite the varying substrate specificities of different 
enzymes [384].  The first prolidase structure solved was from the archaea, Pyrococcus 
furiosus [364,389], which confirmed that prolidases possess many of the structural 
features common to the pita-bread fold superfamily.  However, four large regions of 
primary structure, ranging from 13-25 amino acids in length, are found in the human 
prolidase that do not appear in the P. furiosus sequence [364].  Some of these regions are 
also absent from related pita-bread fold members, including methionine 
aminopeptidases, which cleave N-terminal methionine residues, as well as proline 
aminopeptidases, which cleave N-terminal residues that are followed by proline, from 
both bacterial and human sources [384,390]. 
Interestingly, the peptide regions absent in P. furiosus are present in prolidases 
from Gram negative bacteria, including E. coli and Alteromonas sp.[364], and include 
eleven residues highly conserved between humans and these two bacteria.  E. coli PepQ, 
the only prolidase found in this organism [377], was previously characterized for activity 
against dipeptides, organophosphates and other small molecules [365], though the lack 
of an atomic structure for PepQ has prevented a detailed comparison to other prolidases.  
Examination of the Alteromonas prolidase structure, however, reveals an arginine 
residue reaching into the active site from one of the additional peptide segments.  This 
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residue appears to be involved in positioning a structured water molecule and other 
active site residues and metals, and has been postulated to interact with the C-terminus 
of the substrate dipeptide [379], an interaction similar to that seen in a shifted location 
for proline aminopeptidase [391].  Because proline aminopeptidases cleave tripeptides, 
the positioning of this residue may have evolved to specify substrate length in pita-bread 
fold proteins. 
Here we report the structure of E. coli PepQ, showing it to have the predicted 
pita-bread fold.  We examine its ability to utilize various active site metals, including 
magnesium.  Furthermore, we compare its sequence and structural similarity to proline 
aminopeptidase and other prolidases, showing that the position of the conserved arginine 
has, in fact, moved throughout evolution, likely to accommodate substrate peptide 
length.  We further characterize the role of this arginine, demonstrating that it plays a 
critical role in substrate dipeptide binding. 
 
Experimental Procedures 
Cloning, Expression and Purification of PepQ and PepQ Mutants.  The PepQ 
gene was PCR amplified from purified, chromosomal E. coli DNA, using primers adding 
a 5’-NdeI restriction site and a 3’-XhoI restriction site.  The PCR product was sub-
cloned into the pET21a vector (Novagen) and the sequence of this construct was verified 
by DNA sequencing.  The R370E mutation of the PepQ gene was created via site-
directed mutagenesis of the wild-type construct and was verified by DNA sequencing.  
Either 6 or 12 L of LB-Amp (100 mg/L) were inoculated 1:500 with overnight cultures 
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of BL21[DE3] cells transformed with either the wild-type or R370E PepQ plasmid.  
Upon reaching an A600 = 0.6-0.8, expression was induced with the addition of IPTG to a 
concentration of 400 µM.  After four hours, the cells were centrifuged and the pellets 
were resuspended in cell disruption buffer (20 mM Tris, pH 8, 1 µM MnCl2, 20% (w/w) 
sucrose, 4 mM DTT).  Cells were lysed using a gas-driven cell-disruptor (Microfluidics 
Corporation; Newton, MA) and clarified by ultracentrifugation.  The supernatant was 
loaded onto a fast-flow Q (GE Healthcare) anion exchange column.  The column was 
washed with Buffer A (50 mM Tris, pH 7.4, 1 µM MnCl2, 2 mM DTT) and washed with 
Buffer A containing 100 mM NaCl.  A linear gradient was then developed from 100 mM 
to 500 mM NaCl.  The fractions of the greatest PepQ purity were concentrated by 
precipitation with 70% (w/v) ammonium sulfate.  The pellet was resuspended in a small 
volume of Buffer A containing 500 mM ammonium sulfate and loaded on a phenyl-
sepharose hydrophobic interaction column (GE Healthcare).  After washing with Buffer 
A containing 1 M ammonium sulfate, a linear gradient was developed from 1 M to 300 
mM ammonium sulfate.  Fractions of the greatest PepQ purity were again concentrated 
by precipitation with 70% (w/v) ammonium sulfate.  The pellet was resuspended with a 
small volume of Buffer A and dialyzed against Buffer B (25 mM Tris, pH 7.4, 25 mM 
KCl, 1 µM MnCl2, 2 mM DTT).  Following addition of glycerol to 15% (v/v), the 
sample was aliquoted, snap frozen with liquid nitrogen and stored at -80˚C.  Thawed 
samples showed no detectable loss of enzymatic activity. 
 Cloning, Expression and Purification of Alanine Dehydrogenase (AlaDH).  The 
AlaDH gene was PCR amplified from purified, chromosomal Bacillus subtilis str. 168 
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DNA, using primers adding a 5’-NcoI restriction site (which required a mutation in the 
second codon, which was later reverted with site-directed mutagenesis) and a 3’-XhoI 
restriction site.  The PCR product was sub-cloned into the pETDuet vector (Novagen) 
and the sequence of this construct was verified by DNA sequencing.  Protein expression 
was conducted in 6 L of LB-Amp (100 mg/L) inoculated 1:500 with overnight cultures 
of BL21[DE3] cells transformed with the AlaDH plasmid.  Upon reaching an A600 = 0.6-
0.8, expression was induced with the addition of IPTG to a concentration of 400 µM.  
After four hours, the cells were centrifuged and the pellets were resuspended in cell 
disruption buffer (20 mM Tris, pH 8, 0.5 mM EDTA, 20% (w/w) sucrose, 4 mM DTT).  
Cells were lysed, clarified and loaded onto a fast-flow ion exchange column, as 
described above.  The column was washed with Buffer C (50 mM Tris, pH 7.4, 0.5 mM 
EDTA, 2 mM DTT) containing 150 mM NaCl.  A linear gradient was then developed 
from 150 mM to 500 mM NaCl.  Fractions of the greatest AlaDH purity were 
concentrated by precipitation with 70% (w/v) ammonium sulfate.  The pellet was then 
resuspended in a small volume of Buffer C containing 1 M ammonium sulfate.  The 
sample was then loaded on a phenyl-sepharose hydrophobic interaction column (GE 
Healthcare).  After washing with Buffer C containing 900 mM ammonium sulfate, a 
linear gradient was developed from 900 to 650 mM ammonium sulfate.  Fractions of the 
greatest AlaDH purity were concentrated by precipitation with 70% (w/v) ammonium 
sulfate.  The pellet was resuspended with a small volume of Buffer C and dialyzed 
against Buffer D (25 mM Tris, pH 7.4, 25 mM KCl, 0.5 mM EDTA, 2 mM DTT).  
Following addition of glycerol to 15% (v/v), the sample was aliquoted, snap frozen with 
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liquid nitrogen and stored at -80˚C.  Thawed samples showed no detectable loss of 
enzymatic activity. 
 Crystallization and Refinement of PepQ.  The PepQ sample was buffer-
exchanged into 50 mM Tris, pH 7.4, 5 mM MgCl2 and 5 mM DTT at a final 
concentration of 12 mg/ml.  The protein was crystallized by hanging drop vapor 
diffusion method at 4°C using 20% PEG MME 5000 in 0.1 M Bis-Tris buffer at pH 6.5.  
The crystals were transferred stepwise to a cryobuffer containing 30% PEG 400, 20% 
PEG MME 5000, 0.1 M Bis-Tris at pH 6.5 and flash frozen in liquid nitrogen.  The 
diffraction data were collected at beamline 7.1 at the Stanford Synchrotron Radiation 
Lightsource (SSRL) using a Quantum 315R CCD detector.  The diffraction data were 
processed with the HKL2000 package [392].  The structure was determined by 
molecular replacement using Phaser in the Phenix package [393].  A homology model of 
pepQ generated using Swiss-Model based on the crystal structure of Alteromonas 
macleodii OpaA structure (PDB 3RVA) [379] was used as search model.  The model 
was fine-tuned with Coot [394] and refined using the Phenix package [393].  Statistics of 
data collection and refinement are shown in Table 1.  
 Metal Usage.  Metal usage of PepQ was directly monitored by the decrease in 
absorbance at 222 nm upon cleavage of the substrate peptide bond [365].  E. coli PepQ 
was diluted to 12.5 µM into 50 mM Tris, pH 7.4 and 10 mM EDTA.  Following 
incubation at 25˚C for 30 min, this solution was then diluted 25-fold into 25 mM Tris, 
pH 7.4 containing either a divalent metal (1 mM), EDTA (5 mM) or no additional 
component.  Samples were incubated at 25˚C for an additional 10 min.  This sample was 
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then diluted 10-fold with 10 mM Tris, pH 8 and the substrate dipeptide AlaPro (TCI-
America).  The reaction was immediately assayed at 25˚C.  The final concentration of 
PepQ was 50 nM and Ala-Pro was 0.25 mM in a final volume of 1 mL.  All assays were 
conducted using a Perkin Elmer Lambda 35 spectrophotometer with a PCB 1500 water 
Peltier temperature control system. 
 Docking Simulations.  Preparation of structure files and docking was done as 
described [395].  In brief, substrate and protein structure files were prepared using MGL 
Tools, in which polar hydrogens were added and flexible bonds were designated.  
Autodock Vina was then used to simulate the interaction of the small molecules with the 
active site of PepQ. 
 Enzyme Quaternary Structure.  The stability of the dimeric structure of wild-type 
and R370E PepQ was determined using analytical gel filtration.  PepQ (10 nM) in 50 
mM Tris, pH 7.4, 50 mM KOAc, 10 mM Mg(OAc)2 and 2 mM DTT was injected on a 
Superose 6 gel filtration column (GE), equilibrated in the same buffer, with a constant 
flow rate of 0.4 mL/min driven by an HPLC unit with a binary pump (Waters).  The 
tryptophan fluorescence (excitation at 280 nm, emission at 340 nm) of the sample was 
measured using an in-line, post-column fluorescence detector (Waters). 
 Enzyme Stability.  The thermodynamic stability of wild-type and R370E PepQ 
was determined by the red-shift in the tryptophan fluorescence peak as the protein 
unfolds with increasing concentrations of the chemical denaturant guanidinium-HCl.  
PepQ (50 nM) was incubated at room temperature for 60 minutes in solutions of 50 mM 
Tris, pH 7.4, 10 mM Mg(OAc)2, 2 mM DTT and varying concentrations of guanidinium-
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HCl.  The tryptophan fluorescence was measured using a PTI fluorometer with 
excitation at 295 nm and emission from 315-375 nm.  Solutions of buffer and 
guanidinium at each concentration, without protein, were also measured to account for 
changes in scattered light.  The peak maximum and corresponding wavelength was 
determined using Microsoft Excel (MAX and VLOOKUP functions).   
 Enzyme Kinetics.  The PepQ reaction rate was monitored by coupling the 
hydrolysis of the dipeptide AlaPro to the NAD-dependent oxidation of alanine [396].  
These reactions were conducted in a 1 mL volume in 50 mM Tris, pH 8 and 20 mM 
Mg(OAc)2 at 25˚C with varying concentrations of AlaPro-COOH (TCI America) or 
AlaPro-CONH2 (Chem-Impex), supplemented with 1 µM AlaDH and 2 mM NAD
+ 
(Chem-Impex).  The increase in absorbance at 340 nm was monitored as NADH was 
produced.  All assays were conducted using a Perkin Elmer Lambda 35 
spectrophotometer with a PCB 1500 water Peltier temperature control system. 
 
Results 
E. coli Prolidase Possesses an Expanded Sequence.  To examine the extent of 
sequence conservation in the E. coli prolidase, PepQ, we collected primary structure 
information from organisms with sequenced genomes, including both higher plants and 
animals.  Upon alignment (Figure 4.1), many regions of E. coli PepQ show sequence 
similarity (boxed) and identity (shaded) with the sequences of human and plant 
prolidase, illustrating the conservation of various elements of this protein family.  
Overall, E. coli PepQ shows high sequence identity (~30%) and similarity (~50%) with  
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above the alignment are those from E. coli PepQ, while those shown below the 
alignment are from human PepD.  The aligned proteins (with percent identity/similarity 
to E. coli PepQ, along with the number of aligned positions shown in parentheses; 
followed by the accession number of the sequence) are: Alteromonas sp. PepQ (50/67, 
441), Q44238; E. coli PepP (31/46, 330), P15034; Pyrococcus furiosus PepQ (24/40, 
337), P81535; Arabidopsis thaliana Xaa-Pro Dipeptidsae (34/51, 292), Q8L780; Homo 
sapiens PepD (29/45, 466), P12955.  The degree of identity and similarity was 
determined by two-sequence alignment with BLAST [397]. 
Figure 4.1: Sequence Alignment of Prolidases. Sequence alignment of E. coli PepQ 
(accession number P21165) with eukaryotic and prokaryotic pita-bread fold enzymes 
was performed using CLUSTALW [237] and graphically organized with ESPript [238].  
Completely conserved residues are highlighted in red and highly conserved residues or 
regions are boxed and shown in blue.  Metal-chelating residues are highlighted with 
yellow.  Numbering shown is for E. coli PepQ.  Secondary structure assignments shown 
142 
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the eukaryotic prolidases.  Furthermore, the E. coli sequence shows good coverage of the 
human gene, with only one region of 10-15 residues missing (Figure 4.1, between E. coli  
residues 120-125).  Although these additional regions may be shifted in our alignment, 
in a previous alignment [364], four regions of at least ten residues appeared in E. coli 
and human prolidase, but did not appear in P. furiosus prolidase (E. coli residues 35-53, 
303-321, 360-372 and 391-415).  In these regions, eleven residues (E. coli residues 
Gly36, Asp45, Phe50, Leu309, Ser319, Glu321, Leu369, Arg370, Glu391, Leu393 and 
Leu394) are conserved.  Of these residues, all but two (Ser319 and Glu391) are also 
conserved among E. coli, humans and Arabidopsis (Figure 4.1).  While shorter than ten 
residues, another additional region appears in all of the sequences, but not in P. furiosus 
PepQ – an N-terminal loop extension (94-101), though this region does not include any 
conserved residues.   
To better understand the potential significance of sequence conservation between 
the E. coli and human prolidases, we solved the structure of the bacterial enzyme at 2.0 
Å resolution (Figure 4.2A, Table 4.1).  The protein is comprised of two sections – an N-
terminal domain and a C-terminal catalytic domain.  The catalytic domain features the 
predicted, canonical pita-bread fold common to this family of enzymes.  At the center of 
the pita-bread fold is the active site, containing two metal ions chelated by five residues 
(metals shown in green).  The asymmetric unit contains a single PepQ dimer, which is 
the native oligomeric structure of this protein [365], arranged head-to-tail with inter-
dimer contacts made between both domains.  With tertiary and quaternary features 
appearing as expected, we next focused our analysis on the regions of sequence not  
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Figure 4.2: PepQ Forms a Canonical Pita-Bread Fold with a Binuclear Active Site.  (A) 
The PepQ dimer (PDB entry 4QR8) is shown with one monomer shown in yellow and 
one monomer colored by domain: N-terminal (residues 1-159, red) and catalytic 
(160-443, blue).  The magnesium ions are colored green.  Image was rendered in 
Pymol [398].  (B) The PepQ dimer with new regions of sequence (those not in P. 
furiosus) highlighted (residues 35-53, red; 303-321, blue; 360-372, pink; 391-415, 
yellow).  (C) Electron density shows conserved active site residues coordinating two 
magnesium ions. 
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Table 4.1:  Statistics of Crystallographic Analysis for PepQ. 
 
  
 
PDB Entry 4QR8 
 
Data collection  
 
Space group P212121 
 
Cell dimensions    
 
    a, b, c (Å) 72.57, 97.44, 126.94 
 
    α, β, γ  (°)  90.0, 90.0, 90.0 
 
Resolution (Å) 2.00 (2.03 to 2.00)1,2 
 
3
Rsym or Rmerge 11.6% (0.695) 
 
I / σI 18.0 (2.0) 
 
Completeness (%) 97.0 (92.3) 
 
Redundancy 4.5 (3.5) 
 
Refinement  
 
Resolution (Å) 2.0 
 
No. reflections 59597 
 
4
Rwork / 
5
Rfree 17.39% / 21.1% 
 
No. atoms  
 
    Protein 7052 
 
    Ligand/ion 4 
 
    Water 1314 
 
B-factors  
 
    Protein 20.3 
 
    Ligand/ion 19.6 
 
    Water 31.2 
 
R.m.s. deviations  
 
    Bond lengths (Å) 0.004        
 
    Bond angles (°) 0.80 
 
  
 
 
 
 
 
 
1One crystal was used to collect each of the dataset.   
2Values in parentheses are for highest-resolution shell.   
3Rsym = ∑h∑i |Ii,hkl – <Ihkl>|/∑hkl∑i |Ii,hkl|, where Ihkl,i is the intensity measured for a 
given reflection with Miller indices h, k, and l, and <Ihkl> is the mean intensity of that 
reflection.  4Rwork =∑||Fo|-|Fc||/∑|Fo|, where Fo and Fc are the observed and calculated 
structure-factor amplitudes, respectively.  
5Rfree was calculated as Rwork using a randomly selected subset (10%) of unique 
reflections not used for structure refinement. 
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found in P. furiosus and the residues in those regions that are conserved in other 
sequences.   
These conserved regions consist of two helices and two loop structures, and three 
of these structural features are in the catalytic domain (Figure 4.2B).  The N-terminal 
loop (highlighted in red) makes significant contact with the same loop from the other 
subunit.  The loop in the catalytic domain (highlighted in pink) extends into the active 
site.  The two helices in the catalytic domain (highlighted in blue and yellow) are on the 
outside edge of the domain, with both helices in contact with each other and one also in 
contact with the loop in the catalytic domain (pink).  Given the location of these regions 
of sequence, it is not surprising that only two of the nine residues found in regions absent 
from P. furiosus (but conserved from E. coli into the eukaryia), are located near the 
active site of the enzyme (Asp45 and Arg370).  The Arg370 equivalent residue in 
Alteromonas (also Arg370) has been predicted to play a role in organizing water in the 
active site and, possibly, interacting with the C-terminus of the substrate dipeptide [379].  
Asp45, which reaches into the active site of one monomer from a loop region in the N-
terminal domain of the other monomer, is seen in E. coli to be within interaction distance 
of Arg370, with the charged ends of the side chains approximately 3.5Å apart.  The 
conservation of this interaction suggests co-evolution of these residues in support of 
additional known interactions in the active site. 
The active site of E. coli PepQ also features canonical metal binding residues, 
Asp246, Asp257, His339, Glu384 and Glu423, chelating two metal ions.  Because PepQ 
was crystallized in buffer containing magnesium, the density found in this region is most 
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likely derived from magnesium ions (Figure 4.2C).  Additionally, the mF0-DFc 
difference map shows greater density for one of the two metal ions (chelated by His339), 
consistent with reports from other pita-bread fold peptidases that this binding site has a 
higher affinity for metal ions [391,399].  The decreased occupancy at the second metal 
site is surprising, given that the magnesium concentration during crystallization was in 
the millimolar range.  This observation suggests that the affinity for magnesium of either 
PepQ in general, or this site in particular, is not as high as seen for the preferred 
manganese ion in related proteins, reported to be in the low- or sub-micromolar range 
[381,391,400].  However, metal binding by prolidase does not necessarily convey 
enzymatic activity, leaving the functionality of magnesium-bound PepQ unresolved. 
 E. coli PepQ Can Utilize Mutliple Metals for Catalysis.  Despite the shared pita-
bread fold, prolidases, methionine aminopeptidases and proline amino peptidases from a 
range of taxa, display widely varying abilities to bind and utilize different metals for 
catalysis.  The presence of magnesium ions in both metal binding sites of E. coli PepQ 
(Figure 4.2) suggests that this prolidase might be enzymatically active with this metal, 
though magnesium is not known to be the preferred metal of any pita-bread fold enzyme.  
We therefore examined the ability of PepQ to utilize various divalent cations – testing 
the dominant ions found in pita-bread fold proteases: manganese, zinc, cobalt, iron, 
nickel, copper, magnesium and calcium (Figure 4.3).  As with many proteins in this 
family, manganese appears to be the optimal metal for PepQ activity, with cobalt a 
distant second.  Nickel and copper are not generally employed by this family of 
proteases.  Other metals, such as zinc and calcium, are known to require specific  
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Figure 4.3: PepQ Utilizes Various Divalent Metals with Differing Efficiency.  E. coli 
PepQ (50 nM) was assayed in the presence of various metals, in the absence of added 
metal (Buffer) or in the presence of EDTA.  All metals used were in the form of metal-
dichlorides.  Error bars show the deviation of three independent samples. 
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coordination and spacing regimes that are not easily accessed in the active site of many 
pita-bread fold proteins [391], leading to little or no activity, consistent with our  
observations with PepQ (Figure 4.3).  Magnesium, a metal that only rarely conveys 
activity in other pita-bread proteases, displayed significant levels of activity with PepQ, 
similar to cobalt.  As expected for a metalloprotease, the addition of EDTA abolished the 
activity of PepQ. 
To control for contaminating metal in the buffer, as well as for metal that was not 
removed from the active site prior to the experiment, PepQ was also tested in buffer in 
the absence of any residual metal (Figure 4.3).  An absence of enzymatic activity 
indicates that the pre-incubation of PepQ with EDTA effectively stripped any remaining 
bound metal.  Whether the metals that convey little or no activity do not bind, or bind, 
but are incapable of supporting catalysis, is unknown.  Zinc, for example, has been 
shown to bind to the active site of some pita-bread fold peptidases and still not to convey 
activity [361,364,388,391].  It is possible that the inactivity of PepQ in the presence of 
zinc and nickel is the result of weak metal binding, which could, in principle, be 
examined by increasing in the concentrations of these metals in the PepQ assay.  
However, the concentrations of these metals are not thought to be higher in vivo than 
used here in vitro [401], implying that these metals are not likely used to support 
catalysis in the cell.  
 Ionic Interactions Favor the Substrate Peptide C-Terminus.  While the metal-
chelating residues of prolidase are well-described, the identity of these residues does not 
reliably predict metal usage.  Likewise, de novo prediction of substrate specificity is 
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limited to dipeptides, as well as certain small molecules such as organophosphates that 
are hydrolyzed with far lower efficiency than peptide substrates.  Different prolidases 
have varying affinities for dipeptides, though cleavage of collagen-catabolism products, 
such as GlyPro or AlaPro, seems to be conserved [362,365,388,402].  How dipeptide 
specificity is enforced by prolidase, as well as why these enzymes display a total lack of 
activity toward longer peptides, is not obvious, particularly given the high structural 
similarity between prolidase, which cannot cleave peptides longer than two amino acids, 
and proline aminopeptidase, which can cleave tripeptides (Xaa-Pro-Xaa) at the N-
terminal side of proline.  To further examine these differences, the structures of PepQ 
and PepP, the E. coli proline aminopeptidase, were aligned for comparison (Figure 
4.4A).  In the structure of PepP, which includes a bound tripeptide, Arg371 (of PepP) 
interacts with the C-terminus of the tripeptide.  PepQ Arg370, which is projected further 
into the active site on one of the loop regions conserved in prolidases from higher 
organisms, is placed far enough into the active site that it would physically impede the 
binding of longer peptides, as seen in the overlap between this arginine and the PepP-
bound substrate tripeptide.  PepQ R370 is, however, in an appropriate position for the 
guanidinium group of the arginine to interact with the C-terminus of the proline residue. 
To further examine the potential role of R370 in dipeptide selection by PepQ, the 
structures of model dipeptides were docked into the active site of the PepQ structure 
[395].  Docking of dipeptides resulted in a configuration similar to that seen in PepP – 
the terminus of the dipeptide is in position to interact with Arg370 (Figure 4.4B).  In 
order to experimentally test this interaction, a two-pronged approach was pursued.  First,  
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3.6 Å.  The distances between PepQ R370 and the prolyl-leucyl amide nitrogen and 
oxygen measured at 3.1 and 3.8 Å, respectively.  (B) Docking simulations were 
performed between PepQ (yellow) and substrate dipeptides using AutoDock Vina [395].  
Shown is the substrate PhePro (blue).  The distances between R370 and the dipeptide 
C-terminal oxygens measured at 3.0 and 3.2 Å. (C) E. coli PepQ (yellow) and PepP 
(green) were aligned with P. furiosus prolidase (PDB entry 1PV9, residues 124-345, 
red). PepQ R370, PepP R371 and P. furiosus R295 are highlighted. 
(RMSDEcoliQ-PfuriosusQ = 0.92 Å, 816 atoms aligned; RMSDEcoliP-PfuriosusQ = 0.82 Å, 908 
atoms aligned)  (D) Structure alignment of catalytic domains of E. coli PepQ (yellow) 
and human PepD (PDB entry 2IW2, residues 187-470, purple; RMSD = 0.97 Å, 1179 
atoms aligned).  (E)  R370 in PepQ (yellow) is sequentially and structurally conserved in 
humans (R398, purple).  All structural alignments and distance measurements were 
performed with PyMOL [398]. 
 
Figure 4.4: Structural Alignment of Prolidases Reveals Conserved Arginine. (A) The 
PepQ catalytic domain (residues 160-443) was aligned with E. coli PepP, the proline 
aminopeptidase, with the bound substrate tripeptide ValProLeu (PDB entry 2BHA, 
residues 175-425; RMSD = 1.05 Å, 1020 atoms aligned).  PepQ R370 is shown in 
yellow, PepP R371 is shown in green and the tripeptide is colored blue.  The distances 
between PepP R371 and the C-terminal oxygens of the tripeptide measured at 3.4 and 
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a charge-reversed mutant of PepQ (R370E) was made in which the predicted favorable 
interaction between the peptide carboxylate and R370 was replaced with an unfavorable  
interaction.  The R370E mutant was expressed and purified following the protocols used 
for the wild-type enzyme, and eluted on gel filtration chromatography identically to 
wild-type PepQ (Figure 4.5A), suggesting that both the structure and dimer stability of 
the enzyme was not significantly compromised by the R370E mutation.  To test this 
conclusion further, we examined the thermodynamic stability of the R370E mutant 
relative to wild type PepQ using guanidinium-induced unfolding at 25 °C.  As shown in 
Figure 4.5B, the two proteins show essentially identical unfolding transitions, indicating 
that the thermodynamic stability of PepQ is not affected by the R370E mutation.  
Consequently, any changes in the activity of R370E relative to the wild-type enzyme are 
not likely due to secondary effects of the mutation on protein structure or stability.   
As a second approach to examining the role of R370, we examined the activity of 
PepQ toward a substrate dipeptide featuring a terminal amide, rather than a carboxylic 
acid.  With this modified substrate, the predicted interaction with Arg370 should remain 
favorable, as hydrogen bonding could still occur, though the favorable ionic interaction 
would be lost.  Due to the partial positive charge of the amide nitrogen, a potentially 
favorable ionic interaction between the modified amide terminus of this substrate 
dipeptide and the glutamate of the mutant R370E remained a possibility.  Kinetic 
analysis of both wild-type and R370E PepQ with both AlaPro-COOH and AlaPro-
CONH2 strongly supports the proposed model for the role of R370 (Table 4.2).  R370E 
displayed a considerably higher Km for the substrate AlaPro-COOH than the wild-type  
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Figure 4.5: R370E Mutation Does Not Perturb PepQ Structure or Stability. (A) Wild-type (WT, 
blue) and R370E (green) PepQ (10 nM) were analyzed by size exclusion chromatography.  (B) 
Wild-type (WT, blue) and R370E (green) PepQ (50 nM) were incubated with varying 
concentrations of guanidinium-HCl and the peak position of the tryptophan fluorescence 
emission spectrum of each was determined.  Error bars indicate the deviation from three 
independent samples.  
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 Table 4.2: Kinetic Parameters for the Hydrolysis of the Dipeptides Ala-Pro and Ala-
Pro-NH2 by Wild-Type and R370E PepQ. 
  AlaPro-COOH AlaPro-CONH2 
 
 
kcat/Km  
(M-1s-1) 
kcat (s
-1) Km (mM) 
kcat/Km  
(M-1s-1) 
kcat (s
-1) Km (mM) 
 WT 1.2 x 105 139.1+2.5 1.2+0.1 1.2 x 104 80.7+19.7 6.6+0.5 
 R370E 5.1 x 101 6.5+1.1 127+2 2.3 x 102 1.1+0.4 4.7+0.2 
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protein, while actually having a lower Km for AlaPro-CONH2, when compared to wild-
type prolidase.  The reduction in kcat seen in R370E is likely due the role of this residue 
in the organization of water and other residues in the active site [379].  The changes in 
Km, with information from both a charge-reversed protein and a charge-neutralized 
substrate, strongly suggest an interaction between the substrate carboxylate group and 
R370. 
 The placement of the loop arginine evolved for substrate selectivity.  The location 
of the key R370 residue in PepQ, and similar arginine residues in other pita-bread fold 
enzymes, may have been an important factor in the evolution of prolidase.  To examine 
this idea, the structures of E. coli PepP, E. coli PepQ and P. furiosus PepQ were aligned 
(Figure 4.4C).  The loop region containing this arginine is absent from P. furiosus 
prolidase. While the archaeal prolidase retains an arginine in the same spatial location of 
the active site (Arg295), it appears to be in an intermediate position, relative to PepP and 
PepQ from E. coli.  The active site residues of the three enzymes are nearly super-
imposable, indicating that this change in position is not an artifact of the structure 
alignment.  It thus seems reasonable that the addition of the expanded peptide regions 
containing the arginine in Gram-negative bacteria and eukaryotes could have resulted 
from evolutionary fine tuning of the enzyme for high specificity dipeptidase activity.  
While the loop residues are conserved in the sequence of human prolidase, we sought to 
verify the placement of this residue as a potential means of selecting for dipeptides.  The 
structures of the catalytic domains of human and E. coli prolidases were aligned, 
showing high conservation in the secondary structure elements and an RMSD of less 
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than 1Å (Figure 4.4D, secondary structures shown in Figure 4.1).  The critical arginine is 
observed in the active site of the human prolidase in a position nearly identical to the 
bacterial residue (Figure 4.4E).  This suggests that after the initial evolution of the loop 
regions for the placement of this residue, no further optimization was necessary for the 
selection of dipeptides as the enzyme evolved further over the course of several billion 
years. 
 
Discussion 
The results presented here support a role for substrate length specificity in pita-
bread fold enzymes through the positioning of an active site arginine.  With a high-
resolution structure of E. coli PepQ in hand, we were able to compare it to related 
enzymes, both bioinformatically and structurally.  We found that the position of the 
active site arginine has changed during the evolution in this family of proteins, with a 
shift further into the active site leading to selection against peptide substrates greater 
than two residues in length.  Not only does the placement of this arginine physically 
occlude longer peptides, as seen structurally, but also, kinetic analysis demonstrates the 
important role of the ionic interaction between this positively charged residue and the 
negatively charged C-terminus of the substrate dipeptide.  We have also found that while 
this protein is maximally active with manganese, it can utilize other metals, including 
magnesium, an uncommon property for this family of metalloproteins. 
Although they are very similar proteins, the members of this family of enzymes 
vary in a number of significant ways.  Of particular note is the presence of several large 
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regions of additional residues in the prolidase sequences of Gram-negative bacteria, 
single-celled eukaryotes and higher plants and animals that are absent in the sequences 
of other bacterial prolidases, as well as proline aminopeptidase.  When comparing the 
additional regions found in E. coli that are absent in P. furiosus, perhaps the most 
striking insert is the N-terminal loop.  This loop not only makes significant contact with 
its counterpart on the adjacent subunit, but also contributes to the opening of the active 
site, relative to the loop-less P. furiosus structure.  The role of the two helices inserted 
into the catalytic domain of E. coli is more difficult to surmise, given the distance from 
the active site and the other subunit.  The structural rearrangements created through the 
insertion of the N-terminal loop may be stabilized by the presence of these helices, but 
this remains to be examined.  However, both of these helices, as well as the N-terminal 
loop are found in the sequence and structure of E. coli PepP (Figure 4.1) [381,387,399].  
This suggests that these changes may have occurred in an ancestor of this family before 
the divergence that led to separate substrate specificities of PepQ and PepP.  The 
component found in neither PepP nor P. furiosus PepQ is the loop in the active site of 
the protein, which contains the conserved arginine. 
Enzymes generally dictate specificity by utilizing binding pockets with specific 
interactions that favor some substrates and disfavor or occlude other substrates [403-
406].  Pita-bread fold proteins are no exception – the occlusion of branched amino acids 
and selection against small amino acids in substrates has been observed previously in 
PepP [391] and charge interactions have been observed to dictate specificity in some 
prolidases [407].  Despite the high level of conservation among proteins with the pita-
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bread fold, these enzymes are very specific for their substrates, at least in terms of 
peptide length.  While the evolutionary benefit of selecting for dipeptides stems from the 
availability of byproducts of protein catabolism, like those derived from collagen, the 
movement of this residue also levies an advantage against certain small molecules.  E. 
coli PepQ can not only hydrolyze at least thirteen different dipeptides, but also an 
assortment of organophosphates and other small molecules [365].  While these 
substrates vary considerably on the N-terminal side of the scissile bond, the C-terminal 
end of all previously tested substrates shared a negatively charged group, either a 
carboxylate or a nitro group [365].  Reactivity toward these substrates is likely dictated 
by the positioning of R370 in the active site of the enzyme.  We have shown that the 
addition of a loop in the catalytic domain, near the active site, allowed for the substrate 
peptide length-determining residue to be repositioned, altering the specificity of the 
enzyme.  Utilization of an arginine at the designated position in either PepP or PepQ for 
this selection likely stems from the ability of arginine to interact ionically with both 
oxygens in the C-terminus of the substrate peptide, as well as through hydrogen bonding.  
A lysine at this position is unlikely to interact with both oxygens due to spatial and 
angular limitations.  Although the enzyme is still functional without this interaction, the 
activity is severely compromised, which is consistent with reports that E. coli PepP has 
minor activity against dipeptides [377].  Interestingly, the genomes of sequenced 
Pyrococcus species include PepQ sequences, but lack PepP annotations [408-414].  
Given the intermediate positioning of the conserved arginine in P. furiosus PepQ, a dual 
functionality for cleaving di- and tripeptides may be predicted for that enzyme. 
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While many prolidases share various similarities, structural and biochemical data 
reveal that E. coli prolidase is more similar to the human enzyme than other enzymes.  
The catalytic domains of the E. coli and human prolidases align with an RMSD of less 
than 1.0 Å, and this bacterial enzyme utilizes magnesium to a similar extent as human 
prolidase, suggesting that the specific placement or conformational flexibility that 
influences metal coordination is shared between the enzymes of these two distantly 
related organisms.  Variable metal usage has been postulated to serve as a regulatory role 
in aminopeptidases [386].  Other similarities between these two proteins may allow for 
the E. coli protein to provide insights into the functionality of the human protein.  Not 
only is the placement of the critical arginine residue unchanged in the human prolidase, 
but many other residues are conserved between the two proteins, including some that are 
associated with disease alleles, for example, E412K and G448R in human prolidase 
deficiency [400].   
Interestingly, despite its role in substrate selectivity, no mutation of the 
equivalent R370 residue has yet been associated with the onset of prolidase deficiency in 
humans [372,415-417].  It is possible that mutation of the same residue in the human 
enzyme results in a reduction of enzymatic activity too small to yield an observable 
phenotype.  However, this seems unlikely, given that losing R370 in PepQ results in a 
decrease in enzymatic activity that is orders of magnitude more severe than caused by 
single residue mutants in the human enzyme with known phenotypes [400].   Notably, 
many disease associated mutations also (i) decrease the stability of the enzyme, (ii) have 
a reduced abundance in vivo, and (iii) perturb the dimer binding constant so that 
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formation of active enzyme requires protein concentrations that are much higher than 
needed for the wild-type protein [400].  It is possible that the impact of these mutations 
on folding and stability is, overall, more serious than the loss of activity seen with the 
arginine mutation alone, which has no effect on enzyme stability or folding.  Alternately, 
loss of the active site arginine might have such severe developmental consequences that 
homozygous and many heterozygous genotypes are simply not viable.  It also remains 
possible that the number of studied cases of prolidase deficiency is yet too small to have 
sampled every disease-associated allele.   Although the critical active site arginine 
residue has yet to be associated with the physiological outcomes of reduced activity, 
observed defects in conserved regions in one enzyme generally predict similar defects in 
other, highly homologous enzymes.  Utilizing E. coli PepQ may, therefore, be an 
effective strategy for studying prolidases in general and deficiencies in human prolidase 
specifically. 
Many proteins evolve through the addition of loops or domains to gain solubility, 
new interactions or new activity [418].  Although it is not necessary for a prolidase to 
have the additional catalytic domain loop in order to place specificity-defining residues 
in the active site, as seen in the P. furiosus PepQ, the positioning of this residue in 
Gram-negative bacteria and higher organisms has remained constant during billions of 
years of evolution, indicating a preferred or optimal placement for activity.  While E. 
coli PepQ may serve as a tool for studying prolidases in general, other prolidases may 
provide further insight into the role of these enzymes beyond collagen recycling in 
humans.  One such protein of interest is the Xaa-Pro peptidase from the nearly 
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exclusively catabolic organism Mycoplasma mobile.  Examination of this protein 
structurally and biochemically would reveal how this minimalist organism utilizes this 
enzyme, demonstrating the extent of its role in metabolism.  Despite the continual 
advance of knowledge about prolidases – structurally, biochemically and genetically – 
much is left unknown about the role of these enzymes in metabolism and their 
connection to disease. 
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CHAPTER V 
ALTERED FOLDING OF AN E. COLI SUBSTRATE PROTEIN BY GROEL 
 
Most proteins must fold from linear polypeptides into three-dimensional 
structures that are suited to their intended function.  While this process often occurs 
without incident, the folding of some proteins is intrinsically fraught with slowly 
converting or error-prone intermediates, and any protein can experience difficulties 
during cell stress [123,289,419].  If the rate of adopting a non-native conformation 
exceeds the rate of folding correctly, a protein will fail to acquire its native conformation 
and become kinetically-trapped or misfolded, or may interact with other non-native 
proteins to form aggregates [114,123,190,198,420].  To recover misfolded or aggregated 
proteins, all cells utilize molecular chaperones, proteins that aid other proteins in 
reaching or maintaining the native conformation.  One chaperone system, the Hsp60s, 
alters the kinetics of folding, misfolding, and aggregation to promote native-state 
conformations and correct folding [127,239,240,290,339].  These chaperonins are 
essential to almost every organism across the kingdoms of life [133,213].    
The Hsp60 in Escherichia coli is GroEL, which is a homotetradecamer 
composed of ~57kDa monomers that form two heptameric rings oriented with closed 
ends facing together and open ends facing the solvent [141,152].  Utilizing a large 
hydrophobic surface near the open end of one of these rings, GroEL binds to unfolded or 
misfolded substrate proteins [141,154,157,165,330,421,422].  In an ATP-binding-
dependent manner, GroEL undergoes a large conformational change that expands the 
  
 
165 
apical domains, reducing the hydrophobic surface and causing the release of the 
substrate protein from the GroEL wall, while concomitantly exposing the binding sites 
of the cochaperone GroES, a heptamer totaling ~70kDa [131,154,157,163].  GroES 
binds a GroEL ring like a lid, encapsulating the substrate protein inside the newly-
formed cavity, where folding can occur [154,157,206].  This closed GroEL-ES-ATP 
cavity, known as the cis ring, persists for 5-25 seconds, depending on conditions 
[157,159,163].  The ATP hydrolyzes during this period, but it is the binding of 
nucleotide to the opposite, or trans, ring of GroEL that causes an allosteric change in the 
protein, leading to the release of GroES, nucleotide, and the substrate protein from the 
other ring.  This release occurs regardless of whether or not the substrate protein has 
folded correctly [173,178].  By the time the trans ring binds ATP, this ring has already 
bound a substrate protein that will subsequently be encapsulated, thus continuing the 
GroEL reaction cycle [157,163,173].  While much is known about the reaction cycle, 
how GroEL aids in the folding of substrate proteins has remained a contentious topic, 
even after decades of research, the popular consensus is that this molecular machine is 
believed to work by two primary mechanisms.   
First, encapsulating a substrate protein inside the GroEL-ES cavity effectively 
removes it from the cytosol, preventing any interactions with other proteins.  Here, 
GroEL serves as a passive- or Anfinsen-cage, where the chaperone exists solely to 
protect a folding monomer from intermolecular interactions and aggregation 
[192,193,249].  This model assumes that all proteins are capable of folding 
independently, as long as these folding proteins have no competing, exterior forces.  
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Under this assumption, GroEL exists only to permit this unperturbed folding to occur.  
Kinetically, the chaperonin would simply reduce the aggregation rate to zero.   
In the second mechanism, interactions between the chaperone and the substrate 
protein may alter how the substrate protein folds.  This active model is divided into two 
main sets of interactions: confinement inside the cavity, where the size and character of 
the cavity walls of GroEL and GroES influence potential conformations of the folding 
substrate protein, and iterative annealing, where the conformational change that occurs 
during each round of ATP binding induces unfolding in the bound substrate protein.  
This unfolding disrupts kinetically-trapped conformations and returns the substrate 
protein to a higher energy state, providing a new opportunity to fold [158,159,166-
168,187,190].  The GroEL C-termini, which contribute to controlling cavity size, cavity 
character, the GroEL ATPase rate (and thus the cavity lifetime), and the unfolding action 
of the chaperone [203,204,209,244,250,347,423], are involved in both components of 
the active model.  The active model stresses that interactions between the chaperone and 
the substrate protein change the availability of intermediate folding conformations, 
whether it is the diminishing of non-native forms or the promotion of on-pathway 
intermediates.  While the active model highlights the enhancement of folding rates and 
the reduction of misfolding rates, it generally acknowledges that the aggregation rate of 
the encapsulated protein is also zero.   
 In vivo, GroEL interacts with hundreds of different proteins, including 50-100 
proteins that require the chaperone to fold correctly [89,90].  Research on GroEL, 
however, has focused on a handful of substrate proteins that have been studied 
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extensively in vitro.  While these various substrate proteins have different tendencies for 
folding, misfolding and aggregation, and are influenced by GroEL differently, nearly all 
share the feature of not being E. coli substrate proteins of GroEL 
[148,149,200,205,224,342].  The availability of chaperone inside the cell influences how 
proteins evolve [357,359], so examining the folding of proteins that evolved in the 
presence of the studied chaperone would seem critical.  Recently, a true substrate protein 
of GroEL, E. coli 4-hydroxy-tetrahydrodipicolinate synthase (DapA), was examined, and 
its folding was shown to be altered by GroEL in a manner that mimics the folding of a 
non-E. coli, non-GroEL-utilizing homolog [88].  This finding demonstrates the 
importance of examining substrate proteins that are native to the chaperonin under study.   
 Here we introduce the E. coli prolidase, PepQ, as a new model folding substrate 
protein of GroEL and present evidence that its folding is actively enhanced by the 
chaperonin.  PepQ requires the chaperone in vivo [89,90], and under conditions where 
this protein does not aggregate, folding is stimulated 15-20 fold by GroEL-ES.  GroEL 
induces changes during the early stages of PepQ folding that occur on the timescale 
relevant to the cavity lifetime, and these alterations in folding are dependent on 
interactions with the GroEL C-termini, which influence PepQ unfolding prior to the start 
of folding.  We find that the unfolding action of GroEL is critical for maximizing the 
stimulation of PepQ folding, demonstrating a clear role for the iterative annealing 
mechanism of GroEL function.   
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Experimental Procedures 
Proteins.  Wild-type and variants of GroEL (SR1 and C-terminal truncation 
mutants), GroES, and wild-type E. coli PepQ were all expressed and purified as 
described previously [158,159,166,168,423].  The cysteine mutant of PepQ, A24C, was 
generated via site-directed mutagenesis and the sequence was verified by DNA 
sequencing.  This mutant was expressed and purified following the protocol for wild-
type PepQ.   
 Labeling of PepQ.  A24C PepQ was labeled using either 5-
iodoacetamidofluorescein (fluorescein, F), 5-(2-acetamidoethyl) aminonaphthalene 1-
sulfonate (EDANS, ED), or tetramethylrhodamine-5-iodoacetamide dihydroiodide 
(tetramethylrhoadmine, TMR).  The extent of labeling was determined by protein 
quantification by the Bradford assay (Bio-Rad) and dye quantification under denaturing 
conditions using known molar extinction coefficients [157,316].  Site-specific labeling 
was verified through denaturing anion-exchange chromatography and analysis of 
proteolytic fragments [316].  
 Enzymatic Refolding.  All folding assays were conducted using PepQ that was 
diluted at least 40-fold into 8 M urea, 25 mM glycine phosphate, pH 2, and incubated at 
room temperature for at least 20 minutes prior to further use.  CD spectra show a 
complete loss of secondary structure under these conditions (data not shown).  
Spontaneous refolding of PepQ was initiated by a 50-fold dilution from denaturant into 
TKM buffer (50 mM Tris-HCl, pH 7.4, 50 mM KOAc, 10 mM Mg(OAc)2 and 2 mM 
DTT) and quenched through the addition of excess GroEL.  Chaperone-mediated folding 
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reactions using either wild-type or mutant tetradecameric GroEL began with a 50-fold 
dilution of denatured PepQ into TKM buffer containing chaperone.  GroES and ATP 
were added to initiate the reaction cycle and the reaction was quenched with hexokinase 
and glucose [159,163,166,424].  Folding reactions in single-ring mutants of GroEL were 
done similarly, except quenching was accomplished by the simultaneous addition of 
EDTA and incubation of the sample at 0˚C [163,199,203].  After quenching, all samples 
were incubated for 60 minutes at room temperature to allow for dimerization.  The 
enzyme activity of all samples was measured through a coupled reaction described 
previously [423]. 
 Fluorescence and Light Scattering.  Light scattering and fluorescence 
measurements were conducted with a PTI fluorometer, with temperature regulation 
through a jacketed cuvette holder (Neslab).  For both types of experiments, the assay 
was initiated with chemically-denatured PepQ being diluted 50-fold into temperature-
equilibrated TKM buffer.  Tryptophan fluorescence was monitored with excitation at 
295 nm and emission read at 340 nm.  The excitation and emission wavelengths were 
both 340 nm for light scattering experiments. 
 Stopped-flow Fluorescence.  Stopped-flow experiments were conducted as 
described previously [166,168,316,424], using an SFM-400 rapid mixing unit 
(BioLogic) equipped with a custom-designed two-channel fluorescence detection 
system. Mixing was done using two syringes, one containing GroEL-PepQ complexes 
and one containing GroES and ATP.   
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 Steady-state FRET.  Steady-state fluorescence measurements were conducted 
with a PTI fluorometer, with temperature regulation through a jacketed cuvette holder 
(Neslab).  FRET was calculated from donor-side fluorescence in the presence of 
unlabeled or acceptor-labeled molecules as previously described for other GroEL 
substrate proteins [157,316].   
 Sample Preparation for Fluorescence Correlation Spectroscopy.  24-TMR PepQ 
was diluted greater than 40-fold (to 5 µM) into 8 M urea, 25 mM glycine phosphate, pH 
2 and incubated for 20 minutes at room temperature.  For spontaneous folding reactions, 
this 24-TMR PepQ was then diluted to 100 nM in the same solution.  The folding 
reaction was initiated by dilution of PepQ to 2 nM in TKM buffer.  Folding was 
quenched by the addition of 50 µL to 50 µL of 1 µM GroEL in TKM buffer.  For 
GroEL-mediated folding, 5 µM denatured 24-TMR PepQ was diluted to 100 nM in 
TKM buffer containing GroEL (200 nM final concentration).  After a 10 minute 
incubation at room temperature, this solution was diluted into TKM buffer containing 
GroEL, GroES and an ATP-regeneration system [159].  Folding was initiated by the 
addition of ATP.  The final concentration of ATP was 2 mM, GroEL was 1 µM, and 
GroES was 2 µM.  Folding was quenched by the addition of 20 µL of the reaction 
mixture with an equal volume of hexokinase and glucose.  In refolding assays at both 1 
nM and 2 nM, PepQ dimerization was not observed, even after eight hours (by lack of 
activity, data not shown).   
 Fluorescence Correlation Spectroscopy.  10 µL of the quenched reaction mixture 
was dispensed on a BSA-blocked coverslip mounted on the objective of a custom-built 
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confocal microscope [425] and covered with a humidified chamber to prevent 
evaporation.  Autocorrelation curves were collected for each sample for two minutes 
with a 500 µsec sampling time using a 50 µW laser at 561 nm.  Autocorrelation curves 
were normalized in mean amplitude between 10-6 and 10-5 seconds for display purposes. 
As standards, the autocorrelation curves of PepQ fully bound to GroEL (obtained by not 
adding ATP to a folding reaction), as a native dimer (obtained by diluting native 24-
TMR in buffer), and as a native monomer (obtained by allowing a GroEL-mediated 
folding reaction with 1 nM PepQ to continue an hour) were also determined.  Each 
autocorrelation curve was fit using a multi-component model [426,427] to account for 
populations of freely diffusing and GroEL-bound PepQ.  Each autocorrelation curve was 
fit using two different sets of parameters.  First, the diffusion coefficient of each 
population was fixed and the fractional population was allowed to vary.  Second, the 
average diffusion coefficient of the entire population was determined and was 
normalized using the observed diffusion coefficients for free and bound PepQ.  These 
methods yielded statistically consistent results.      
 Protease Protection.  The protease sensitivity of non-native PepQ bound to 
a GroEL ring was conducted as described previously for the substrate protein RuBisCO 
[158,166]. Briefly, 24F-PepQ was bound to asymmetric GroEL-GroES ADP bullets. 
Chymotrypsin was added, and time points were taken, with the reaction stopped with 
PMSF. Samples were run on 10% SDS-PAGE and imaged using a Typhoon Trio (GE 
Healthcare). 
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 GroEL ATPase Activity.  The ATPase activity of GroEL was assayed using a 
coupled reaction as reported previously [158,159,424,428,429].  The rate of spontaneous 
ATP hydrolysis under each condition without GroEL was also determined to control for 
effects on the coupling system.   
 PepQ Unfolding in Guanidinium.  The unfolding of PepQ was monitored by the 
decrease in tryptophan fluorescence with increasing concentrations of guanidinium-HCl. 
PepQ (50 nM) was incubated at room temperature for 60 minutes in solutions of 50 mM 
Tris, pH 7.4, 10 mM Mg(OAc)2, 2 mM DTT and varying concentrations of 
guanidinium-HCl. The tryptophan fluorescence was measured using a PTI fluorometer 
with excitation at 295 nm and emission at 340 nm.  Solutions of buffer and guanidinium 
alone were also measured to control for changes in scattered light. 
 
Results 
GroEL stimulates the folding of PepQ.  PepQ is an enzyme that catalyzes the 
hydrolysis of dipeptides containing a C-terminal proline residue.  It forms a homodimer, 
with each monomer (~50.2 kDa) containing N-terminal and C-terminal domains, the 
latter of which adopts a pita-bread fold and contains the active site [384,423].  PepQ was 
predicted by two independent proteomics studies to require GroEL-ES in vivo [89,90], 
but to determine whether PepQ requires GroEL to reach its native conformation, the 
extent of folding of PepQ was measured in vitro over time, both with and without the 
chaperonin system.  Upon dilution from chemical denaturant, PepQ is capable of 
spontaneously folding at room temperature to a yield of 50-60% with a halftime of ~20  
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Figure 5.1: GroEL Enhances the Rate and Yield of PepQ Folding. (A) The refolding of 
PepQ was monitored by the recovery of enzymatic activity. Chemically denatured, wild-
type PepQ was diluted either directly into buffer (100 nM, Spontaneous; green) or bound 
to wild-type GroEL (200 nM) and refolded in the presence of GroES (400 nM) and ATP 
(2 mM) (+GroEL/ES/ATP; blue).  Alternatively, the same PepQ was bound to the single 
ring mutant of GroEL, SR1 (300 nM) and refolded in the presence of GroES (600 nM) 
and ATP (2 mM) (+SR1/ES/ATP; purple).  The data were fit to a single-exponential rate 
law (solid lines), resulting in the observed rates of 0.62 + 0.05 min-1 for GroEL-mediated 
folding, 0.62 + 0.09 min-1 for SR1-mediated folding and 0.035 + 0.005 min-1 for 
spontaneous folding.  Error bars show the standard deviation from three independent 
folding experiments. (B) The rate that PepQ becomes refractory to GroEL activity was 
monitored by the recovery of enzymatic activity. Chemically denatured, wild-type PepQ 
was diluted directly into buffer (100 nM; green).  At given time-points, samples of this 
solution were mixed with an equal volume of a solution containing wild-type GroEL 
(400 nM) and GroES (800 nM).  ATP (2mM) was added immediately thereafter and the 
reactions were incubated at room temperature for 60 minutes before quenching.  The 
data were fit to a single-exponential rate law (solid line), resulting in the observed rates 
of 0.033 + 0.006 min-1.  n = 3 replicates. 
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minutes (Figure 5.1A).  The GroEL-mediated folding of PepQ under the same 
conditions achieved a yield of 80-90% and was completed with a halftime of ~1 minute  
(Figure 5.1A).  Although PepQ does not require GroEL to fold, the chaperonin 
stimulates the folding rate by 15-20 fold, while also increasing the yield.  To determine 
whether confinement inside the GroEL cavity is critical to the stimulation of PepQ 
folding, the single ring mutant of GroEL (SR1) was utilized.  Upon encapsulation inside 
SR1, PepQ folds inside the SR1-ES cavity until exposure to conditions that disrupt this 
chaperone complex; the use of this non-cycling GroEL mutant removes the variables 
associated with the cycling of the chaperone machinery [206].  PepQ folding inside the 
SR1-ES cavity achieved a rate similar to wild-type GroEL, though to a lower yield 
(Figure 5.1A).     
 Although PepQ can fold to some extent spontaneously, the observed decrease in 
rate and yield suggests that some fraction of the folding PepQ population is acquiring a 
non-native state.  This conformation may be at equilibrium with productive 
intermediates formed during PepQ folding; the intercoversion between these two 
populations could results in an observed decrease in the folding rate.  To probe for a 
non-native conformation, spontaneously folding PepQ was subjected to the chaperonin 
system at various time-points during the course of spontaneous folding so that any 
protein that remains in an uncommitted state can bind to GroEL and be refolded by the 
chaperone machinery.  If PepQ adopts a conformation that cannot be refolded by GroEL, 
a decrease in yield over time would be predicted.  As shown in Figure 5.1B, PepQ 
becomes refractory to the chaperone at a similar rate as its spontaneous folding.  In the 
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initial characterization of the substrate protein RuBisCO from Rhodospirillum rubrum 
[87], this same strategy showed a rapid loss of RuBisCO’s capability to bind and be 
refolded by GroEL, which was shown to be the result of intermolecular aggregation.  
Knowing that aggregation could be the source of the reduced spontaneous folding of 
PepQ, we next sought to examine whether PepQ also suffers from a propensity to 
aggregate. 
 To determine whether PepQ folding is limited by aggregation, a number of 
approaches were employed.  Protein aggregation requires the coalescence of smaller 
particles, such as non-native monomers, into larger particles.  This transition can be 
observed by light scattering, where larger particles scatter more light than smaller 
particles.  When PepQ is diluted from chemical denaturant, no increase in light scatter is 
observed (Figure 5.2A).  As controls, native PepQ was diluted from buffer and showed 
no increase in light scatter, while unfolded RuBisCO was diluted from chemical 
denaturant, and showed a large increase in light scatter (Figure 5.2A).  Although PepQ 
produced no aggregates observable by light scattering, we understood that this method is 
not very sensitive to small aggregates.  Therefore, a more sensitive approach was 
employed that utilizes FRET to monitor protein aggregation.  This method has been used 
effectively in the study of other GroEL-dependent substrate proteins [168].  Using 
fluorescently labeled variants of PepQ, with an introduced cysteine on the N-terminal 
helix labeled with either a donor or acceptor dye (position 24, with 5-
iodoacetamidofluorescein (fluorescein, 24F) or 5-(2-acetamidoethyl) aminonaphthalene 
1-sulfonate (EDANS, 24ED), respectively), FRET was utilized to examine aggregation  
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Figure 5.2: PepQ is Not Prone to Aggregation under Permissive Folding Conditions. 
(A) The aggregation of PepQ was monitored by light scattering.  Chemically denatured, 
wild-type PepQ (100 nM; green) or chemically denatured, wild-type RuBisCO (100 nM; 
red) was diluted directly into buffer and the static light scattering was monitored at 340 
nm and 90 degrees.  The traces shown are the average of 3 replicates. (B) Structure of 
the PepQ dimer showing the position of the dyes.  The PDB file (4QR8) was altered 
using PyMol to visualize the mutation of residue 24 to cysteine and attachment of small 
fluorescent dyes (EDANS on the yellow monomer, fluorescein on the blue monomer).  
The distance between the beta-carbons of the cysteines was measured with PyMol to be 
64.9 Å. (C) Aggregation of PepQ was monitored by intermolecular FRET.  PepQ was 
labeled at an introduced cysteine (24C) with either IAEDANS (donor, ED) or 5-IAF 
(acceptor, F).  Chemically denatured, donor-labeled PepQ (50 nM) and either chemically 
denatured, unlabeled PepQ (50 nM) or chemically denatured, acceptor-labeled PepQ (50 
nM) were mixed and allowed to fold spontaneously at room temperature (green), fold 
spontaneously at 50˚C (brown), or fold with GroEL (200 nM), GroES (400 nM) and 
ATP (2 mM) (blue).  The FRET efficiency was calculated from the donor quenching 
using matched donor-only and donor-acceptor samples.  Error bars show the deviation of 
n = 3 replicates. (D) The spontaneous folding of PepQ was monitored as a function of 
PepQ concentration.  Chemically denatured, wild-type PepQ was diluted 50-fold into 
buffer to yield a folding reaction at the designated final concentration.  Each rate (blue) 
was derived from a fit of the folding data to a single- exponential rate law.  Each yield 
(black) is the yield achieved after folding for 60 minutes.  Error bars show the standard 
deviation from three independent folding experiments. 
177 
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by measuring the proximity of the differently-labeled monomers (Figure 5.2B).  In these 
experiments, both labeled proteins, or donor-labeled and unlabeled PepQ, were unfolded 
together (at a 1:1 ratio) in chemical denaturant and then diluted into buffer for a 
spontaneous folding reaction, a GroEL-mediated folding reaction, and a spontaneous 
folding reaction conducted under non-permissive conditions.  Non-permissive conditions 
are achieved by raising the temperature to 50˚C, which leads to aggregation as seen by a 
lack of activity and increased light scattering (data not shown).  The matched donor-
fluorescence from each sample was used to calculate the FRET efficiency (Figure 
5.2C).  The lack of FRET in the GroEL-folded sample is due to two factors: 1) the beta-
carbons of the labeled residue in the native dimer are ~65Å apart, well outside the 
Fӧrster distance for this dye pair [430] and 2) only 50% of the dimers contain one of 
each differently-labeled monomer.  The folding reaction conducted at 50˚C shows a 
large FRET signal, indicating the formation of substancial aggregates.  The spontaneous 
reaction conducted at room temperature, however, shows a similar FRET efficiency as 
the GroEL-mediated sample, which strongly suggests that slow and inefficient folding 
PepQ folding is not caused by aggregation. 
 To further examine whether PepQ forms aggregates, the spontaneous folding of 
PepQ was measured over a range of protein concentrations.  As aggregation is a 
multimolecular process, it is highly concentration-dependent; therefore, under conditions 
where aggregation is occurring, the rate and yield should be significantly decreased.  
Over the range of 25-500 nM PepQ, the halftime of folding is unchanged, though a 
decrease in the yield is observed at 250 and 500 nM (Figure 5.2D).  The decrease in 
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yield indicates that aggregation is occurring at these higher concentrations; however, the 
standard folding conditions used for most of the work presented here (e.g. Figure 5.1) 
were 100 nM PepQ, which shows no difference in folding rate or yield from the folding 
reactions conducted with lower protein concentrations.  In this experiment, the lower 
bound of protein concentration was limited by the able to conduct enzyme assays.  
Examining the folding of PepQ below 25 nM was precluded by the timescale of PepQ 
dimerization, a process that is necessary for activity.  Although the reactions at 25 and 
100 nM PepQ showed the same rates and yields, we sought to further expand the range 
of sampled concentrations. 
 In order to examine folding at even lower concentrations, fluorescence 
correlation spectroscopy (FCS) was utilized.  Fluorescently-labeled PepQ (24TMR) was 
diluted 50-fold from chemical denaturant to 2 nM and allowed to fold spontaneously.  At 
given time points, reaction samples were quenched by the addition of a large excess of 
GroEL.  Using FCS, the apparent diffusion time of each sample was measured.  As 
controls, samples of PepQ bound to GroEL and native PepQ were also measured to 
establish the diffusive behavior of the reference states.  The normalized autocorrelation 
curves of these controls are shown in Figure 5.3A.  Using the bounds established by the 
minimum and maximum diffusion times, the relative fraction bound to GroEL in each 
sample was determined (Figure 5.3B).  The fraction bound to GroEL is proportional to 
the fraction that remains unfolded, and this was used to determine the folding halftime, 
which for spontaneous folding was ~53 minutes and for GroEL-mediated folding was 
~3.6 minutes, which is an enhancement of ~15 fold.  These rates match the folding rates  
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Figure 5.3: GroEL Stimulates the Folding of the PepQ Monomer. (A) Example FCS 
curves.  Shown are the curves for folded, monomeric PepQ (green) and GroEL-bound 
PepQ (blue). (B) The refolding of PepQ was monitored by the shift in the apparent 
diffusion time.  PepQ was labeled at an introduced cysteine (24C) with 5-TMRIA 
(TMR).  Chemically denatured, TMR-labeled PepQ was diluted either directly into 
buffer (2 nM, Spontaneous; green) or bound to wild-type GroEL (1 uM) and refolded in 
the presence of GroES (2 uM) and ATP (2 mM) (+GroEL/ES/ATP; blue).  The data 
were fit to a single-exponential rate law (solid lines), resulting in the observed rates of 
0.19 + 0.04 min-1 for GroEL-mediated folding and 0.013 + 0.002 min-1 for spontaneous 
folding.  n = 3 replicates. 
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of the same labeled PepQ molecule at 100 nM (data not shown).  This observation 
further demonstrates that the process that limits the spontaneous folding of PepQ is not 
concentration-dependent.  Slow folding of PepQ cannot be due to aggregation and must, 
therefore, be due to misfolding. 
 GroEL alters the folding trajectory of PepQ.  As it is not required to block 
aggregation, GroEL must enhance PepQ folding through some other mechanism.  
Recently, it was shown that GroEL enhances the folding of only some specific sections 
of the E. coli protein DapA [88].  To investigate whether GroEL alters how PepQ folds, 
the tryptophan fluorescence of PepQ was observed during different folding reactions.   
Importantly, PepQ has multiple tryptophans, while both GroEL and GroES contain none.  
The tryptophan fluorescence of spontaneously folding PepQ shows a single, downward 
transition (Figure 5.4A).  Tryptophan fluorescence often increases during protein 
folding in response to the burial of these residues inside the protein resulting in an 
increase in quantum yield upon shielding from solvent and burial in more non-polar 
environments.  Unfolding PepQ with chemical denaturant supports this concept, as the 
tryptophan fluorescence decreases with increasing concentrations of denaturant (Figure 
5.5).  The most important difference between the folding and the unfolding experiments 
is the oligomeric state of PepQ at the beginning of measurement.  The change in 
tryptophan fluorescence observed with denaturant could be dominated by alterations in 
the dimer structure.  Alternatively, some tryptophans may remain quenched by nearby 
residues until a much later conformation, including the native dimer, is formed.  It is also  
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Figure 5.4: GroEL Alters the Folding Trajectory of PepQ. (A) The folding of PepQ was 
monitored by tryptophan fluorescence.  Chemically denatured, wild-type PepQ (100 nM) 
was diluted directly into buffer.  The fluorescence of tryptophan was observed 
(excitation at 295 nm, emission at 340 nm).  The traces are the average of 10 replicates. 
(B) Chemically denatured, wild-type PepQ (100 nM) was bound to wild-type GroEL 
(200 nM) and refolded in the presence of GroES (400 nM) and ATP (2 mM).  The 
fluorescence of tryptophan was observed (excitation at 295 nm, emission at 340 nm).  
The traces are the average of 10 replicates. (C) Chemically denatured, wild-type PepQ 
(100 nM) was bound to the single-ring mutant of GroEL, SR1 (300 nM) and refolded in 
the presence of GroES (600 nM) and ATP (2 mM).  The fluorescence of tryptophan was 
observed (excitation at 295 nm, emission at 340 nm).  The traces are the average of 10 
replicates. 
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Figure 5.5: PepQ Unfolds in Response to the Chemical Denaturant Guanidinium. PepQ 
(50 nM) was incubated with varying concentrations of guanidinium-HCl and the 
tryptophan fluorescence at 340 nm each sample was determined.  Error bars indicate the 
standard deviation from three independent samples. 
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possible that the changes in tryptophan fluorescence of misfolding PepQ offset 
observable changes occurring in correctly folding PepQ.  
Unlike the fluorescence change during spontanoues PepQ folding, an increase in 
fluorescence is seen during the early phase of GroEL-mediated folding, which is 
followed by a subsequent decrease (Figure 5.4B).  This increase in fluorescence must be 
reporting on some aspect of PepQ folding, as it is too slow to simply be the response to 
GroES binding or release of the bound substrate protein from the GroEL cavity wall 
[158,166,168].  Although folding in this system quickly becomes asynchronous, the 
transition between increasing and decreasing fluorescence occurs after roughly one 
cavity lifetime [157,163].  This suggests that the folding transition that is reported by the 
increase in fluorescence occurs inside the GroEL-ES cavity.  To investigate this, the 
single-ring mutant was employed.  Folding of PepQ inside SR1 only showed the 
increase in fluorescence, but not the subsequent decrease (Figure 5.4C), which suggests 
that the subsequent decrease in fluorescence is reporting on some aspect of folding that 
occurs after PepQ has been released from the GroEL cavity.     
 PepQ benefits from increased unfolding.  We next sought to determine the 
interaction between GroEL and PepQ during folding that results in the a new folding 
transition reported by tryptophan fluorescence.  Recently, the intrinsically disordered C-
termini of GroEL were shown to alter the early folding behavior of the stringent 
substrate RuBisCO [424].  To investigate whether these C-terminal tails are involved in 
altering the folding of PepQ, C-terminal truncation mutants of wild-type GroEL and SR1 
were used to examine chaperone-mediated folding.  These mutants, known as ∆526 and 
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SR∆526 respectively, lack the C-terminal 23 residues and have previously been shown 
to form stable tetradecamers, which are capable of efficiently encapsulating and folding 
substrate proteins [424].   
 Comparing the intracavity folding of PepQ inside full-length and truncated 
single-ring mutants shows that the largest component of the increase in tryptophan 
fluorescence is no longer observed in the absence of the GroEL C-termini (Figure 
5.6A).  If this transition reports on a process that is important for the stimulation of 
folding, then a decrease in the folding rate in the C-terminal truncation mutant would be 
predicted.  Examining the folding with both the single-ring and tetradecameric 
truncation mutants shows decreased folding rates, with folding halftimes in SR∆526 of 
~2.1 minutes and in ∆526 of ~6.3 minutes (Figure 5.6B).  Although folding with both 
truncated chaperones is several fold slower than in the full-length counterpart, the 
deficiency in ∆526 is significantly greater than in SR∆526, indicating that the role of the 
C-terminal tails is more important in the cycling system.  The key difference between 
tetradecameric GroEL and the single-ring mutant is that substrate proteins are iteratively 
bound and released with the wild-type chaperone, whereas the single-ring mutant only 
undergoes this process once.   
 When a substrate protein is bound by GroEL, the substrate protein undergoes a 
binding-driven conformational change where it adopts a more unfolded structure, and 
the extent of substrate protein unfolding is directly correlated to the subsequent rate of 
early, productive folding [166].  To examine whether the conformation of PepQ is 
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Figure 5.6: The Interactions with the GroEL C-Termini are Required for Maximal 
Enhancement. (A) Intra-cavity folding of PepQ at early times monitored by changes in 
tryptophan fluorescence following addition of GroES and ATP to complexes of wild-
type PepQ bound to SR1 (blue) or SR∆526 (green). Chemically denatured, wild-type 
PepQ (100 nM) was bound to SR1 (300 nM) and was rapidly mixed with an equal 
volume of GroES (600 nM) and ATP (2 mM) in a stopped-flow apparatus and monitored 
with a sampling time of 20 ms.  Traces are the average of 20 replicates. (B) Chemically 
denatured PepQ was bound to the C-terminal truncation mutant of GroEL, ∆526 (200 
nM, pink) or the single ring truncation mutant, SR∆526 (300 nM, orange) and refolded 
in the presence of GroES (400 and 600 nM, respectively) and ATP (2 mM).  The data 
were fit to a single-exponential rate law (solid lines), resulting in the observed rates of 
0.106 + 0.003 min-1 for ∆526-mediated folding and 0.332 + 0.038 min-1 for SR∆526-
mediated folding.  Error bars show the standard deviation from three independent 
folding experiments. 
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altered by the GroEL C-termini, the susceptibility of PepQ to protease degradation when 
bound to full-length or C-terminally-truncated GroEL-ES ADP bullets was determined.  
PepQ bound to the full-length GroEL ring was degraded by chymotrypsin ~2.5 fold 
faster than PepQ bound to the ∆526 ring (Figure 5.7).  This result indicates that PepQ 
has a more unfolded conformation when the GroEL C-termini are present. 
 Although the substrate protein is more unfolded when bound to a wild-type 
GroEL ring than when bound to ∆526, a correlation between the unfolding and 
productive folding of PepQ has not been established.  To examine whether PepQ 
benefits from being unfolded on GroEL, the chaperone-mediated folding rate of PepQ 
was examined under conditions where the cycling rate of GroEL is increased.  Previous 
studies have established that the cycling rate of the chaperone is accelerated in the 
presence of substrate protein [157,176,244], so the addition of other proteins into the 
folding reaction could be one mechanism for increasing the cycling rate.  To maintain a 
constant concentration of PepQ, and to reduce the additional competition for GroEL 
binding, native bovine serum albumin (BSA), rather than unfolded or non-native protein, 
was added to the reaction.  Although BSA is a folded protein, its ability to bind lipids 
could potentially give it the necessary binding surfaces to transiently interact with the 
chaperone.  As a measure of the cycling rate, the ATPase rate of the cycling chaperone 
was measured in the presence of varying concentrations of BSA, which showed that the 
addition of BSA does accelerate the cycling rate of GroEL by as much as 50% (Figure 
5.8a).  Under the same conditions, the folding rate of PepQ with the cycling chaperone is 
increased, while there is no significant effect on spontaneous folding (Figure 5.8b).   
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Figure 5.7: The GroEL C-Termini Modify the Conformation of Bound PepQ. (A) The 
extent of residual secondary structure of GroEL-bound PepQ was examined by protease 
susceptibility.  Fluorescently labeled PepQ (24F; 100 nM) was chemically denatured and 
bound to the trans ring of either GroEL or ∆526 ADP bullets (120 nM) and then treated 
with chymotrypsin for the indicated times before quenching with PMSF (1mM). The 
samples were analyzed by SDS-PAGE and laser-excited fluorescence gel scanning.  (B) 
The amount of full-length PepQ remaining at each time point in (A) was quantified and 
plotted as a function of time.  The data were fit to a single-exponential rate law.  The 
half-time for the digestion of PepQ bound to full-length ADP bullets was 0.53 + 0.06 
min (EL, blue) and 1.66 + 0.17 min for C-terminal deletion ADP bullets (∆526, green).  
Error bars represent the standard deviation of three independent experiments. 
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The enhanced folding seen with the wild-type chaperone over the truncation mutant, as 
well as the enhanced folding seen with faster cycling of the chaperone machinery – both 
of which are conditions with greater extent or rate of unfolding – suggests that GroEL 
aids PepQ folding through the disruption of kinetically-trapped intermediates. 
 
Discussion 
 The results presented here strongly support an active role for GroEL in the 
folding of the E. coli protein PepQ.  Under conditions where aggregation is not limiting, 
the rate of PepQ folding is enhanced 15-20 fold by the chaperone over spontaneous 
folding.  Distinct changes in early folding transitions of PepQ are mediated by the 
chaperone, although these alterations and much of the stimulation of folding disappear in 
the absence of the GroEL C-termini.  We show that these C-terminal tails alter the 
conformation of the bound substrate protein prior to encapsulation beneath GroES, 
leading to a more unfolded state of PepQ.  The role of the unfolding action of the 
chaperone was examined further by modulating the rate of unfolding.  Under conditions 
where the GroEL cycling rate is stimulated, the chaperone-mediated folding of PepQ is 
also stimulated, although spontaneous folding is not improved.  Importantly, the massive 
improvement in the folding rate of PepQ, from ~20 minutes to ~1 minute, would prevent 
partially-folded conformations from residing in the cell for extended periods of time, 
which could divert other chaperones to bind this substrate protein or lead PepQ to be 
degraded.   
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Figure 5.8: PepQ Folding Benefits from the Repetitive Unfolding Action of GroEL. (A) 
The GroEL ATPase rate was examined in the presence of different concentrations of 
BSA.  The steady-state rate of ATP hydrolysis by GroEL (200 nM) in the presence of 
GroES (400 nM) and ATP (2 mM) was measured in the presence of varying 
concentrations of native BSA.  Error bars show the standard deviation of three 
independent experiments. (B) The rate of spontaneous and GroEL-mediated PepQ 
folding was examined in the presence of different concentrations of BSA.  As in Figure 
5.1A, except with native BSA in the buffer.  Error bars show the standard deviation of 
three independent experiments. 
 
 
 
 
 
 
 
 
 
 
  
 
191 
 In the context of the common models for GroEL function (passive protection 
from aggregation, confinement inside the cavity, and iterative annealing), these 
observations clearly demonstrate an active role for GroEL in the folding of PepQ.  An 
exclusive role for the chaperone as an Anfinsen cage can be eliminated, as PepQ does 
not depend upon the chaperone to protect folding monomers from aggregation (Figure 
5.2&5.3).  The stimulation of PepQ monomer folding at very low concentrations by 
GroEL indicates that the chaperone enhances folding by changing how the protein folds, 
suggesting a role for confinement or iterative annealing.  The GroEL cavity is essential 
for the stimulation of folding, and inside this cavity changes occur in the folding 
transitions of PepQ (Figure 5.4).  Interactions between GroEL and this substrate protein 
significantly enhance its folding, as seen through the differences between full-length and 
truncated chaperone (Figure 5.6).  However, confinement inside the GroEL-ES cavity 
alone is not sufficient for the maximal enhancement of folding, as the stimulation of the 
folding rate is further improved by accelerating the rate of cavity turnover (Figure 5.8).  
This observation suggests that another mechanism contributes to PepQ folding and is 
consistent with the iterative annealing model of GroEL function, which predicts that any 
enhancement of the magnitude or rate of unfolding should also enhance the folding rate 
of the substrate protein [188].  Under this model, with each new cycle of the chaperone 
machinery, the residual structure of the bound substrate protein is disrupted, providing a 
new opportunity for the substrate protein to fold from a higher energy state. 
 A role for substrate protein unfolding is central to the interactions between the 
GroEL C-terminal tails and the bound substrate protein [424].  The ∆526 mutation 
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removes 161 amino acids and ~14.4 kDa of mass from the bottom of the GroEL cavity, 
which could greatly impact the environment of a protein folding inside the chaperonin 
cavity.  Despite the influence of this alteration of cavity size and character, the changes 
in folding induced by this mutation fit into the paradigm of iterative annealing more than 
cavity confinement.  Prior to encapsulation, the GroEL C-termini enhance the unfolding 
of the chaperone-bound PepQ (Figure 5.7); this observation predicts that the folding of 
PepQ would be slowed in the absence of these C-termini.  Comparison of intracavity 
folding between full-length SR1 and truncated SR∆526 shows that folding preceded by 
more extensive unfolding is roughly twice as fast in the case of PepQ.  Adding the 
effects of cycling in the tetradecameric protein yields different predictions for the cavity 
confinement and iterative annealing models.  In the confinement model, there should be 
no difference in the folding rates between cycling and non-cycling systems, as the 
mutation affects both cavities equally.  However, a further decrease in the folding rate is 
observed in the truncated chaperone.  The exacerbation of the difference between folding 
in cycling, full-length and truncated chaperonin further supports a role for the iterative 
annealing model, as the rate of unfolding is also decreased in the more slowly cycling 
∆526 machine [424].  While the perturbation of the unfolding action of the chaperone 
machinery, either by mutation or by exogenously altering the cycling rate, has a direct 
influence on the folding of substrate proteins, the importance of this mechanism does not 
exclude all possible roles for substrate protein confinement.     
 Although only changes in the folding of PepQ are reported here, other studies 
with the substrate protein RuBisCO from R. rubrum have shown the impact of 
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chaperone-mediated unfolding and of the interactions with the GroEL C-termini on that 
protein [158,159,166,168,424].  While PepQ and RuBisCO are only two proteins among 
thousands that utilize the chaperonin machinery, common themes are observed in the 
mechanisms by which their folding is enhanced, despite the critical differences between 
the structures and the folding propensities of the two proteins.  While it is not possible to 
compare the GroEL-mediated folding and the spontaneous folding of RuBisCO, both 
proteins undergo processes that are enhanced by the GroEL C-termini, including an 
unfolding action before encapsulation and changes in the earliest observed transitions in 
folding.  Although neither the GroEL C-termini nor unfolding were analyzed therein, a 
recent study of the folding of the E. coli protein DapA showed clear changes in the early 
folding of this protein with GroEL relative to its spontaneous folding [88].  Unlike 
RuBisCO and DapA, PepQ does not have a TIM-barrel fold; rather, the catalytic domain 
is formed by a pita-bread fold [384,423].  The changes in substrate protein folding seen 
in these three proteins highlight a potentially universal mechanism for protein folding 
inside the GroEL cavity that is independent of the eventual protein structure or fold, 
where the removal of the kinetics barriers that may slow or block productive folding 
through forced unfolding is coupled with inhibition of off-pathway conformations 
through confinement inside the cavity.  
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CHAPTER VI 
 SUMMARY AND CONCLUSIONS 
 
The purpose of this study was to examine the role of the intrinsically-disordered 
C-terminal residues of the E. coli chaperonin GroEL in the various aspects of the folding 
reaction cycle.  The GroEL-ES chaperonin system, which is highly conserved among 
bacteria, mitochondria and chloroplasts, aids substrate protein folding though several 
different mechanisms: protecting folding intermediates from intermolecular aggregation, 
restricting the allowable volume to limit or promote folding intermediates, and unfolding 
unproductive folding intermediates to restart the folding process.  The first mechanism is 
described as the passive model, where GroEL serves as an Anfinsen Cage to allow 
intramolecular folding to occur without intermolecular interactions.  Conversely, the 
second and third mechanisms dictate an active role for GroEL, where specific 
conformational changes in the chaperone or interactions between the chaperone and the 
substrate protein alter the configuration of available folding intermediates.  While no 
single proposed mechanism for the function of GroEL is sufficient for the folding of 
every protein in the proteome, the necessity of each mechanism is unknown, and 
determining the contribution of each mechanism to the folding of any one substrate 
protein requires extensive in vitro experimentation.  In order to better understand roles of 
both the passive and active functions of the chaperonin system, the folding of two 
different substrate proteins was examined in the context of these mechanisms, with a 
focus on the influence of the C-terminal tail of GroEL on each mechanism. 
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 The substrate protein RuBisCO was previously shown to have an extremely high 
propensity for aggregation and to require the chaperonin system in vivo, both in plant 
chloroplasts and in the cytoplasm of photosynthetic bacteria [87,91,252].  The RuBisCO 
used in my studies, which came from the bacterium Rhodospirillum rubrum, does not 
fold independently in vitro, even under conditions where it does not aggregate 
[148,163,168].  GroEL-mediated folding proceeds under the same conditions with a 
halftime of roughly 3.5 minutes [163].  While RuBisCO does fold in the single-ring 
mutant of GroEL, SR1, at the same rate as in wild-type GroEL at room temperature, 
folding in the cycling system is accelerated at higher temperatures, while folding in non-
cycling SR1 mutant is unchanged [159].  Because the intracavity interactions would 
change equally in the cycling and non-cycling systems, the increased folding rate must 
be correlated with the faster turnover of the cycling system at higher temperatures.   
Faster turnover of the GroEL-ES complex shortens the duration of intracavity 
folding for substrate proteins and increases the rate at which substrate proteins will 
reinitiate the folding process.  Therefore, the most dramatic difference between the 
cycling and non-cycling systems is the frequency of chaperone-mediated unfolding of 
the substrate protein.  This implies that the iterative unfolding action of GroEL, rather 
than confinement inside the GroEL-ES cavity, may be the critical mechanism for the 
folding of RuBisCO, as the folding rate and cavity lifetime are inversely proportional.  
Simply stated, spending more time inside the GroEL cavity does not always directly 
translate into more folded protein.  This observation supports the notion that the 
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unfolding mechanism of GroEL is critical, while the other models predict exactly the 
opposite result.   
In the examination of the role of the GroEL C-terminal tail, the same inverse 
correlation was observed: increasing the cavity lifetime of GroEL corresponded to 
slower folding of RuBisCO.  However, this mutation alters variables other than the 
cavity lifetime.  Removal of the C-terminal tail also abolishes interactions between those 
GroEL residues and the substrate protein.  These interactions are likely important for the 
function of the chaperonin, as the length and character of the C-terminus, which is 
comprised of 23 amino acids, have been maintained throughout evolution.  The mildly 
hydrophobic and intrinsically disordered nature of this C-terminus, combined with the 
visualization of the interaction with substrate proteins, led to the hypothesis that these 
residues in the chaperone represent a binding region outside of the GroEL apical 
domains [424].  This binding site provides for additional interactions with substrate 
proteins outside of the GroEL apical domains [347,424].  One important component of 
this interaction is that it leads to the migration of the substrate protein deeper into the 
cavity, which increases the time required to diffuse away from the chaperone, thus 
improving the probability of encapsulating the substrate protein inside the GroEL-ES 
cavity.  The same interaction that leads to this migration is also critical in unfolding the 
substrate protein during the binding process.  This unfolding of GroEL-bound substrate 
proteins is correlated to productive early folding.  Additionally, changes in the 
subsequent, slower folding processes are observed, indicating that the starting state of a 
protein dictates how a protein can fold.  The concept that not all intermediate 
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conformations are available in every possible folding pathway of a protein has been 
suggested by computational models [431-433].    
 The effects of the GroEL C-terminal tail observed in the folding of RuBisCO are 
also seen in the folding of the substrate protein PepQ, which is a metalloprotease from E. 
coli.  PepQ was chosen for examination as a new model substrate protein, because all 
other model substrate proteins at the time of choice were derived from other organisms 
or do not utilize the chaperone in vivo.  Additionally, PepQ was predicted to require 
GroEL in vivo by two independent studies [89,90].  As no studies had been published on 
the folding of PepQ or a PepQ homolog, and the only research published about this 
protein focused on its enzymology [365], PepQ was a tabula rasa and an ideal target for 
introduction as a new substrate protein.  Folding experiments bore out that PepQ does 
not require the chaperonin in vitro, though its folding rate is massively improved by 
GroEL.  Importantly, unlike RuBisCO, PepQ shows no propensity for aggregation under 
the conditions used, suggesting that the enhancement of its folding is due to another 
mechanism of GroEL.  Like RuBisCO, the binding-driven conformational changes in 
PepQ prior to folding are critical in optimizing the ability of the protein to fold, and the 
GroEL C-terminus has an important role in inducing these conformational changes.  As 
likewise observed with RuBisCO, an early folding process occurs in GroEL-mediated 
folding but is not observed in spontaneous folding or folding mediated by the GroEL C-
terminal truncation mutant. 
For both RuBisCO and PepQ, three distinct effects arise from interactions with 
the GroEL C-terminal tail: the substrate protein adopts a more unfolded conformation 
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prior to folding, the processes by which the protein folds are altered, and folding is 
accelerated.  These changes may appear disconnected, although it is very likely that the 
changes in starting conformation alter the availability of intermediates during the 
folding.  Through this kinetic alteration of the folding landscape, the chaperone-
mediated changes provide a more efficient pathway for productive folding.  Although 
many of the predictions of the cavity confinement model are contested by experimental 
observations, it is impossible to rule out any role for confinement.  For example, the 
explanation of the decrease in the folding rate of both RuBisCO and PepQ in the single-
ring truncation mutant cannot exclude a combined effect of both unfolding and 
confinement.  In fact, confinement inside the GroEL-ES cavity is essential for the 
chaperone-mediated folding of many proteins, but due to its role in folding hundreds of 
different proteins in vivo [89,90], GroEL could not have evolved to make specific, 
beneficial interactions inside the cavity with any of these proteins without potentially 
reducing the enhancement in folding other proteins [224].  With the broad specificity of 
the substrate binding region on the apical domain [157,165], this chaperone retains the 
ability to bind and subsequently unfold virtually all kinetically-trapped or partially-
folded intermediates.  Iterative annealing and unfolding, however, is also insufficient as 
an exclusive mechanism for GroE, as folding without GroES or folding in the presence 
of other chaperones (such as Hsp70s) does not lead to the same extent of stimulation of 
folding.  Although such experiments have not carefully tested the variables of chaperone 
concentration and cycling rate on the protein folding rate, current evidence supports a 
requirement for coupled unfolding and confinement.  Significantly, while this research 
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and other studies highlight the critical role for the active mechanisms of GroEL, many 
GroEL substrate proteins are highly aggregation-prone, and the cell is a crowded 
environment.    
In the context of the cellular environment, proteins benefit from a number of 
different chaperones, although GroEL is unique in isolating substrate proteins in a closed 
cavity.  Examining chaperonin function in the context of the passive model, the GroEL-
ES cavity provides a setting for proteins to fold without the complication of 
intermolecular aggregation.  Aggregation into non-native conformations may not be the 
only intermolecular interaction that is successfully avoided.  Other chaperone systems, 
especially DnaK/DnaJ/GrpE and ClpB in E. coli, are critical in disassembling aggregates 
and unfolding proteins [120,124,197,434]; the latter is a mechanism shared by GroEL.  
In the case of DnaK, multiple chaperones could be bound to the same polypeptide 
simultaneously, which could inhibit folding both locally and globally.  These chaperones 
are likely released only upon the threading of the substrate protein through the chaperone 
ClpB [124,434-436].  For slowly folding proteins, GroEL not only can unfold misfolded 
intermediates, thus resetting the energy landscape, but may also serve to block other 
chaperones from interacting with the folding substrate protein, which could potentially 
be recognized by exposed hydrophobic regions.  In this scenario, GroEL is utilizing a 
well-accepted mechanism for other chaperones – unfolding – and is also coupling the 
existence of this newly unfolded conformation of the substrate protein to the creation of 
an environment in which it can fold without detrimental intermolecular interactions.  
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Here, a passive function for the chaperone is only successful after the utilization of an 
active mechanism. 
This study on the folding of the substrate proteins RuBisCO and PepQ has 
provided observations in support of the active roles of GroEL.  The unfolding action of 
the chaperone clearly benefits the subsequent intracavity folding of the substrate protein.  
The GroEL C-terminal tail, although important in many roles, is critical for modulating 
the unfolding action of the chaperonin, in terms of both magnitude and rate.  Despite the 
observations herein that argue against GroEL simply serving as a passive Anfinsen-cage 
and against substrate protein confinement as the primary mechanistic role for the 
chaperone, evidence supports both of these models as well [189,191,198,437].  It is 
important to acknowledge that all three mechanisms contribute to the folding of the 
proteome, which contains hundreds of proteins.  These proteins experience many 
different folding conditions over the lifetime of the organism and require different forms 
of assistance at different times.  GroEL serves as an equal-opportunity chaperone.   
 
The Future 
 There is much remaining to be studied concerning the role of the C-terminal tail 
of GroEL in stimulating the folding of substrate proteins.  While E. coli has been the 
model organism for Hsp60-mediated folding, many organisms contain variants of GroEL 
with specific alterations to the C-terminus that are important for its function.  
Increasingly, organisms that contain multiple copies of the chaperonin are being 
scrutinized for the roles of each variant of GroEL.  For example, alleles of GroEL 
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homologs containing significantly altered C-terminal sequences have been found in 
cyanobacteria and actinobacteria and shown as essential for viability, biofilm formation 
and pathogenesis [213,226,276].  Alternatively, in the mitochondria of S. cerevisiae, the 
C-terminus of the GroEL homolog contains several interspersed prolines, which are 
absent in the common model organisms elsewhere across the hierarchy of life [255-
260,438-440].  Examining the folding of substrate proteins by these GroEL homologs or 
with E. coli GroEL containing an altered C-terminal sequence may not only provide 
insight as to the specific roles of these alterations on the folding of critical proteins in 
their host organisms, but may also reveal greater detail about the sophisticated allostery 
of the GroEL reaction cycle or the mechanisms by which GroEL folds proteins.  
The ability to examine PepQ folding has been limited by an inability to label the 
protein with fluorescent dyes without greatly perturbing its folding, as well as by a 
cryptic site in PepQ which is unproductively labeled by maleimide-containing dyes.  
Attempts to identify this site by tryptic digest, peptide purification, and mass 
spectrometry have failed, presumably due to an incompatibility of the labeled peptide 
with the MALDI-TOF mass spectrometry method.  Utilization of a different maleimide-
containing dye may yield peptide fragments that can be analyzed by this method.  
Mutating this cryptic site does not solve the challenge that many labeled sites greatly 
perturb folding.  Although many sites have been analyzed, more will need to be tested to 
identify PepQ mutants that can be labeled without this complication.  These mutants will 
allow for the use of intramolecular FRET, which can be used not only to examine the 
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conformation of PepQ bound to GroEL, but also to monitor the folding of the two 
domains of PepQ.   
This capability may offer insight into the structural constraints that make PepQ 
GroEL-dependent when the two other pita-bread fold-containing proteins in E. coli, 
PepP and MetAP, do not require the chaperone.  These three proteins share very high 
structural and sequence homology in the catalytic domain, though they vary substantially 
in the N-terminal domain.  MetAP has an N-terminal domain containing ~30 amino 
acids, while the N-terminal domain of PepQ is comprised of ~160 amino acids 
[255,384].  Individually expressing and purifying these domains may provide insight 
into the GroEL-dependence of PepQ folding.  When coupled with intramolecular FRET, 
the study of these domains could reveal specific details about the intramolecular 
interactions that dominate PepQ folding, both spontaneously and when mediated by 
GroEL.  Attempts to create these constructs have only yielded insoluble or degraded 
proteins, even in the presence of excess chaperone.  Further testing of expression 
conditions and alterations of the constructs may allow for the folding of these domains to 
be analyzed.       
Many other research routes have already been sampled, and some of these 
research areas show some promise.  While the truncation of the GroEL C-terminus leads 
to changes in multiple aspects of chaperone activity, examining the impact of cavity size 
on the folding of substrate proteins through the utilization of GroES homologs that either 
increase or decrease the cavity size may prove to be a less complicated alternative for 
studying the role of substrate protein confinement.  Preliminary work done with gp31, 
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the GroES homolog from bacteriophage T4 that is known to increase the cavity size 
relative to E. coli GroES, showed major alterations in intracavity folding of RuBisCO by 
FRET, though the overall folding rate appeared unchanged.  And despite its ability to 
fold RuBisCO, attempts at studying the GroES homolog from Sulfurospirillum 
deleyianum, which by bioinformatics was predicted to produce a smaller cavity than E. 
coli GroES when bound to GroEL, was complicated by instability of the heptameric 
structure.  Revisiting these GroES homologs may prove fruitful, as both showed 
behavior that was dissimilar to GroES.  Additionally, the use of PepQ as a substrate 
protein does not suffer the same challenges of using RuBisCO, which would make some 
aspects of studying these GroES homologs less difficult. 
 While the study of individual substrate proteins can provide key biochemical 
and biophysical data to support the various models of chaperone function, the chaperone 
interacts with hundreds of proteins in vivo, and the effect of GroEL on any one protein 
cannot be immediately translated to effects on every protein.  To understand the various 
aspects of GroEL across all of its natural substrate proteins, examination of the GroEL 
folding proteome would be ideal.  Alterations to the system, such as introducing 
mutations that have known effects on substrate protein binding, the ATPase activity of 
the chaperone, or the allostery of the machinery, could provide insight into how each of 
these variables impacts the folding of each of the individual proteins that rely on GroEL.  
The initial proteomics study, which examined the folding proteome with and without the 
GroEL C-terminus, showed promise through the early stages and could potentially 
identify proteins that require either the unfolding action or the interactions of the C-
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terminal tail for correct folding.  A similar proteomics study could also be done with the 
GroES homologs to identify proteins that have specific confinement requirements for 
folding.  While such experiments are inherently prone to failure, the potential reward of 
identifying such proteins would cement the various active mechanisms into the dogma of 
GroEL-mediated folding. 
While GroEL has been the object of scientific study for several decades, insights 
into the functioning of the chaperone still provide clues as to the problems that arise 
during protein folding and serve as valuable tools in the study of other proteins.  As a 
tool, GroEL is most commonly used to aid in the expression of proteins, but this 
chaperone is capable of more sophisticated use [441].  For example, recent studies 
utilized GroEL in determining the structure and mechanism of the active anthrax toxin 
[442].  The chaperonin serves as a great implement in other fields, but studying how the 
cell manages and repairs the off-pathway products of protein folding could lead to a new 
prospective for combating protein folding diseases, such as cystic fibrosis, amyotrophic 
lateral sclerosis, and Huntington’s, Alzheimer’s and Parkinson’s diseases.  The leap 
from studying chaperone-mediated protein folding and addressing these ailments may 
seem titanic, but no one knows what the next great breakthrough will be until it happens. 
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